Patent Publication Number: US-9832999-B1

Title: Bicyclic compounds as pest control agents

Description:
CROSS-REFERENCE TO RELATED APPLICATIONS 
     This application is a National Stage entry of International Application No. PCT/EP2015/078051, filed Nov. 30, 2015, which claims priority to European Patent Application No. 14195951.0, filed Dec. 2, 2014. 
     BACKGROUND 
     The present application relates to novel bicyclic compounds, to compositions comprising these compounds, to their use for controlling animal pests and to processes and intermediates for their preparation. 
     DESCRIPTION OF RELATED ART 
     Recently, bicyclic compounds having insecticidal properties have been disclosed (WO 2015/038503 A1). 
     WO 2010/078408 A1 describes the preparation and pharmaceutical use of Raf kinase inhibitors and WO 2013/259064 A1 describes the synthesis of anti-HIV agents and their use for the treatment of HIV infections, which compounds contain, inter alia, an N-substituted 2H-pyrazolo[3,4-b]pyridin-1-yl fragment. WO 2010/056999 describes the preparation of parasiticides containing an N-substituted 2H-pyrazolo[3,4-b]pyridin-1-yl fragment. 
     Modern crop protection compositions have to meet many demands, for example in relation to extent, persistence and spectrum of their action and possible use. Questions of toxicity and of combinability with other active compounds or formulation auxiliaries play a role, as does the question of the expense that the synthesis of an active compound requires. In addition, resistances can occur. For all these reasons alone, the search for novel crop protection compositions cannot be considered complete, and there is a constant need for novel compounds having improved properties compared to the known compounds, at least in relation to individual aspects. 
    
    
     SUMMARY 
     It was an object of the present invention to provide compounds which widen the spectrum of the pesticides under various aspects. 
     The object, and further objects which are not stated explicitly but can be discerned or derived from the connections discussed herein, are achieved by compounds of the formula (I) 
                         
in which
     A represents an A radical from the group consisting of (A-a) to (A-f)   

     
       
         
         
             
             
         
       
         
         
           
             where the broken line represents the bond to the nitrogen atom of the bicyclic system of the formula (I) and 
           
         
         G 1  represents N or C—B 1 , 
         B 1  represents a radical from the group consisting of hydrogen, halogen, cyano, nitro, alkyl, haloalkyl, alkoxy, haloalkoxy and in each case optionally substituted cycloalkyl and cycloalkenyl, 
         B 2  represents a radical from the group consisting of hydrogen, halogen, cyano, nitro, alkyl, haloalkyl, alkoxy, haloalkoxy and in each case optionally substituted cycloalkyl and cycloalkenyl, 
         T represents oxygen or an electron pair, 
         R 2  a) represents a radical from the group consisting of (B-1) to (B-36) 
       
    
     
       
         
         
             
             
         
       
       
         
         
             
             
         
       
       
         
         
             
             
         
       
         
         
           
             where the broken line denotes the bond to the carbon atom of the bicyclic system of the formula (I), or 
           
         
         R 2  b) represents a D radical from the group consisting of (D-1) to (D-3) 
       
    
     
       
         
         
             
             
         
       
         
         
           
             where the broken line denotes the bond to the carbon atom of the bicyclic system of the formula (I), or 
           
         
         R 2  c) represents a radical of the formula 
       
    
     
       
         
         
             
             
         
       
         
         
           
             where the broken line denotes the bond to the carbon atom of the bicyclic system of the formula (I), or 
           
         
         R 2  d) represents a radical of the formula 
       
    
     
       
         
         
             
             
         
       
         
         
           
             where the broken line denotes the bond to the carbon atom of the bicyclic system of the formula (I), or 
           
         
         R 2  e) represents an F radical from the group consisting of (F-1) to (F-11) 
       
    
                                           
where the broken line denotes the bond to the carbon atom of the bicyclic system of the formula (I), or
     R 2  f) represents a radical from the group consisting of haloalkyl, carboxyl and amino,
       in which   
       G 2  represents hydrogen or a radical from the group consisting of halogen, nitro, amino, cyano, alkylamino, haloalkylamino, dialkylamino, alkyl, haloalkyl, alkoxycarbonylalkyl, saturated or unsaturated cycloalkyl which is optionally substituted and optionally interrupted by one or more heteroatoms, cycloalkylalkyl, alkoxy, haloalkoxy, alkoxyalkyl, halogenated alkoxyalkyl, alkylthioalkyl, alkylsulfinylalkyl, alkylsulfonylalkyl, bis(alkoxy)alkyl, bis(haloalkoxy)alkyl, alkoxy(alkylsulfanyl)alkyl, alkoxy(alkylsulfinyl)alkyl, alkoxy(alkylsulfonyl)alkyl, bis(alkylsulfanyl)alkyl, bis(haloalkylsulfanyl)alkyl, bis(hydroxyalkylsulfanyl)alkyl, alkoxycarbonyl, alkoxycarbonylalkyl, alpha-hydroxyiminoalkoxycarbonylalkyl, alpha-alkoxyiminoalkoxycarbonylalkyl, C(X 2 )NR 3 R 4 , NR 6 R 7 , alkylthio, alkylsulfinyl, alkylsulfonyl, the heterocyclyl radicals dioxanyl, dioxolanyl, dioxepanyl, dioxocanyl, oxathianyl, oxathiolanyl, oxathiepanyl, oxathiocanyl, dithianyl, dithiolanyl, dithiepanyl, dithiocanyl, oxathianyl oxide, oxathiolanyl oxide, oxathiepanyl oxide, oxathiocanyl oxide, oxathianyl dioxide, oxathiolanyl dioxide, oxathiepanyl dioxide, oxathiocanyl dioxide, morpholinyl, triazolinonyl, oxazolinyl, dihydrooxadiazinyl, dihydrodioxazinyl, dihydrooxazolyl, dihydrooxazinyl and pyrazolinonyl (which for their part may be substituted by alkyl, haloalkyl, alkoxy and alkoxyalkyl), phenyl (which for its part may be substituted by halogen, cyano, nitro, alkyl and haloalkyl), the heteroaryl radicals pyridyl, pyridyl N-oxide, pyrimidyl, imidazolyl, pyrazolyl, oxazolyl, thiazolyl, furanyl, thienyl, triazolyl, tetrazolyl, oxadiazolyl, thiadiazolyl, pyrazinyl, triazinyl, tetrazinyl and isoquinolinyl (which for their part may be substituted by halogen, nitro, alkyl, haloalkyl, alkoxy, haloalkoxy, alkoxyalkyl, alkylthio, alkylthioalkyl and cycloalkyl) and the heteroarylalkyl radicals triazolylalkyl, pyridylalkyl, pyrimidylalkyl and oxadiazolylalkyl (which for their part may be substituted by halogen and alkyl),
       or   
       G 2  represents a C radical from the group consisting of (C-1) to (C-9)   

     
       
         
         
             
             
         
       
         
         
           
             where the broken line denotes the bond to the radicals (B-1) to (B-36), 
           
         
         X represents oxygen or sulfur, 
         X 1  represents a radical from the group consisting of hydrogen, halogen, cyano, nitro, alkyl, haloalkyl, cycloalkyl, alkoxy and haloalkoxy, 
         X 2  represents oxygen, sulfur, NR 5  or NOH, 
         L represents oxygen or sulfur, 
         V—Z represents R 24 CH—CHR 25  or R 24 C═CR 25 , 
         n represents 1 or 2, 
         m represents 1, 2, 3 or 4, 
         R represents NR 18 R 19 , or represents an in each case optionally substituted radical from the group consisting of alkyl, alkenyl, alkynyl, alkoxyalkyl, alkyl-S-alkyl, alkyl-S(O)-alkyl, alkyl-S(O) 2 -alkyl, R 18 —CO-alkyl, NR 18 R 19 —CO-alkyl, cycloalkyl, cycloalkenyl, cycloalkylalkyl, cycloalkenylalkyl, heterocyclyl, heterocyclylalkyl, phenyl, phenylalkyl, hetaryl and hetarylalkyl, 
         R 3  represents hydrogen or alkyl, 
         R 4  represents a radical from the group consisting of hydrogen, alkyl, haloalkyl, cyanoalkyl, alkynyl, cycloalkyl, cycloalkylalkyl, alkoxyalkyl, alkoxycarbonyl, alkoxycarbonylalkyl, alkylthioalkyl, alkylsulfinylalkyl, alkylsulfonylalkyl, aryl, arylalkyl and hetarylalkyl, 
         R 5  represents a radical from the group consisting of hydrogen, alkyl, haloalkyl, cyanoalkyl, alkynyl, cycloalkyl, cycloalkylalkyl, alkoxyalkyl, alkoxycarbonyl, alkoxycarbonylalkyl, alkylthioalkyl, aryl, arylalkyl and hetarylalkyl, or 
         R 3  and R 4  together with the nitrogen atom to which they are attached form a ring which may contain one or more further heteroatoms from the group consisting of nitrogen, oxygen and sulfur, or 
         R 3  and R 5  together with the nitrogen atoms to which they are attached form a ring, 
         R 6  represents hydrogen or alkyl, 
         R 7  represents a radical from the group consisting of hydrogen, alkyl, haloalkyl, cyanoalkyl, alkynyl, cycloalkyl, cycloalkylalkyl, alkoxy, haloalkoxy, alkoxyalkyl, alkylthioalkyl, alkylsulfinylalkyl, alkylsulfonylalkyl, alkoxycarbonyl, alkoxycarbonylalkyl, alkylthioalkyl, aryl, arylalkyl and hetarylalkyl, or 
         R 6  and R 7  together with the nitrogen atom to which they are attached form a ring which may contain one or more further heteroatoms from the group consisting of nitrogen, oxygen and sulfur, 
         R 8  represents a radical from the group consisting of hydrogen, alkyl, haloalkyl, cyanoalkyl, alkoxy, haloalkoxy, alkenyl, alkoxyalkyl, in each case optionally halogen-substituted alkylcarbonyl and alkylsulfonyl, optionally halogen-substituted alkoxycarbonyl, optionally halogen-, alkyl-, alkoxy-, haloalkyl- and cyano-substituted cycloalkylcarbonyl, or a cation, or an optionally alkyl- or arylalkyl-substituted ammonium ion, 
         R 9  represents a radical from the group consisting of in each case optionally substituted alkyl, alkenyl and alkynyl, in each case optionally substituted cycloalkyl, cycloalkylalkyl and cycloalkenyl, in which the rings may contain at least one heteroatom from the group consisting of sulfur, oxygen (where oxygen atoms must not be directly adjacent to one another) and nitrogen, in each case optionally substituted aryl, heteroaryl, arylalkyl and heteroarylalkyl and an optionally substituted amino group, 
         R 8  and R 9  in the radicals (C-1) and (F-1) may also form, together with the N—S(O)n group to which they are attached, a saturated or unsaturated and optionally substituted 4- to 8-membered ring which may contain one or more further heteroatoms from the group consisting of sulfur, oxygen (where oxygen atoms must not be directly adjacent to one another) and nitrogen and/or at least one carbonyl group, 
         R 10  represents hydrogen or alkyl, 
         R 8  and R 10  in the radicals (C-2) and (F-2), together with the nitrogen atoms to which they are attached, may also be a saturated or unsaturated and optionally substituted 4- to 8-membered ring which may contain at least one further heteroatom from the group consisting of sulfur, oxygen (where oxygen atoms must not be directly adjacent to one another) and nitrogen and/or at least one carbonyl group, 
         R 9  and R 10  in the radicals (C-2) and (F-2), together with the N—S(O)n group to which they are attached, may also form a saturated or unsaturated and optionally substituted 4- to 8-membered ring which may contain one or more further heteroatoms from the group consisting of sulfur, oxygen (where oxygen atoms must not be directly adjacent to one another) and nitrogen and/or at least one carbonyl group, 
         R 11  represents an in each case optionally substituted radical from the group consisting of alkyl, alkenyl, alkynyl, alkoxy, alkenyloxy, alkynyloxy, cycloalkyl, cycloalkyloxy, cycloalkenyloxy, cycloalkylalkoxy, alkylthio, alkenylthio, phenoxy, phenylthio, benzyloxy, benzylthio, heteroaryloxy, heteroarylthio, heteroarylalkoxy and heteroarylalkylthio, 
         R 12  represents an in each case optionally substituted radical from the group consisting of alkyl, alkenyl, alkynyl, alkoxy, alkenyloxy, alkynyloxy, cycloalkyl, cycloalkyloxy, cycloalkenyloxy, cycloalkylalkoxy, alkylthio, alkenylthio, phenoxy, phenylthio, benzyloxy, benzylthio, heteroaryloxy, heteroarylthio, heteroarylalkoxy and heteroarylalkylthio, 
         R 11  and R 12  in the radicals (C-3) and (F-3), together with the phosphorus atom to which they are attached, may also form a saturated or unsaturated and optionally substituted 5- to 7-membered ring which may contain one or two heteroatoms from the group consisting of oxygen (where oxygen atoms must not be directly adjacent to one another) and sulfur, 
         R 13  represents an in each case optionally substituted radical from the group consisting of alkyl, alkenyl, alkynyl, phenyl and phenylalkyl, 
         R 14  represents an in each case optionally substituted radical from the group consisting of alkyl, alkenyl, alkynyl, phenyl and phenylalkyl, 
         R 15  represents a radical from the group consisting of in each case optionally substituted alkyl, alkenyl and alkynyl, in each case optionally substituted cycloalkyl, cycloalkylalkyl and cycloalkenyl, in which the rings may contain at least one heteroatom from the group consisting of sulfur, oxygen (where oxygen atoms must not be directly adjacent to one another) and nitrogen, in each case optionally substituted aryl, heteroaryl, arylalkyl and heteroarylalkyl and an optionally substituted amino group, 
         R 8  and R 15  in the radicals (C-6) and (F-6), together with the N—S(O)n group to which they are attached, may also form a saturated or unsaturated and optionally substituted 4- to 8-membered ring which may contain one or more further heteroatoms from the group consisting of sulfur, oxygen (where oxygen atoms must not be directly adjacent to one another) and nitrogen and/or at least one carbonyl group, 
         R 16  represents a radical from the group consisting of hydrogen, in each case optionally substituted alkyl, alkoxy, alkenyl and alkynyl, in each case optionally substituted cycloalkyl, cycloalkylalkyl and cycloalkenyl, in which the rings may contain at least one heteroatom from the group consisting of sulfur, oxygen (where oxygen atoms must not be directly adjacent to one another) and nitrogen, in each case optionally substituted aryl, heteroaryl, arylalkyl and heteroarylalkyl and an optionally substituted amino group, 
       
    
     R 8  and R 16  in the radicals (C-7) and (F-7), together with the nitrogen atom to which they are attached, may also form a saturated or unsaturated and optionally substituted 4- to 8-membered ring which may contain one or more further heteroatoms from the group consisting of sulfur, oxygen (where oxygen atoms must not be directly adjacent to one another) and nitrogen and/or at least one carbonyl group,
     R 17  represents a radical from the group consisting of in each case optionally substituted alkyl, alkoxy, alkenyl and alkynyl, in each case optionally substituted cycloalkyl, cycloalkylalkyl and cycloalkenyl, in which the rings may contain at least one heteroatom from the group consisting of sulfur, oxygen (where oxygen atoms must not be directly adjacent to one another) and nitrogen, in each case optionally substituted aryl, heteroaryl, arylalkyl and heteroarylalkyl and an optionally substituted amino group,   R 8  and R 17  in the radicals (C-8) and (F-8), together with the N—C(X) group to which they are attached, may also form a saturated or unsaturated and optionally substituted 4- to 8-membered ring which may contain one or more further heteroatoms from the group consisting of sulfur, oxygen (where oxygen atoms must not be directly adjacent to one another) and nitrogen and/or at least one carbonyl group,   R 18  represents a radical from the group consisting of hydrogen, hydroxy, in each case optionally substituted alkyl, alkoxy, alkoxyalkyl, alkylthioalkyl, alkylsulfinylalkyl, alkylsulfonylalkyl, alkylcarbonyl, alkoxycarbonyl, alkenyl and alkynyl, in each case optionally substituted cycloalkyl, cycloalkylalkyl, cycloalkenyl and cycloalkenylalkyl, in which the rings may contain at least one heteroatom from the group consisting of sulfur, oxygen (where oxygen atoms must not be directly adjacent to one another) and nitrogen, in each case optionally substituted aryl, arylalkyl, heteroaryl and heteroarylalkyl and an optionally substituted amino group,   R 19  represents a radical from the group consisting of hydrogen, represents an alkali metal or alkaline earth metal ion or represents an ammonium ion which is optionally mono- to tetrasubstituted by C 1 -C 4 -alkyl or represents an in each case optionally halogen- or cyano-substituted alkyl, alkoxy, alkoxyalkyl, alkylthioalkyl, alkylsulfinylalkyl, alkylsulfonylalkyl radical,   Y 1  and Y 2  independently of one another represent C═O or S(O) 2 ,   Y 3  represents a radical from the group consisting of hydrogen, halogen, cyano, alkyl, cycloalkyl, haloalkyl, alkoxy, haloalkoxy and NR 20 R 21 ,   W represents a radical from the group consisting of O, S, SO and SO 2 ,   R 22  represents a radical from the group consisting of alkyl, optionally halogen-, carbamoyl-, thiocarbamoyl- or cyano-substituted cycloalkyl, haloalkyl, alkoxy, haloalkoxy, alkoxyalkyloxy, alkylthio, alkylsulfinyl, alkylsulfonyl, haloalkylthio, haloalkylsulfinyl, haloalkylsulfonyl, alkylthioalkyl, alkylsulfinylalkyl, alkylsulfonylalkyl, alkylthioalkyloxy, alkylsulfinylalkyloxy, alkylsulfonylalkyloxy, haloalkylthioalkyl, halogenalkylsulfinylalkyl, haloalkylsulfonylalkyl, alkylthioalkenyl, alkylsulfinylalkenyl, alkylsulfonylalkenyl, alkenylthioalkyl, alkenylsulfinylalkyl, alkenylsulfonylalkyl, alkylcarbonylalkyl, haloalkylcarbonylalkyl, alkoxyalkyl, haloalkoxyalkyl, alkoxycarbonylalkyl, haloalkoxycarbonylalkyl, alkylaminosulfonyl, di(alkylamino)sulfonyl, or,
       in the case R 2 =d),   
       R 22  also represents optionally substituted aryl or represents an E radical from the group consisting of E-1 to E-51   

     
       
         
         
             
             
         
       
       
         
         
             
             
         
       
       
         
         
             
             
         
       
       
         
         
             
             
         
       
       
         
         
             
             
         
       
         
         R 20  represents a radical from the group consisting of hydrogen, halogen, cyano, nitro, amino, hydroxy and in each case optionally substituted alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, alkoxy, alkenyloxy, alkynyloxy, cycloalkyloxy, alkylcarbony, loxy, alkenylcarbonyloxy, alkynylcarbonyloxy, cycloalkylcarbonyloxy, alkoxycarbonyloxy, alkylsulfonyloxy, alkylamino, alkenylamino, alkynylamino, cycloalkylamino, alkylthio, haloalkylthio, alkenylthio, alkynylthio, cycloalkylthio, alkylsulfinyl, alkylsulfonyl, alkylcarbonyl, alkoxyiminoalkyl, alkoxycarbonyl, aminocarbonyl, alkylaminocarbonyl, dialkylaminocarbonyl, aminothiocarbonyl, alkylaminosulfonyl, alkylsulfonylamino, alkylcarbonylamino, alkenylcarbonylamino, alkynylcarbonylamino, cycloalkylcarbonylamino, alkoxycarbonylamino, alkylthiocarbonylamino, bicycloalkyl, aryl, aryloxy, heteroaryl and heteroaryloxy, where the substituents are independently of one another selected from halogen, cyano, nitro, hydroxy, amino, alkyl and haloalkyl, 
         R 21  represents a radical from the group consisting of hydrogen, alkyl, cycloalkyl, haloalkyl, alkenyl, alkynyl, cycloalkylalkyl, cyanoalkyl, alkylcarbonyl, alkenylcarbonyl, haloalkylcarbonyl, haloalkenylcarbonyl, alkoxyalkyl, alkoxycarbonyl, alkylsulfonyl and haloalkylsulfonyl, 
         R 23  represents a radical from the group consisting of hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, alkoxy, alkenyloxy, alkynyloxy, cycloalkyloxy, alkylthioalkyl, alkenylthioalkyl, cyanoalkyl, alkoxyalkyl and 
         R 24  represents hydrogen or an in each case optionally substituted radical from the group consisting of alkyl, alkenyl, alkynyl, phenyl and phenylalkyl and 
         R 25  represents hydrogen or an in each case optionally substituted radical from the group consisting of alkyl, alkenyl, alkynyl, phenyl and phenylalkyl, 
         R 27  represents hydrogen or alkyl and 
         R 26  represents a radical from the group consisting of hydrogen, alkyl, haloalkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, alkoxyalkyl, alkylthioalkyl, alkylsulfinylalkyl, alkylsulfonylalkyl and cyanoalkyl. 
       
    
     It has been additionally found that the compounds of the formula (I) have good efficacy as pesticides, for example against arthropods and especially insects, and additionally generally have very good compatibility with plants, especially crop plants, and/or have favourable toxicological and/or favourable environmentally relevant properties. 
     Range of preference (1): Preference is given to compounds of the formula (I) in which
     A represents a radical from the group consisting of (A-a), (A-b) and (A-f)   

     
       
         
         
             
             
         
       
         
         
           
             where the broken line represents the bond to the nitrogen atom of the bicyclic system of the formula (I) and 
           
         
         G 1  represents N or C—B 1 . 
         B 1  represents a radical from the group consisting of hydrogen, halogen, C 1 -C 6 -alkyl and C 1 -C 4 -haloalkyl, 
         B 2  represents a radical from the group consisting of hydrogen, halogen, C 1 -C 6 -alkyl and C 1 -C 4 -haloalkyl, 
         T represents oxygen or an electron pair, 
         R 2  a) represents a radical from the group consisting of (B-1) to (B-36) 
       
    
     
       
         
         
             
             
         
       
       
         
         
             
             
         
       
       
         
         
             
             
         
       
         
         
           
             where the broken line denotes the bond to the carbon atom of the bicyclic system of the formula (I), or 
           
         
         R 2  b) represents a D radical from the group consisting of (D-1) to (D-3) 
       
    
     
       
         
         
             
             
         
       
         
         
           
             where the broken line denotes the bond to the carbon atom of the bicyclic system of the formula (I), or 
           
         
         R 2  c) represents a radical of the formula 
       
    
     
       
         
         
             
             
         
       
         
         
           
             where the broken line denotes the bond to the carbon atom of the bicyclic system of the formula (I), or 
           
         
         R 2  d) represents a radical of the formula 
       
    
     
       
         
         
             
             
         
       
         
         
           
             where the broken line denotes the bond to the carbon atom of the bicyclic system of the formula (I), or 
           
         
         R 2  e) represents a radical from the group consisting of (F-1), (F-8), (F-10) and (F-11) 
       
    
     
       
         
         
             
             
         
       
         
         
           
             where the broken line denotes the bond to the carbon atom of the bicyclic system of the formula (I), 
           
         
         R 2  f) represents a radical from the group consisting of C 1 -C 6 -haloalkyl, carboxyl and amino, in which 
         G 2  represents hydrogen or represents a radical from the group consisting of halogen, nitro, amino, cyano, C 1 -C 4 -alkylamino, halo-C 1 -C 4 -alkylamino, di-(C 1 -C 4 -alkyl)-amino, C 1 -C 4 -alkyl, halo-C 1 -C 4 -alkyl, C 1 -C 4 -alkoxycarbonyl-C 1 -C 4 -alkyl, C 3 -C 6 -cycloalkyl, C 3 -C 6 -cycloalkenyl, C 3 -C 6 -cycloalkyl-C 1 -C 4 -alkyl, C 1 -C 4 -alkoxy, halo-C 1 -C 4 -alkoxy, C 1 -C 4 -alkoxy-C 1 -C 4 -alkyl, halogenated C 1 -C 4 -alkoxy-C 1 -C 4 -alkyl, bis(C 1 -C 4 -alkoxy)-C 1 -C 4 -alkyl, bis(halo-C 1 -C 4 -alkoxy)-C 1 -C 4 -alkyl, C 1 -C 4 -alkoxy-(C 1 -C 4 -alkylsulfanyl)-C 1 -C 4 -alkyl, C 1 -C 4 -alkoxy-(C 1 -C 4 -alkylsulfinyl)-C 1 -C 4 -alkyl, C 1 -C 4 -alkoxy-(C 1 -C 4 -alkylsulfonyl)-C 1 -C 4 -alkyl, bis(C 1 -C 4 -alkylsulfanyl)-C 1 -C 4 -alkyl, bis(halo-C 1 -C 4 -alkylsulfanyl)-C 1 -C 4 -alkyl, bis(hydroxy-C 1 -C 4 -alkylsulfanyl)-C 1 -C 4 -alkyl, C 1 -C 4 -alkoxycarbonyl, C 1 -C 4 -alkoxycarbonyl-C 1 -C 4 -alkyl, alpha-hydroxyimino-C 1 -C 4 -alkoxycarbonyl-C 1 -C 4 -alkyl, alpha-C 1 -C 4 -alkoxyimino-C 1 -C 4 -alkoxycarbonyl-C 1 -C 4 -alkyl, C(X 2 )NR 3 R 4 , NR 6 R 7 , C 1 -C 4 -alkylthio, C 1 -C 4 -alkylsulfinyl, C 1 -C 4 -alkylsulfonyl, the heterocyclyl radicals dioxanyl, dioxolanyl, dioxepanyl, dioxocanyl, oxathianyl, oxathiolanyl, oxathiepanyl, oxathiocanyl, dithianyl, dithiolanyl, dithiepanyl, dithiocanyl, oxathianyl oxide, oxathiolanyl oxide, oxathiepanyl oxide, oxathiocanyl oxide, oxathianyl dioxide, oxathiolanyl dioxide, oxathiepanyl dioxide, oxathiocanyl dioxide, morpholinyl, triazolinonyl, oxazolinyl, dihydrooxadiazinyl, dihydrodioxazinyl, dihydrooxazolyl, dihydrooxazinyl and pyrazolinonyl (which for their part may be substituted by C 1 -C 4 -alkyl, halo-C 1 -C 4 -alkyl, C 1 -C 4 -alkoxy and C 1 -C 4 -alkoxy-C 1 -C 4 -alkyl), phenyl (which for its part may be substituted by halogen, cyano, nitro, C 1 -C 4 -alkyl and halo-C 1 -C 4 -alkyl), the heteroaryl radicals pyridyl, pyridyl N-oxide, pyrimidyl, imidazolyl, pyrazolyl, oxazolyl, thiazolyl, furanyl, thienyl, triazolyl, tetrazolyl, oxadiazolyl, thiadiazolyl, pyrazinyl, triazinyl, tetrazinyl and isoquinolinyl (which for their part may be substituted by halogen, nitro, C 1 -C 4 -alkyl, halo-C 1 -C 4 -alkyl, C 1 -C 4 -alkoxy, halo-C 1 -C 4 -alkoxy, C 1 -C 4 -alkoxy-C 1 -C 4 -alkyl, C 1 -C 4 -alkylthio, C 1 -C 4 -alkylthio-C 1 -C 4 -alkyl and C 3 -C 6 -cycloalkyl) and the heteroaryl-C 1 -C 4 -alkyl radicals triazolyl-C 1 -C 4 -alkyl, pyridyl-C 1 -C 4 -alkyl, pyrimidyl-C 1 -C 4 -alkyl and oxadiazolyl-C 1 -C 4 -alkyl (which for their part may be substituted by halogen and C 1 -C 4 -alkyl),
       or   
     
         G 2  represents a C radical from the group consisting of (C-1) and (C-6) to (C-9) 
       
    
     
       
         
         
             
             
         
       
         
         
           
             where the broken line denotes the bond to the radicals (B-1) to (B-36), 
           
         
         X represents oxygen or sulfur, 
         X 1  represents a radical from the group consisting of hydrogen, halogen, cyano, nitro, C 1 -C 6 -alkyl, C 1 -C 6 -haloalkyl, C 3 -C 6 -cycloalkyl, C 1 -C 6 -alkoxy and C 1 -C 6 -haloalkoxy, 
         X 2  represents oxygen, sulfur, NR 5  or NOH, 
         V—Z represents R 24 CH—CHR 25  or R 24 C═CR 25 , 
         n represents 1 or 2, 
         R represents NR 18 R 19  or represents C 1 -C 6 -alkyl, C 3 -C 6 -alkenyl, C 3 -C 6 -alkynyl, C 1 -C 6 -alkoxy-C 1 -C 4 -alkyl, C 1 -C 6 -alkyl-S—C 1 -C 4 -alkyl, C 1 -C 6 -alkyl-S(O)—C 1 -C 4 -alkyl, C 1 -C 6 -alkyl-S(O) 2 —C 1 -C 4 -alkyl, each of which is optionally substituted by halogen, oxygen (leads to C═O) or cyano, represents R 18 —CO—C 1 -C 4 -alkyl, represents NR 18 R 19 —CO—C 1 -C 4 -alkyl, represents C 3 -C 6 -cycloalkyl which is optionally mono- or disubstituted by oxygen (leads to C═O), C 1 -C 4 -alkyl, C 3 -C 8 -cycloalkyl, C 1 -C 4 -alkoxy and C 1 -C 4 -haloalkyl, represents C 3 -C 8 -cycloalkenyl which is optionally mono- or disubstituted by oxygen (leads to C═O), C 1 -C 4 -alkyl, C 3 -C 6 -cycloalkyl, C 1 -C 4 -alkoxy and C 1 -C 4 -haloalkyl, represents C 3 -C 6 -cycloalkyl-C 1 -C 4 -alkyl which is optionally mono- or disubstituted by oxygen (leads to C═O), C 1 -C 4 -alkyl, C 3 -C 6 -cycloalkyl, C 1 -C 4 -alkoxy and C 1 -C 4 -haloalkyl, represents C 3 -C 6 -cycloalkenyl-C 1 -C 4 -alkyl which is optionally mono- or disubstituted by oxygen (leads to C═O), C 1 -C 4 -alkyl, C 3 -C 6 -cycloalkyl, C 1 -C 4 -alkoxy and C 1 -C 4 -haloalkyl, represents heterocyclyl which is optionally mono- or disubstituted by oxygen (leads to C═O), C 1 -C 4 -alkyl, C 3 -C 6 -cycloalkyl, C 1 -C 4 -alkoxy and C 1 -C 4 -haloalkyl, represents heterocyclyl-C 1 -C 4 -alkyl which is optionally mono- or disubstituted by oxygen (leads to C═O), C 1 -C 4 -alkyl, C 3 -C 6 -cycloalkyl, C 1 -C 4 -alkoxy and C 1 -C 4 -haloalkyl, or represents phenyl, phenyl-C 1 -C 4 -alkyl, hetaryl and hetaryl-C 1 -C 4 -alkyl, each of which is optionally mono- to trisubstituted by halogen, cyano, C 1 -C 4 -alkyl, C 1 -C 4 -haloalkyl, C 3 -C 6 -cycloalkyl, C 1 -C 4 -alkoxy or C 1 -C 4 -haloalkoxy, 
         R 3  represents hydrogen or C 1 -C 6 -alkyl, 
         R 4  represents a radical from the group consisting of hydrogen, C 1 -C 4 -alkyl, halo-C 1 -C 4 -alkyl, cyano-C 1 -C 4 -alkyl, C 2 -C 4 -alkynyl, C 3 -C 6 -cycloalkyl, C 3 -C 6 -cycloalkyl-C 1 -C 4 -alkyl, C 1 -C 4 -alkoxy-C 1 -C 4 -alkyl, C 1 -C 4 -alkoxycarbonyl, C 1 -C 4 -alkoxycarbonyl-C 1 -C 4 -alkyl, C 1 -C 4 -alkylthio-C 1 -C 4 -alkyl, aryl, aryl-C 1 -C 4 -alkyl and hetaryl-C 1 -C 4 -alkyl, 
         R 5  represents a radical from the group consisting of hydrogen, C 1 -C 4 -alkyl, halo-C 1 -C 4 -alkyl, cyano-C 1 -C 4 -alkyl, C 2 -C 4 -alkynyl, C 3 -C 6 -cycloalkyl, C 3 -C 6 -cycloalkyl-C 1 -C 4 -alkyl, C 1 -C 4 -alkoxy-C 1 -C 4 -alkyl, C 1 -C 4 -alkoxycarbonyl, C 1 -C 4 -alkoxycarbonyl-C 1 -C 4 -alkyl, C 1 -C 4 -alkylthio-C 1 -C 4 -alkyl, aryl, aryl-C 1 -C 4 -alkyl and hetaryl-C 1 -C 4 -alkyl, or 
         R 3  and R 4  together with the nitrogen atom to which they are attached form a 4- to 7-membered ring which may contain one or two further heteroatoms from the group consisting of nitrogen, oxygen and sulfur (where oxygen and sulfur atoms must not be directly adjacent to one another), 
         R 6  represents hydrogen or C 1 -C 4 -alkyl, 
         R 7  represents a radical from the group consisting of hydrogen, C 1 -C 4 -alkyl, halo-C 1 -C 4 -alkyl, cyano-C 1 -C 4 -alkyl, C 2 -C 4 -alkynyl, C 3 -C 6 -cycloalkyl, C 3 -C 4 -cycloalkyl-C 1 -C 4 -alkyl, C 1 -C 4 -alkoxy, halo-C 1 -C 4 -alkoxy, C 1 -C 4 -alkoxy-C 1 -C 4 -alkyl, C 1 -C 4 -alkoxycarbonyl, C 1 -C 4 -alkoxycarbonyl-C 1 -C 4 -alkyl, C 1 -C 4 -alkylthio-C 1 -C 4 -alkyl, aryl, aryl-C 1 -C 4 -alkyl and hetaryl-C 1 -C 4 -alkyl, or 
         R 6  and R 7  together with the nitrogen atom to which they are attached form a 4- to 7-membered ring which may contain one or two further heteroatoms from the group consisting of nitrogen, oxygen and sulfur (where oxygen and sulfur atoms must not be directly adjacent to one another), 
         R 8  represents a radical from the group consisting of hydrogen, C 1 -C 6 -alkyl, C 1 -C 6 -haloalkyl, cyano-C 1 -C 6 -alkyl, C 1 -C 6 -alkoxy, C 1 -C 6 -haloalkoxy, C 2 -C 6 -alkenyl, C 1 -C 6 -alkoxy-C 1 -C 6 -alkyl, in each case optionally halogen-substituted C 1 -C 6 -alkylcarbonyl and C 1 -C 6 -alkylsulfonyl, optionally halogen-substituted C 1 -C 6 -alkoxycarbonyl, optionally halogen-, C 1 -C 6 -alkyl-, C 1 -C 6 -alkoxy-, C 1 -C 6 -haloalkyl- and cyano-substituted C 3 -C 6 -cycloalkylcarbonyl, or represents a cation or an optionally C 1 -C 6 -alkyl- or aryl-C 1 -C 6 -alkyl-substituted ammonium ion, 
         R 9  represents a radical from the group consisting of in each case optionally halogen-, C 1 -C 6 -alkoxy-, C 1 -C 6 -haloalkoxy-, C 1 -C 6 -alkylthio-, C 1 -C 6 -haloalkylthio-, C 1 -C 6 -alkylsulfinyl-, C 1 -C 6 -haloalkylsulfinyl-, C 1 -C 6 -alkylsulfonyl- and C 1 -C 6 -haloalkylsulfonyl-substituted C 1 -C 6 -alkyl, C 2 -C 6 -alkenyl and C 2 -C 6 -alkynyl, in each case optionally halogen-, C 1 -C 6 -alkyl-, C 1 -C 6 -haloalkyl-, C 1 -C 6 -alkoxy- or C 1 -C 6 -haloalkoxy-substituted C 3 -C 6 -cycloalkyl, C 3 -C 6 -cycloalkyl-C 1 -C 6 -alkyl and C 3 -C 6 -cycloalkenyl, in which one ring member may be replaced by a heteroatom from the group consisting of sulfur, oxygen (where oxygen atoms must not be directly adjacent to one another) and nitrogen (and here in particular represent 
       
    
     
       
         
         
             
             
         
       
         
         
           
             where the arrow in each case marks the bond to the sulfur atom in the (C-1) radical and in the (F-1) radical), in each case optionally halogen-, cyano- (including in the alkyl moiety), nitro-, C 1 -C 6 -alkyl-, C 1 -C 6 -haloalkyl-, C 3 -C 6 -cycloalkyl-, C 1 -C 6 -alkoxy-, C 1 -C 6 -haloalkoxy-, C 1 -C 6 -alkylthio-, C 1 -C 6 -haloalkylthio-, C 1 -C 6 -alkylsulfinyl-, C 1 -C 6 -haloalkylsulfinyl-, C 1 -C 6 -alkylsulfonyl-, C 1 -C 6 -haloalkylsulfonyl-, amino-, C 1 -C 6 -alkylamino-, di(C 1 -C 6 -alkyl)amino-, C 1 -C 6 -alkylcarbonylamino-, C 1 -C 6 -alkoxycarbonylamino-, C 1 -C 6 -alkoxy-C 1 -C 6 -alkyl-, C 1 -C 6 -haloalkoxy-C 1 -C 6 -alkyl, C 2 -C 6 -alkenyl-, C 2 -C 6 -alkynyl-, C 3 -C 6 -cycloalkyl-C 1 -C 6 -alkyl-, C 1 -C 6 -alkylcarbonyl-, C 1 -C 6 -alkoxycarbonyl- or aminocarbonyl-substituted aryl, heteroaryl, aryl-C 1 -C 6 -alkyl, heteroaryl-C 1 -C 6 -alkyl, or is NR′R″ in which R′ and R″ are independently a radical from the group consisting of hydrogen, C 1 -C 6 -alkyl, C 1 -C 6 -haloalkyl, C 3 -C 6 -cycloalkyl, C 1 -C 6 -alkoxy, C 1 -C 6 -alkylcarbonyl and C 1 -C 6 -alkoxycarbonyl, or 
           
         
         R 8  and R 9  in the radical (C-1) and in the radical (F-1), together with the N—S(O) n  group to which they are attached, may also form a saturated or unsaturated and optionally halogen-, C 1 -C 6 -alkyl-, C 1 -C 6 -haloalkyl-, C 1 -C 6 -alkoxy-, C 1 -C 6 -haloalkoxy-substituted 5- to 7-membered ring which may contain one or two heteroatoms from the group consisting of sulfur, oxygen (where oxygen atoms must not be directly adjacent to one another) and nitrogen and/or at least one and preferably one carbonyl group; in particular, R 8  and R 9  together with the N—S(O) n  group to which they are attached may represent a radical from the group consisting of 
       
    
     
       
         
         
             
             
         
       
         
         
           
             (in which the arrow in each case marks the bond to the C(X) group) 
           
         
         R 15  represents a radical from the group consisting of in each case optionally methyl-, cyano-, carbamoyl-substituted C 1 -C 6 -alkyl, C 2 -C 6 -alkenyl and C 2 -C 6 -alkynyl, in each case optionally methyl-, trifluoromethyl-, halogen-, cyano- or carbamoyl-substituted C 3 -C 6 -cycloalkyl, C 3 -C 6 -cycloalkyl-C 1 -C 2 -alkyl and C 3 -C 6 -cycloalkenyl, in which the rings may contain at least one heteroatom from the group consisting of sulfur, oxygen (where oxygen atoms must not be directly adjacent to one another) and nitrogen, in each case optionally C 1 -C 4 -alkyl-, C 1 -C 4 -haloalkyl-, C 1 -C 4 -alkoxy-, C 1 -C 4 -haloalkoxy-, C 1 -C 4 -alkylthio-, C 1 -C 4 -haloalkylthio-, C 1 -C 4 -haloalkylsulfinyl-, C 1 -C 4 -haloalkylsulfonyl-, C 1 -C 4 -alkylamino-, di-(C 1 -C 4 -alkyl)-amino-, halogen-, nitro- or cyano-substituted aryl, heteroaryl, aryl-C 1 -C 4 -alkyl and heteroaryl-C 1 -C 2 -alkyl and an optionally C 1 -C 4 -alkyl-, C 1 -C 4 -alkylcarbonyl-, C 1 -C 4 -alkyl-C 1 -C 4 -alkoxycarbonyl- or C 1 -C 4 -alkylsulfonyl-substituted amino group, 
         R 8  and R 15  in the radical (C-6), together with the N—S(O)n group to which they are attached, may also form a saturated or unsaturated and optionally substituted 4- to 8-membered ring which may contain one or two further heteroatoms from the group consisting of sulfur, oxygen (where oxygen and sulfur atoms must not be directly adjacent to one another) and nitrogen and/or at least one carbonyl group, 
         R 16  represents a radical from the group consisting of hydrogen, in each case optionally methyl-, cyano-, carbamoyl- or carboxyl-substituted C 1 -C 6 -alkyl, C 1 -C 6 -alkoxy, C 2 -C 4 -alkenyl and C 2 -C 4 -alkynyl, in each case optionally halogen-, cyano-, nitro-, C 1 -C 6 -alkyl-, C 1 -C 6 -haloalkyl-, C 3 -C 6 -cycloalkyl-, C 1 -C 6 -alkoxy-, C 1 -C 6 -haloalkoxy-, C 1 -C 6 -alkylthio-, C 1 -C 6 -haloalkylthio-, C 1 -C 6 -alkylsulfinyl-, C 1 -C 6 -haloalkylsulfinyl-, C 1 -C 6 -alkylsulfonyl-, C 1 -C 6 -haloalkylsulfonyl-, amino-, C 1 -C 6 -alkylamino-, di-(C 1 -C 6 -alkyl)amino-, C 1 -C 6 -alkylcarbonylamino-, C 1 -C 6 -alkoxycarbonylamino-, C 2 -C 6 -alkenyl-, C 2 -C 6 -alkynyl- or C 1 -C 6 -alkylcarbonyl-substituted C 3 -C 6 -cycloalkyl, C 3 -C 6 -cycloalkyl-C 1 -C 4 -alkyl and C 3 -C 6 -cycloalkenyl in which the rings may contain at least one heteroatom from the group consisting of sulfur, oxygen (where oxygen atoms must not be directly adjacent to one another) and nitrogen, in each case optionally halogen-, cyano-, nitro-, C 1 -C 6 -alkyl-, C 1 -C 6 -haloalkyl-, C 3 -C 6 -cycloalkyl-, C 1 -C 6 -alkoxy-, C 1 -C 6 -haloalkoxy-, C 1 -C 6 -alkylthio-, C 1 -C 6 -haloalkylthio-, C 1 -C 6 -alkylsulfinyl-, C 1 -C 6 -haloalkylsulfinyl-, C 1 -C 6 -alkylsulfonyl-, C 1 -C 6 -haloalkylsulfonyl-, amino-, C 1 -C 6 -alkylamino-, di-(C 1 -C 6 -alkyl)amino-, C 1 -C 6 -alkylcarbonylamino-, C 1 -C 6 -alkoxycarbonylamino-, C 2 -C 6 -alkenyl-, C 2 -C 6 -alkynyl- or C 1 -C 6 -alkylcarbonyl-substituted aryl, heteroaryl, aryl-C 1 -C 2 -alkyl and heteroaryl-C 1 -C 2 -alkyl and an optionally C 1 -C 6 -alkyl-, C 1 -C 6 -haloalkyl-, C 3 -C 6 -cycloalkyl-, C 1 -C 6 -alkoxy-, C 1 -C 6 -haloalkoxy-, C 1 -C 6 -alkylthio-, C 1 -C 6 -haloalkylthio-, C 1 -C 6 -alkylsulfinyl-, C 1 -C 6 -haloalkylsulfinyl-, C 1 -C 6 -alkylsulfonyl-, C 1 -C 6 -haloalkylsulfonyl-, C 2 -C 6 -alkenyl-, C 2 -C 6 -alkynyl- or C 1 -C 6 -alkylcarbonyl-substituted amino group, 
         R 17  represents a radical from the group consisting of in each case optionally halogen-, C 1 -C 6 -alkoxy-, C 1 -C 6 -haloalkoxy, C 1 -C 6 -alkylthio-, C 1 -C 6 -haloalkylthio-, C 1 -C 6 -alkylsulfinyl-, C 1 -C 6 -haloalkylsulfinyl-, C 1 -C 6 -alkylsulfonyl- or C 1 -C 6 -haloalkylsulfonyl-substituted C 1 -C 6 -alkyl, C 1 -C 6 -alkoxy, C 2 -C 6 -alkenyl and C 2 -C 6 -alkynyl, in each case optionally halogen-, C 1 -C 6 -alkyl-, C 1 -C 6 -haloalkyl-, C 1 -C 6 -alkoxy-, or C 1 -C 6 -haloalkoxy-substituted C 3 -C 6 -cycloalkyl, C 3 -C 6 -cycloalkyl-C 1 -C 6 -alkyl and C 3 -C 6 -cycloalkenyl, N-pyrrolidinyl, N-piperidinyl, N-morpholinyl, N-thiomorpholinyl, N-thiomorpholinyl 1-oxide, N-thiomorpholinyl 1,1-dioxide, N-piperazinyl, N-1-methylpiperazinyl or N-2-oxo-1-methylpiperazinyl, in each case optionally halogen-, cyano- (also in the alkyl moiety), nitro-, C 1 -C 6 -alkyl-, C 1 -C 6 -haloalkyl-, C 3 -C 6 -cycloalkyl-, C 1 -C 6 -alkoxy-, C 1 -C 6 -haloalkoxy-, C 1 -C 6 -alkylthio-, C 1 -C 6 -haloalkylthio-, C 1 -C 6 -alkylsulfinyl-, C 1 -C 6 -haloalkylsulfinyl-, C 1 -C 6 -alkylsulfonyl-, C 1 -C 6 -haloalkylsulfonyl-, amino-, C 1 -C 6 -alkylamino-, di(C 1 -C 6 -alkyl)amino-, C 1 -C 6 -alkylcarbonylamino-, C 1 -C 6 -alkoxycarbonylamino-, C 1 -C 6 -alkoxy-C 1 -C 6 -alkyl-, C 1 -C 6 -haloalkoxy C 1 -C 6 -alkyl, C 2 -C 6 -alkenyl-, C 2 -C 6 -alkynyl-, C 3 -C 6 -cycloalkyl-, C 1 -C 6 -alkyl-, C 1 -C 6 -alkylcarbonyl-, C 1 -C 6 -alkoxycarbonyl- or aminocarbonyl-substituted aryl, heteroaryl, aryl-C 1 -C 6 -alkyl-, heteroaryl-C 1 -C 6 -alkyl or represents NR′R″ in which R′ and R″ independently of one another each represent a radical from the group consisting of hydrogen, C 1 -C 6 -alkyl-, C 1 -C 6 -haloalkyl-, C 3 -C 6 -cycloalkyl, C 1 -C 6 -alkoxy, C 1 -C 6 -alkylcarbonyl and C 1 -C 6 -alkoxycarbonyl, 
         R 8  and R 17  in the radical (C-8) and in the radical (F-8), together with the N—C(X) group to which they are attached, may also form a saturated or unsaturated and optionally halogen-, C 1 -C 6 -alkyl-, C 1 -C 6 -haloalkyl-, C 1 -C 6 -alkoxy-, C 1 -C 6 -haloalkoxy-substituted 5- to 7-membered ring which may contain one or two further heteroatoms from the group consisting of sulfur, oxygen (where oxygen atoms must not be directly adjacent to one another) and nitrogen and/or one carbonyl group; in particular, R 8  and R 17  together with the N—C(X) group to which they are attached may represent a radical from the group consisting of 
       
    
     
       
         
         
             
             
         
       
         
         
           
             (where the arrow in each case denotes the bond to the sulfur atom in the radical (C-8) and in the radical (F-8)), 
           
         
         R 18  represents a radical from the group consisting of hydrogen, hydroxy, of C 1 -C 6 -alkyl, C 1 -C 6 -alkoxy, C 1 -C 6 -alkoxy-C 1 -C 4 -alkyl, C 1 -C 6 -alkyl-S—C 1 -C 4 -alkyl, C 1 -C 6 -alkyl-S(O)—C 1 -C 4 -alkyl, C 1 -C 6 - alkyl-S(O) 2 —C 1 -C 4 -alkyl, C 1 -C 6 -alkylcarbonyl, C 1 -C 6 -alkoxycarbonyl, C 3 -C 6 -cycloalkyl, C 3 -C 6 -cycloalkenyl, C 3 -C 6 -cycloalkyl-C 1 -C 3 -alkyl, C 3 -C 6 -cycloalkenyl-C 1 -C 3 -alkyl, heterocyclyl, heterocyclyl-C 1 -C 3 -alkyl, each of which is optionally mono- or polysubstituted by halogen or mono- or disubstituted by cyano, and phenyl, phenyl-C 1 -C 3 -alkyl, hetaryl and hetaryl-C 1 -C 3 -alkyl, each of which is optionally mono- to tetrasubstituted by C 1 -C 4 -alkyl, C 1 -C 4 -haloalkyl, C 1 -C 4 -alkoxy, C 1 -C 4 -haloalkoxy, C 3 -C 6 -cycloalkyl, halogen or cyano, 
         R 19  represents hydrogen, an alkali or alkaline earth metal ion, or represents an ammonium ion which is optionally mono- to tetrasubstituted by C 1 -C 4 -alkyl, or represents a radical from the group consisting of C 1 -C 4 -alkyl, C 1 -C 4 -alkoxy, C 1 -C 4 -alkoxy-C 1 -C 4 -alkyl, C 1 -C 4 -alkyl-S—C 1 -C 4 -alkyl, C 1 -C 4 -alkyl-S(O)—C 1 -C 4 -alkyl and C 1 -C 4 -alkyl-S(O) 2 —C 1 -C 4 -alkyl, each of which is optionally mono- or polysubstituted by halogen or mono- or disubstituted by cyano, 
         Y 3  represents a radical from the group consisting of hydrogen, halogen, cyano, C 1 -C 6 -alkyl, C 1 -C 6 -haloalkyl, C 3 -C 6 -cycloalkyl, C 1 -C 6 -alkoxy, C 1 -C 6 -haloalkoxy and NR 20 R 21 , 
         W represents a radical from the group consisting of O, S, SO and SO 2 , 
         R 22  represents a radical from the group consisting of C 1 -C 6 -alkyl, optionally halogen-, carbamoyl-, thiocarbamoyl- or cyano-substituted C 3 -C 6 -cycloalkyl, C 1 -C 6 -haloalkyl, C 1 -C 6 -alkoxy, C 1 -C 4 -haloalkoxy, C 1 -C 6 -alkoxy, —C 1 -C 6 -alkyloxy, C 1 -C 4 -alkylthio, C 1 -C 4 -alkylsulfinyl, C 1 -C 4 -alkylsulfonyl, C 1 -C 4 -haloalkylthio, C 1 -C 4 -haloalkylsulfinyl, C 1 -C 4 -haloalkylsulfonyl, C 1 -C 4 -alkylthio-C 1 -C 4 -alkyl, C 1 -C 4 -alkylsulfinyl-C 1 -C 4 -alkyl, C 1 -C 4 -alkylsulfonyl-C 1 -C 4 -alkyl, C 1 -C 4 -alkylthio-C 1 -C 4 -alkyloxy, C 1 -C 4 -alkylsulfinyl-C 1 -C 4 -alkyloxy, C 1 -C 4 -alkylsulfonyl-C 1 -C 4 -alkyloxy, C 1 -C 4 -haloalkylthio-C 1 -C 4 -alkyl, C 1 -C 4 -haloalkylsulfinyl-C 1 -C 4 -alkyl, C 1 -C 4 -haloalkylsulfonyl-C 1 -C 4 -alkyl, C 1 -C 4 -alkylthio-C 2 -C 4 -alkenyl, C 1 -C 4 -alkylsulfinyl-C 2 -C 4 -alkenyl, C 1 -C 4 -alkylsulfonyl-C 2 -C 4 -alkenyl, C 2 -C 4 -alkenylthio-C 1 -C 4 -alkyl, C 2 -C 4 -alkenylsulfinyl-C 1 -C 4 -alkyl, C 2 -C 4 -alkenylsulfonyl-C 1 -C 4 -alkyl, C 1 -C 4 -alkylcarbonyl-C 1 -C 4 -alkyl, C 1 -C 4 -haloalkylcarbonyl-C 1 -C 4 -alkyl, C 1 -C 4 -alkoxy-C 1 -C 4 -alkyl, C 1 -C 4 -haloalkoxy-C 1 -C 4 -alkyl, C 1 -C 4 -alkoxycarbonyl-C 1 -C 4 -alkyl, C 1 -C 4 -haloalkoxycarbonyl-C 1 -C 4 -alkyl, C 1 -C 4 -alkylaminosulfonyl, di(C 1 -C 4 -alkyl)aminosulfonyl,
       in the case R 2 =d),   
     
         R 22  also represents optionally halogen-, cyano-, nitro-, amino-, hydroxy-, C 1 -C 6 -alkyl-, C 1 -C 6 -haloalkyl-, C 2 -C 6 -alkenyl-, C 2 -C 6 -alkynyl-, C 3 -C 6 -cycloalkyl-, C 3 -C 6 -alkenyloxy-, C 3 -C 6 -alkynyloxy-, C 1 -C 6 -alkoxy-, C 1 -C 4 -haloalkoxy-, C 1 -C 6 -alkoxycarbonyloxy-, C 1 -C 6 -alkylamino-, C 3 -C 6 -alkenylamino-, C 3 -C 6 -alkynylamino-, C 3 -C 6 -cycloalkylamino-, C 1 -C 6 -alkylthio-, C 1 -C 4 -alkylsulfinyl-, C 1 -C 4 -alkylsulfonyl-, C 3 -C 6 -alkenylthio-, C 3 -C 6 -alkynylthio-, C 3 -C 6 -cycloalkylthio-, C 1 -C 4 -haloalkylthio-, C 1 -C 4 -haloalkylsulfinyl-, C 1 -C 4 -haloalkylsulfonyl-, C 1 -C 6 -alkylcarbonyl-, aminocarbonyl-, C 1 -C 6 -alkylaminocarbonyl-, di-(C 1 -C 6 )-alkylaminocarbonyl-, C 1 -C 6 -alkylcarbonylamino-, C 1 -C 6 -alkylamino- or C 1 -C 6 -dialkylamino-substituted aryl or represents an E radical from the group consisting of E-1 to E-51 
       
    
     
       
         
         
             
             
         
       
       
         
         
             
             
         
       
       
         
         
             
             
         
       
       
         
         
             
             
         
       
       
         
         
             
             
         
       
         
         R 20  represents a radical from the group consisting of hydrogen, halogen, cyano, nitro, amino, hydroxy, C 1 -C 6 -alkyl, C 1 -C 6 -haloalkyl, cyano-C 1 -C 6 -alkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -alkynyl, C 3 -C 6 -cycloalkyl, C 3 -C 6 -cycloalkyl-C 1 -C 6 -alkyl, C 1 -C 6 -alkoxy, C 1 -C 6 -haloalkoxy, C 3 -C 6 -alkenyloxy, C 3 -C 6 -alkynyloxy, C 3 -C 6 -cycloalkyloxy, C 1 -C 6 -alkylcarbonyloxy, C 2 -C 6 -alkenylcarbonyloxy, C 2 -C 6 -alkynylcarbonyloxy, C 3 -C 6 -cycloalkylcarbonyloxy, C 1 -C 6 -alkoxycarbonyloxy, C 1 -C 6 -alkylsulfonyloxy, C 1 -C 6 -alkylamino, C 3 -C 6 -alkenylamino, C 3 -C 6 -alkynylamino, C 3 -C 6 -cycloalkylamino, C 1 -C 6 -alkylthio, C 1 -C 6 -haloalkylthio, C 3 -C 6 -alkenylthio, C 3 -C 6 -alkynylthio, C 3 -C 6 -cycloalkylthio, C 1 -C 6 -alkylsulfinyl, C 1 -C 6 -alkylsulfonyl, C 1 -C 6 -alkylcarbonyl, C 1 -C 6 -alkoxyimino-C 1 -C 6 -alkyl, C 1 -C 6 -alkoxycarbonyl, aminocarbonyl, C 1 -C 6 -alkylaminocarbonyl, di-(C 1 -C 6 )-alkylaminocarbonyl, aminothiocarbonyl, C 1 -C 6 -alkylaminosulfonyl, C 1 -C 6 -alkylsulfonylamino, C 1 -C 6 -alkylcarbonylamino, C 1 -C 6 -alkylthiocarbonylamino, of phenyl, phenoxy, pyridinyl and pyridinyloxy, each of which is optionally substituted by a radical from the group consisting of halogen, cyano, nitro, amino, hydroxy, C 1 -C 6 -alkyl and C 1 -C 6 -haloalkyl, 
         R 21  represents a radical from the group consisting of hydrogen, C 1 -C 6 -alkyl, C 3 -C 6 -cycloalkyl, C 1 -C 6 -haloalkyl, C 3 -C 6 -alkenyl, C 2 -C 6 -alkynyl, C 3 -C 6 -cycloalkyl-C 1 -C 6 -alkyl, cyano-C 1 -C 6 -alkyl, C 1 -C 6 -alkylcarbonyl, C 2 -C 6 -alkenylcarbonyl, C 1 -C 6 -haloalkylcarbonyl, C 2 -C 6 -haloalkenylcarbonyl, C 1 -C 6 -alkoxy-C 1 -C 6 -alkyl, C 1 -C 6 -alkoxycarbonyl, C 1 -C 6 -alkylsulfonyl and C 1 -C 6 -haloalkylsulfonyl, 
         R 23  represents a radical from the group consisting of hydrogen, C 1 -C 6 -alkyl, C 2 -C 4 -alkenyl, C 2 -C 4 -alkynyl, C 3 -C 6 -cycloalkyl, C 3 -C 6 -cycloalkenyl, C 1 -C 6 -alkoxy, C 2 -C 6 -alkenyloxy, C 2 -C 6 -alkynyloxy, C 3 -C 6 -cycloalkyloxy, C 1 -C 4 -alkylthio-C 1 -C 4 -alkyl, C 2 -C 4 -alkenylthio-C 1 -C 4 -alkyl, cyano-C 1 -C 4 -alkyl, C 1 -C 4 -alkoxy-C 1 -C 4 -alkyl, 
         R 24  represents hydrogen or represents an in each case optionally halogen- or cyano-substituted radical from the group consisting of C 1 -C 4 -alkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -alkynyl, phenyl and phenyl-C 1 -C 2 -alkyl, 
         R 25  represents hydrogen or represents an in each case optionally halogen- or cyano-substituted radical from the group consisting of C 1 -C 4 -alkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -alkynyl, phenyl and phenyl-C 1 -C 2 -alkyl, 
         R 27  represents hydrogen or C 1 -C 4 -alkyl and 
         R 26  represents a radical from the group consisting of hydrogen, C 1 -C 4 -alkyl, C 1 -C 4 -haloalkyl, C 2 -C 4 -alkenyl, C 2 -C 4 -alkynyl, C 3 -C 6 -cycloalkyl, C 3 -C 6 -cycloalkyl-C 1 -C 4 -alkyl, C 1 -C 4 -alkoxy-C 1 -C 2 -alkyl, C 1 -C 4 -alkylthio-C 1 -C 2 -alkyl, C 1 -C 4 -alkylsulfinyl-C 1 -C 2 -alkyl, C 1 -C 4 -alkylsulfonyl-C 1 -C 2 -alkyl and cyano-C 1 -C 4 -alkyl. 
       
    
     Range of preference (2): Particular preference is given to compounds of the formula (I) in which
     A represents a radical from the group consisting of (A-a), (A-b) and (A-f)   

     
       
         
         
             
             
         
       
         
         
           
             where the broken line represents the bond to the nitrogen atom of the bicyclic system of the formula (I), 
           
         
         G 1  represents N or C—B 1 , 
         B 1  represents a radical from the group consisting of hydrogen, halogen, C 1 -C 6 -alkyl and C 1 -C 4 -haloalkyl, 
         B 2  represents a radical from the group consisting of hydrogen, halogen, C 1 -C 6 -alkyl and C 1 -C 4 -haloalkyl, 
         T represents oxygen or an electron pair, 
         R 2  a) represents a B radical from the group consisting of 
       
    
     
       
         
         
             
             
         
       
       
         
         
             
             
         
       
       
         
         
             
             
         
       
         
         
           
             where the broken line denotes the bond to the carbon atom of the bicyclic system of the formula (I), or 
           
         
         R 2  b) represents a radical from the group consisting of (D-1) to (D-3) 
       
    
     
       
         
         
             
             
         
       
         
         
           
             where the broken line denotes the bond to the carbon atom of the bicyclic system of the formula (I), or 
           
         
         R 2  c) represents a radical of the formula 
       
    
     
       
         
         
             
             
         
       
         
         
           
             where the broken line denotes the bond to the carbon atom of the bicyclic system of the formula (I), or 
           
         
         R 2  d) represents a radical of the formula 
       
    
     
       
         
         
             
             
         
       
         
         
           
             where the broken line denotes the bond to the carbon atom of the bicyclic system of the formula (I), or 
           
         
         R 2  e) represents an F radical from the group consisting of (F-1), (F-8) and (F-10) 
       
    
     
       
         
         
             
             
         
       
         
         
           
             where the broken line represents the bond to the carbon atom in the formula (I) or 
           
         
         R 2  f) represents a radical from the group consisting of C 1 -C 6 -haloalkyl, carboxyl and amino,
 
in which
 
         G 2  represents hydrogen or a radical from the group consisting of halogen, nitro, amino, cyano, C 1 -C 4 -alkylamino, halo-C 1 -C 4 -alkylamino, C 1 -C 4 -dialkylamino, C 1 -C 4 -alkyl, C 1 -C 4 -alkoxycarbonyl-C 1 -C 4 -alkyl, halo-C 1 -C 4 -alkyl, C 1 -C 4 -alkoxy, halo-C 1 -C 4 -alkoxy, C 1 -C 4 -alkoxy-C 1 -C 4 -alkyl, halogenated C 1 -C 4 -alkoxy-C 1 -C 4 -alkyl, bis(C 1 -C 4 -alkoxy)-C 1 -C 4 -alkyl, bis(halo-C 1 -C 4 -alkoxy)-C 1 -C 4 -alkyl, C 1 -C 4 -alkoxy-(C 1 -C 4 -alkylsulfanyl)-C 1 -C 4 -alkyl, C 1 -C 4 -alkoxy-(C 1 -C 4 -alkylsulfinyl)-C 1 -C 4 -alkyl, C 1 -C 4 -alkoxy-(C 1 -C 4 -alkylsulfonyl)-C 1 -C 4 -alkyl, bis(C 1 -C 4 -alkylsulfanyl)-C 1 -C 4 -alkyl, bis(halo-C 1 -C 4 -alkylsulfanyl)-C 1 -C 4 -alkyl, bis(hydroxy-C 1 -C 4 -alkylsulfanyl)-C 1 -C 4 -alkyl, C 1 -C 4 -alkoxycarbonyl, C 1 -C 4 -alkoxycarbonyl-C 1 -C 4 -alkyl, C(X 2 )NR 3 R 4 , NR 6 R 7 , C 1 -C 4 -alkylthio, C 1 -C 4 -alkylsulfinyl, C 1 -C 4 -alkylsulfonyl, the heterocyclyl radicals dioxanyl, dioxolanyl, dioxepanyl, dioxocanyl, oxathianyl, oxathiolanyl, oxathiepanyl, oxathiocanyl, dithianyl, dithiolanyl, dithiepanyl, dithiocanyl, oxathianyl oxide, oxathiolanyl oxide, oxathiepanyl oxide, oxathiocanyl oxide, oxathianyl dioxide, oxathiolanyl dioxide, oxathiepanyl dioxide, oxathiocanyl dioxide, morpholinyl, triazolinonyl, oxazolinyl, dihydrooxadiazinyl, dihydrodioxazinyl, dihydrooxazolyl, dihydrooxazinyl and pyrazolinonyl (which for their part may be substituted by C 1 -C 4 -alkyl, halo-C 1 -C 4 -alkyl, C 1 -C 4 -alkoxy and C 1 -C 4 -alkoxy-C 1 -C 4 -alkyl), phenyl (which for its part may be substituted by halogen, cyano, nitro, C 1 -C 4 -alkyl and halo-C 1 -C 4 -alkyl), the heteroaryl radicals pyridyl, pyridyl N-oxide, pyrimidyl, imidazolyl, pyrazolyl, oxazolyl, thiazolyl, furanyl, thienyl, triazolyl, tetrazolyl, oxadiazolyl, thiadiazolyl, pyrazinyl, triazinyl, tetrazinyl and isoquinolinyl (which for their part may be substituted by halogen, nitro, C 1 -C 4 -alkyl, halo-C 1 -C 4 -alkyl, C 1 -C 4 -alkoxy, halo-C 1 -C 4 -alkoxy, C 1 -C 4 -alkoxy-C 1 -C 4 -alkyl, C 1 -C 4 -alkylthio, C 1 -C 4 -alkylthio-C 1 -C 4 -alkyl and C 3 -C 6 -cyclo-C 1 -C 4 -alkyl) and the heteroaryl-C 1 -C 4 -alkyl radicals triazolyl-C 1 -C 4 -alkyl, pyridyl-C 1 -C 4 -alkyl, pyrimidyl-C 1 -C 4 -alkyl and oxadiazolyl-C 1 -C 4 -alkyl (which for their part may be substituted by halogen and C 1 -C 4 -alkyl),
       or   
     
         G 2  represents a C radical from the group consisting of (C-1), (C-6) and (C-9) 
       
    
                         
where the broken line denotes the bond to the B radicals,
     X represents oxygen,   

     X 1  represents a radical from the group consisting of hydrogen, fluorine, chlorine, bromine, iodine, cyano, nitro, C 1 -C 4 -alkyl, C 1 -C 4 -haloalkyl, C 3 -C 6 -cycloalkyl, C 1 -C 4 -alkoxy and C 1 -C 4 -haloalkoxy,
     X 2  represents oxygen, sulfur, NR 5  or NOH,   n represents 2,   R represents NR 18 R 19  or represents C 1 -C 6 -alkyl, C 3 -C 6 -alkenyl, C 3 -C 6 -alkynyl, C 1 -C 4 -alkoxy-C 1 -C 3 -alkyl, C 1 -C 4 -alkyl-S—C 1 -C 3 -alkyl, C 1 -C 4 -alkyl-S(O)—C 1 -C 3 -alkyl, C 1 -C 4 -alkyl-S(O) 2 —C 1 -C 3 -alkyl, each of which is optionally mono- to heptasubstituted by halogen, mono- or disubstituted by oxygen (leads to C═O) or mono- or disubstituted by cyano, represents R 18 —CO—C 1 -C 2 -alkyl, represents NR 18 R 19 —CO—C 1 -C 2 -alkyl, represents C 3 -C 6 -cycloalkyl which is optionally mono- or disubstituted by oxygen (leads to C═O), C 1 -C 4 -alkyl, C 3 -C 6 -cycloalkyl, C 1 -C 4 -alkoxy and C 1 -C 4 -haloalkyl, represents C 3 -C 8 -cycloalkenyl which is optionally mono- or disubstituted by oxygen (leads to C═O), C 1 -C 4 -alkyl, C 3 -C 6 -cycloalkyl, C 1 -C 4 -alkoxy and C 1 -C 4 -haloalkyl, represents C 3 -C 6 -cycloalkyl-C 1 -C 4 -alkyl which is optionally mono- or disubstituted by oxygen (leads to C═O), C 1 -C 4 -alkyl, C 3 -C 6 -cycloalkyl, C 1 -C 4 -alkoxy and C 1 -C 4 -haloalkyl, represents C 3 -C 6 -cycloalkenyl-C 1 -C 4 -alkyl which is optionally mono- or disubstituted by oxygen (leads to C═O), C 1 -C 4 -alkyl, C 3 -C 6 -cycloalkyl, C 1 -C 4 -alkoxy and C 1 -C 4 -haloalkyl, represents heterocyclyl which is optionally mono- or disubstituted by oxygen (leads to C═O), C 1 -C 4 -alkyl, C 3 -C 6 -cycloalkyl, C 1 -C 4 -alkoxy and C 1 -C 4 -haloalkyl, represents heterocyclyl-C 1 -C 4 -alkyl which is optionally mono- or disubstituted by oxygen (leads to C═O), C 1 -C 4 -alkyl, C 3 -C 6 -cycloalkyl, C 1 -C 4 -alkoxy and C 1 -C 4 -haloalkyl, or represents phenyl, phenyl-C 1 -C 4 -alkyl, hetaryl and hetaryl-C 1 -C 4 -alkyl, each of which is optionally mono- to trisubstituted by halogen, cyano, C 1 -C 4 -alkyl, C 1 -C 4 -haloalkyl, C 3 -C 6 -cycloalkyl, C 1 -C 4 -alkoxy or C 1 -C 4 -haloalkoxy,   R 3  represents C 1 -C 4 -alkyl,   R 4  represents a radical from the group consisting of hydrogen, C 1 -C 4 -alkyl, halo-C 1 -C 4 -alkyl, cyano-C 1 -C 4 -alkyl, C 2 -C 4 -alkynyl, C 3 -C 6 -cycloalkyl, C 3 -C 6 -cycloalkyl-C 1 -C 4 -alkyl, C 1 -C 4 -alkoxy-C 1 -C 4 -alkyl, C 1 -C 4 -alkoxycarbonyl, C 1 -C 4 -alkoxycarbonyl-C 1 -C 4 -alkyl and C 1 -C 4 -alkylthio-C 1 -C 4 -alkyl,   R 5  represents a radical from the group consisting of hydrogen, C 1 -C 4 -alkyl, halo-C 1 -C 4 -alkyl, cyano-C 1 -C 4 -alkyl, C 2 -C 4 -alkynyl, C 3 -C 6 -cycloalkyl, C 3 -C 6 -cycloalkyl-C 1 -C 4 -alkyl, C 1 -C 4 -alkoxy-C 1 -C 4 -alkyl, C 1 -C 4 -alkoxycarbonyl, C 1 -C 4 -alkoxycarbonyl-C 1 -C 4 -alkyl and C 1 -C 4 -alkylthio-C 1 -C 4 -alkyl,   R 6  represents hydrogen or C 1 -C 4 -alkyl,   R 7  represents a radical from the group consisting of hydrogen, C 1 -C 4 -alkyl, halo-C 1 -C 4 -alkyl, cyano-C 1 -C 4 -alkyl, C 2 -C 4 -alkynyl, C 1 -C 4 -alkoxy, halo-C 1 -C 4 -alkoxy, C 1 -C 4 -alkoxy-C 1 -C 4 -alkyl, C 1 -C 4 -alkoxycarbonyl, C 1 -C 4 -alkoxycarbonyl-C 1 -C 4 -alkyl, C 1 -C 4 -alkylthio-C 1 -C 4 -alkyl, aryl-C 1 -C 4 -alkyl and hetaryl-C 1 -C 4 -alkyl or   R 6  and R 7  together with the nitrogen atom to which they are attached form a 4- to 7-membered ring which may contain one or two further heteroatoms from the group consisting of nitrogen, oxygen and sulfur (where oxygen and sulfur atoms must not be directly adjacent to one another),   R 8  represents a radical from the group consisting of hydrogen, C 1 -C 6 -alkyl, C 1 -C 6 -haloalkyl, cyano-C 1 -C 6 -alkyl, C 1 -C 6 -alkoxy, C 1 -C 6 -haloalkoxy, C 2 -C 6 -alkenyl, C 1 -C 6 -alkoxy-C 1 -C 6 -alkyl, in each case optionally halogen-substituted C 1 -C 6 -alkylcarbonyl and C 1 -C 6 -alkylsulfonyl, optionally halogen-substituted C 1 -C 6 -alkoxycarbonyl and optionally halogen-, C 1 -C 6 -alkyl-, C 1 -C 6 -alkoxy-, C 1 -C 6 -haloalkyl- and cyano-substituted C 3 -C 6 -cycloalkylcarbonyl, or represents a cation or an optionally C 1 -C 6 -alkyl- or aryl-C 1 -C 6 -alkyl-substituted ammonium ion,   R 9  represents a radical from the group consisting of in each case optionally halogen-, C 1 -C 4 -alkoxy-, C 1 -C 4 -haloalkoxy-, C 1 -C 4 -alkylthio-, C 1 -C 4 -haloalkylthio-, C 1 -C 4 -alkylsulfinyl-, C 1 -C 4 -haloalkylsulfinyl-, C 1 -C 4 -alkylsulfonyl- and C 1 -C 4 -haloalkylsulfonyl-substituted C 1 -C 4 -alkyl, C 2 -C 4 -alkenyl and C 2 -C 4 -alkynyl, in each case optionally halogen-, C 1 -C 4 -alkyl-, C 1 -C 4 -haloalkyl-, C 1 -C 4 -alkoxy-, C 1 -C 4 -haloalkoxy-substituted C 3 -C 6 -cycloalkyl, C 3 -C 6 -cycloalkyl-C 1 -C 4 -alkyl and C 3 -C 4 -cycloalkenyl, in which one or two ring members may in each case be replaced by a heteroatom from the group consisting of sulfur, oxygen (where oxygen atoms must not be directly adjacent to one another) and nitrogen (and here in particular represent   

     
       
         
         
             
             
         
       
         
         
           
             where the arrow in each case marks the bond to the sulfur atom in the radical (C-1) and in the radical (F-1)), in each case optionally halogen-, cyano- (also in the alkyl moiety), nitro-, C 1 -C 4 -alkyl-, C 1 -C 4 -haloalkyl-, C 3 -C 6 -cycloalkyl-, C 1 -C 4 -alkoxy-, C 1 -C 4 -haloalkoxy-, C 1 -C 4 -alkylthio-, C 1 -C 4 -haloalkylthio-, C 1 -C 4 -alkylsulfinyl-, C 1 -C 4 -haloalkylsulfinyl-, C 1 -C 4 -alkylsulfonyl-, C 1 -C 4 -haloalkylsulfonyl-, amino-, C 1 -C 4 -alkylamino-, di(C 1 -C 4 -alkyl)amino-, C 1 -C 4 -alkylcarbonylamino-, C 1 -C 4 -alkoxycarbonylamino-, C 1 -C 4 -alkoxy-C 1 -C 4 -alkyl-, C 1 -C 4 -haloalkoxy-C 1 -C 4 -alkyl-, C 2 -C 4 -alkenyl-, C 2 -C 4 -alkynyl-, C 3 -C 6 -cycloalkyl-C 1 -C 4 -alkyl-, C 1 -C 4 -alkylcarbonyl-, C 1 -C 4 -alkoxycarbonyl- or aminocarbonyl-substituted aryl, heteroaryl, aryl-C 1 -C 4 -alkyl, heteroaryl-C 1 -C 4 -alkyl or represent NR′R″ in which R′ and R″ independently of one another represent a radical from the group consisting of hydrogen and C 1 -C 4 -alkyl, or 
           
         
         R 8  and R 9  in the radical (C-1) and in the radical (F-1), together with the N—S(O)n group to which they are attached, may also form a saturated or unsaturated and optionally halogen-, C 1 -C 6 -alkyl-, C 1 -C 6 -haloalkyl-, C 1 -C 6 -alkoxy-, C 1 -C 6 -haloalkoxy-substituted 5- to 7-membered ring which may contain one or two heteroatoms from the group consisting of sulfur, oxygen (where oxygen atoms must not be directly adjacent to one another) and nitrogen and/or at least one and preferably exactly one carbonyl group; in particular, R 8  and R 9  together with the N—S(O)n group to which they are attached may represent a radical from the group consisting of 
       
    
     
       
         
         
             
             
         
       
         
         
           
             (in which the arrow in each case marks the bond to the C(X) group) 
           
         
         R 15  represents a radical from the group consisting of in each case optionally methyl-substituted C 1 -C 6 -alkyl, C 2 -C 6 -alkenyl and C 2 -C 6 -alkynyl, in each case optionally methyl-, halogen-, cyano- or carbamoyl-substituted C 3 -C 6 -cycloalkyl, C 3 -C 6 -cycloalkyl-C 1 -C 2 -alkyl and C 3 -C 6 -cycloalkenyl, 
         R 8  and R 15  in the radical (C-6), together with the N—S(O)n group to which they are attached, may also form a saturated or unsaturated and optionally substituted 4- to 8-membered ring which may contain one or two further heteroatoms from the group consisting of sulfur, oxygen (where oxygen and sulfur atoms must not be directly adjacent to one another) and nitrogen and/or at least one carbonyl group, 
         R 17  represents a radical from the group consisting of in each case optionally halogen-, C 1 -C 4 -alkoxy-, C 1 -C 4 -haloalkoxy C 1 -C 4 -alkylthio-, C 1 -C 4 -haloalkylthio-, C 1 -C 4 -alkylsulfinyl-, C 1 -C 4 -haloalkylsulfinyl-, C 1 -C 4 -alkylsulfonyl- and C 1 -C 4 -haloalkylsulfonyl-substituted C 1 -C 4 -alkyl, C 2 -C 4 -alkenyl and C 2 -C 4 -alkynyl, in each case optionally halogen-, C 1 -C 4 -alkyl-, C 1 -C 4 -haloalkyl-, C 1 -C 4 -alkoxy-, C 1 -C 4 -haloalkoxy-substituted C 3 -C 6 -cycloalkyl, C 3 -C 6 -cycloalkyl-C 1 -C 4 -alkyl and C 3 -C 4 -cycloalkenyl, N-pyrrolidinyl, N-piperidinyl, N-morpholinyl, N-thiomorpholinyl, N-thiomorpholinyl 1-oxide, N-thiomorpholinyl 1,1-dioxide, N-piperazinyl, N-1-methylpiperazinyl or N-2-oxo-1-methylpiperazinyl, in each case optionally halogen-, cyano- (also in the alkyl moiety), nitro-, C 1 -C 4 -alkyl-, C 1 -C 4 -haloalkyl-, C 3 -C 6 -cycloalkyl-, C 1 -C 4 -alkoxy-, C 1 -C 4 -haloalkoxy-, C 1 -C 4 -alkylthio-, C 1 -C 4 -haloalkylthio-, C 1 -C 4 -alkylsulfinyl-, C 1 -C 4 -haloalkylsulfinyl-, C 1 -C 4 -alkylsulfonyl-, C 1 -C 4 -haloalkylsulfonyl-, amino-, C 1 -C 4 -alkylamino-, di(C 1 -C 4 -alkyl)amino-, C 1 -C 4 -alkylcarbonylamino-, C 1 -C 4 -alkoxycarbonylamino-, C 1 -C 4 -alkoxy-C 1 -C 4 -alkyl-, C 1 -C 4 -haloalkoxy-C 1 -C 4 -alkyl-, C 2 -C 4 -alkenyl-, C 2 -C 4 -alkynyl-, C 3 -C 6 -cycloalkyl-C 1 -C 4 -alkyl-, C 1 -C 4 -alkylcarbonyl-, C 1 -C 4 -alkoxycarbonyl- or aminocarbonyl-substituted aryl, heteroaryl, aryl-C 1 -C 4 -alkyl and heteroaryl-C 1 -C 4 -alkyl or represents NR′R″ in which R′ and R″ independently of one another represent a radical from the group consisting of hydrogen and C 1 -C 4 -alkyl, 
         R 18  represents a radical from the group consisting of hydrogen, hydroxy, of C 1 -C 4 -alkyl, C 1 -C 4 -alkoxy, C 1 -C 4 -alkoxy-C 1 -C 4 -alkyl, C 1 -C 4 -alkyl-S—C 1 -C 3 -alkyl, C 1 -C 4 -alkyl-S(O)—C 1 -C 3 -alkyl, C 1 -C 4 - alkyl-S(O) 2 —C 1 -C 3 -alkyl, C 1 -C 4 -alkylcarbonyl, C 1 -C 4 -alkoxycarbonyl, C 3 -C 6 -cycloalkyl, C 3 -C 6 -cycloalkyl-C 1 -C 3 -alkyl, heterocyclyl, heterocyclyl-C 1 -C 3 -alkyl, each of which is optionally mono- or polysubstituted by halogen or mono- or disubstituted by cyano, and of phenyl, benzyl, pyridyl, pyrimidyl, thiazolyl, oxazolyl, pyrazolyl, thienyl, furanyl, pyridinylmethyl and thiazolylmethyl, each of which is optionally mono- to trisubstituted by C 1 -C 4 -alkyl, C 1 -C 3 -haloalkyl, C 1 -C 3 -alkoxy, C 1 -C 3 -haloalkoxy, cyclopropyl, fluorine, chlorine, bromine or cyano, 
         R 19  represents hydrogen, represents an alkali or alkaline earth metal ion, or represents an ammonium ion which is optionally mono- to tetrasubstituted by C 1 -C 4 -alkyl, or represents a radical from the group consisting of C 1 -C 4 -alkyl, C 1 -C 4 -alkoxy, C 1 -C 4 -alkoxy-C 1 -C 2 -alkyl, C 1 -C 4 -alkyl-S—C 1 -C 2 -alkyl, C 1 -C 4 -alkyl-S(O)—C 1 -C 2 -alkyl and C 1 -C 4 -alkyl-S(O) 2 —C 1 -C 2 -alkyl, each of which is optionally mono- or polysubstituted by halogen or mono- or disubstituted by cyano, 
         Y 3  represents a radical from the group consisting of hydrogen, fluorine, chlorine, bromine, iodine, cyano, C 1 -C 4 -alkyl, C 1 -C 4 -haloalkyl, C 3 -C 6 -cycloalkyl, C 1 -C 4 -alkoxy and C 1 -C 4 -haloalkoxy, 
         W represents a radical from the group consisting of S, SO and SO 2 , 
         R 22 , if R 2  represents the radical c), represents a radical from the group consisting of C 1 -C 6 -alkyl, optionally halogen-, carbamoyl-, thiocarbamoyl- or cyano-substituted C 3 -C 6 -cycloalkyl, C 1 -C 6 -haloalkyl, C 1 -C 6 -alkoxy, C 1 -C 4 -haloalkoxy, C 1 -C 6 -alkoxy-C 1 -C 6 -alkyloxy, C 1 -C 4 -alkylthio, C 1 -C 4 -alkylsulfinyl, C 1 -C 4 -alkylsulfonyl, C 1 -C 4 -haloalkylthio, C 1 -C 4 -haloalkylsulfinyl, C 1 -C 4 -haloalkylsulfonyl, C 1 -C 4 -alkylthio-C 1 -C 4 -alkyl, C 1 -C 4 -alkylsulfinyl-C 1 -C 4 -alkyl, C 1 -C 4 -alkylsulfonyl-C 1 -C 4 -alkyl, C 1 -C 4 -alkylthio-C 1 -C 4 -alkyloxy, C 1 -C 4 -alkylsulfinyl-C 1 -C 4 -alkyloxy, C 1 -C 4 -alkylsulfonyl-C 1 -C 4 -alkyloxy, C 1 -C 4 -haloalkylthio-C 1 -C 4 -alkyl, C 1 -C 4 -haloalkylsulfinyl-C 1 -C 4 -alkyl, C 1 -C 4 -haloalkylsulfonyl-C 1 -C 4 -alkyl, C 1 -C 4 -alkylthio-C 2 -C 4 -alkenyl, C 1 -C 4 -alkylsulfinyl-C 2 -C 4 -alkenyl, C 1 -C 4 -alkylsulfonyl-C 2 -C 4 -alkenyl, C 2 -C 4 -alkenylthio-C 1 -C 4 -alkyl, C 2 -C 4 -alkenylsulfinyl-C 1 -C 4 -alkyl, C 2 -C 4 -alkenylsulfonyl-C 1 -C 4 -alkyl, C 1 -C 4 -alkylcarbonyl-C 1 -C 4 -alkyl, C 1 -C 4 -haloalkylcarbonyl-C 1 -C 4 -alkyl, C 1 -C 4 -alkoxy-C 1 -C 4 -alkyl, C 1 -C 4 -haloalkoxy-C 1 -C 4 -alkyl, C 1 -C 4 -alkoxycarbonyl-C 1 -C 4 -alkyl, C 1 -C 4 -haloalkoxycarbonyl-C 1 -C 4 -alkyl, C 1 -C 4 -alkylaminosulfonyl, di-(C 1 -C 4 -alkyl)-aminosulfonyl, 
         R 23 , if R 2  represents the radical c), represents a radical from the group consisting of hydrogen, C 1 -C 6 -alkyl, C 2 -C 4 -alkenyl, C 2 -C 4 -alkynyl, C 1 -C 4 -alkylthio-C 1 -C 4 -alkyl, C 2 -C 4 -alkenylthio-C 1 -C 4 -alkyl, cyano-C 1 -C 4 -alkyl, C 1 -C 4 -alkoxy-C 1 -C 4 -alkyl, 
         R 23 , if R 2  represents the radical d) or e), represents a radical from the group consisting of hydrogen, C 1 -C 6 -alkyl, C 2 -C 4 -alkenyl, C 2 -C 4 -alkynyl, C 3 -C 6 -cycloalkyl, C 3 -C 6 -cycloalkenyl, C 1 -C 6 -alkoxy, C 2 -C 6 -alkenyloxy, C 2 -C 6 -alkynyloxy, C 3 -C 6 -cycloalkyloxy, C 1 -C 4 -alkylthio-C 1 -C 4 -alkyl, C 2 -C 4 -alkenylthio-C 1 -C 4 -alkyl, cyano-C 1 -C 4 -alkyl, C 1 -C 4 -alkoxy-C 1 -C 4 alkyl,
       or, in the case R 2 =d),   
     
         R 22  also represents optionally halogen-, cyano-, nitro-, amino-, hydroxy-, C 1 -C 6 -alkyl-, C 1 -C 6 -haloalkyl-, C 3 -C 6 -cycloalkyl-, C 1 -C 6 -alkoxy-, C 1 -C 4 -haloalkoxy-, C 1 -C 6 -alkoxycarbonyloxy-, C 1 -C 6 -alkylamino-, C 1 -C 6 -alkylthio-, C 1 -C 4 -haloalkylthio-, C 1 -C 4 -alkylsulfinyl-, C 1 -C 4 -alkylsulfonyl-, C 1 -C 6 -alkylcarbonyl-, aminocarbonyl-, C 1 -C 6 -alkylaminocarbonyl-, di-(C 1 -C 6 -alkyl)-aminocarbonyl-, C 1 -C 6 -alkylcarbonylamino-substituted phenyl or represents an E radical from the group consisting of 
       
    
     
       
         
         
             
             
         
       
       
         
         
             
             
         
       
       
         
         
             
             
         
       
         
         R 27  represents hydrogen or C 1 -C 4 -alkyl and 
         R 26  represents hydrogen, C 1 -C 4 -alkyl, C 2 -C 4 -alkenyl, C 2 -C 4 -alkynyl, C 3 -C 6 -cycloalkyl, C 3 -C 6 -cycloalkyl-C 1 -C 4 -alkyl, C 1 -C 4 -alkoxy-C 1 -C 2 -alkyl, C 1 -C 4 -alkylthio-C 1 -C 2 -alkyl, C 1 -C 4 -alkylsulfinyl-C 1 -C 2 -alkyl, C 1 -C 4 -alkylsulfonyl-C 1 -C 2 -alkyl or cyano-C 1 -C 4 -alkyl. 
       
    
     Range of preference (3): Very particular preference is given to compounds of the formula (I) in which
     A represents a radical from the group consisting of (A-a), (A-b) and (A-f)   

     
       
         
         
             
             
         
       
         
         
           
             where the broken line represents the bond to the nitrogen atom of the bicyclic system of the formula (I), 
           
         
         G 1  represents N or C—B 1 , 
         B 1  represents a radical from the group consisting of hydrogen and fluorine, 
         B 2  represents hydrogen, 
         T represents oxygen or an electron pair, 
         R 2  represents a B radical from the group consisting of 
       
    
     
       
         
         
             
             
         
       
       
         
         
             
             
         
       
       
         
         
             
             
         
       
         
         
           
             where the broken line denotes the bond to the carbon atom of the bicyclic system of the formula (I), or 
           
         
         R 2  b) represents a D radical from the group consisting of (D-1) to (D-3) 
       
    
                         
where the broken line denotes the bond to the carbon atom of the bicyclic system of the formula (I), or
     R 2  c) represents a radical of the formula   

     
       
         
         
             
             
         
       
         
         
           
             where the broken line denotes the bond to the carbon atom of the bicyclic system of the formula (I), or 
           
         
         R 2  d) represents a radical of the formula 
       
    
     
       
         
         
             
             
         
       
         
         
           
             where the broken line denotes the bond to the carbon atom of the bicyclic system of the formula (I), or 
           
         
         R 2  e) represents an F radical from the group consisting of (F-1), (F-8) and (F-10) 
       
    
     
       
         
         
             
             
         
       
         
         
           
             where the broken line represents the bond to the carbon atom in the formula (I), or 
           
         
         R 2  f) represents a radical from the group consisting of C 1 -C 6 -haloalkyl, carboxyl and amino, where 
         G 2  represents hydrogen or a radical from the group consisting of halogen, nitro, amino, cyano, C 1 -C 4 -alkylamino, halo-C 1 -C 4 -alkylamino, C 1 -C 4 -dialkylamino, C 1 -C 4 -alkyl, C 1 -C 4 -alkoxycarbonyl-C 1 -C 4 -alkyl, halo-C 1 -C 4 -alkyl, C 1 -C 4 -alkoxy, halo-C 1 -C 4 -alkoxy, C 1 -C 4 -alkoxy-C 1 -C 4 -alkyl, halogenated C 1 -C 4 -alkoxy-C 1 -C 4 -alkyl, bis(C 1 -C 4 -alkoxy)-C 1 -C 4 -alkyl, bis(halo-C 1 -C 4 -alkoxy)-C 1 -C 4 -alkyl, C 1 -C 4 -alkoxy(C 1 -C 4 -alkylsulfanyl)-C 1 -C 4 -alkyl, C 1 -C 4 -alkoxy(C 1 -C 4 -alkylsulfinyl)-C 1 -C 4 -alkyl, C 1 -C 4 -alkoxy(C 1 -C 4 -alkylsulfonyl)-C 1 -C 4 -alkyl, bis(C 1 -C 4 -alkylsulfanyl)-C 1 -C 4 -alkyl, bis(halo-C 1 -C 4 -alkylsulfanyl)-C 1 -C 4 -alkyl, bis(hydroxy-C 1 -C 4 -alkylsulfanyl)-C 1 -C 4 -alkyl, C 1 -C 4 -alkoxycarbonyl, C 1 -C 4 -alkoxycarbonyl-C 1 -C 4 -alkyl, C(X 2 )NR 3 R 4 , NR 6 R 7 , C 1 -C 4 -alkylthio, C 1 -C 4 -alkylsulfinyl and C 1 -C 4 -alkylsulfonyl,
       or   
     
         G 2  represents a C radical (C-1) or (C-9) 
       
    
     
       
         
         
             
             
         
       
         
         
           
             where the broken line denotes the bond to the B radicals, 
           
         
         X represents oxygen, 
         X 1  represents a radical from the group consisting of hydrogen, fluorine, chlorine, bromine, cyano, methyl, ethyl, trifluoromethyl, methoxy, ethoxy, difluoromethoxy and trifluoromethoxy, 
         X 2  represents oxygen, sulfur, NR 5  or NOH, 
         n represents 2, 
         R represents NR 18 R 19  or represents a radical from the group consisting of C 1 -C 4 -alkyl, C 3 -C 4 -alkenyl, C 3 -C 4 -alkynyl, C 1 -C 2 -alkoxy-C 1 -C 2 -alkyl and C 1 -C 2 -alkyl-S—C 1 -C 2 -alkyl, C 1 -C 2 -alkyl-S(O)—C 1 -C 2 -alkyl, C 1 -C 2 -alkyl-S(O) 2 —C 1 -C 2 -alkyl, each of which is optionally mono-, di-, tri-, tetra- or pentasubstituted by fluorine, chlorine or mono- or disubstituted by cyano, represents R 18 —CO—C 1 -C 2 -alkyl, represents NR 18 R 19 —CO—C 1 -C 2 -alkyl, represents C 3 -C 6 -cycloalkyl which is optionally mono- or disubstituted by C 1 -C 2 -alkyl, C 1 -C 2 -alkoxy or C 1 -C 2 -haloalkyl or by an oxygen atom (leads to C═O), represents C 3 -C 6 -cycloalkenyl which is optionally mono- or disubstituted by C 1 -C 2 -alkyl, C 1 -C 2 -alkoxy or C 1 -C 2 -haloalkyl or by an oxygen atom (leads to C═O), represents C 3 -C 6 -cycloalkyl-C 1 -C 2 -alkyl which is optionally mono- or disubstituted by C 1 -C 2 -alkyl, C 1 -C 2 -alkoxy or C 1 -C 2 -haloalkyl, represents C 3 -C 6 -cycloalkenyl-C 1 -C 2 -alkyl which is optionally mono- or disubstituted by C 1 -C 2 -alkyl, C 1 -C 2 -alkoxy or C 1 -C 2 -haloalkyl, represents heterocyclyl which is optionally mono- or disubstituted by C 1 -C 2 -alkyl, C 1 -C 2 -alkoxy or C 1 -C 2 -haloalkyl, represents heterocyclyl-C 1 -C 2 -alkyl which is optionally mono- or disubstituted by C 1 -C 2 -alkyl, C 1 -C 2 -alkoxy or C 1 -C 2 -haloalkyl or represents phenyl, benzyl, pyridyl, pyrimidyl, thiazolyl, oxazolyl, pyrazolyl, thienyl, furanyl, pyridinylmethyl or thiazolylmethyl, each of which is optionally mono- or disubstituted by fluorine, chlorine, bromine, cyano, methyl, ethyl, difluoromethyl, trifluoromethyl, methoxy, ethoxy, difluoromethoxy or trifluoromethoxy, 
         R 3  represents C 1 -C 4 -alkyl, 
         R 4  represents a radical from the group consisting of hydrogen, C 1 -C 4 -alkyl, halo-C 1 -C 4 -alkyl, cyano-C 1 -C 4 -alkyl, C 2 -C 4 -alkynyl, C 3 -C 6 -cycloalkyl, C 3 -C 6 -cycloalkyl-C 1 -C 4 -alkyl, C 1 -C 4 -alkoxy-C 1 -C 4 -alkyl, C 1 -C 4 -alkoxycarbonyl, C 1 -C 4 -alkoxycarbonyl-C 1 -C 4 -alkyl and C 1 -C 4 -alkylthio-C 1 -C 4 -alkyl, 
         R 5  represents a radical from the group consisting of hydrogen, C 1 -C 4 -alkyl, halo-C 1 -C 4 -alkyl, cyano-C 1 -C 4 -alkyl, C 2 -C 4 -alkynyl, C 3 -C 6 -cycloalkyl, C 3 -C 6 -cycloalkyl-C 1 -C 4 -alkyl, C 1 -C 4 -alkoxy-C 1 -C 4 -alkyl, C 1 -C 4 -alkoxycarbonyl, C 1 -C 4 -alkoxycarbonyl-C 1 -C 4 -alkyl and C 1 -C 4 -alkylthio-C 1 -C 4 -alkyl, 
         R 6  represents hydrogen or C 1 -C 4 -alkyl, 
         R 7  represents a radical from the group consisting of hydrogen, C 1 -C 4 -alkyl, halo-C 1 -C 4 -alkyl, cyano-C 1 -C 4 -alkyl, C 2 -C 4 -alkynyl, C 1 -C 4 -alkoxy, halo-C 1 -C 4 -alkoxy, C 1 -C 4 -alkoxy-C 1 -C 4 -alkyl, C 1 -C 4 -alkoxycarbonyl, C 1 -C 4 -alkoxycarbonyl-C 1 -C 4 -alkyl, C 1 -C 4 -alkylthio-C 1 -C 4 -alkyl, aryl-C 1 -C 4 -alkyl and hetaryl-C 1 -C 4 -alkyl or 
         R 6  and R 7  together with the nitrogen atom to which they are attached form a 4- to 7-membered ring which may contain one or two further heteroatoms from the group consisting of nitrogen, oxygen and sulfur (where oxygen and sulfur atoms must not be directly adjacent to one another), 
         R 8  represents a radical from the group consisting of hydrogen, C 1 -C 6 -alkyl, C 1 -C 6 -haloalkyl, cyano-C 1 -C 6 -alkyl, C 1 -C 6 -alkoxy, C 1 -C 6 -haloalkoxy, C 2 -C 6 -alkenyl, C 1 -C 6 -alkoxy-C 1 -C 6 -alkyl, in each case optionally halogen-substituted C 1 -C 6 -alkylcarbonyl and C 1 -C 6 -alkylsulfonyl, optionally halogen-substituted C 1 -C 6 -alkoxycarbonyl, optionally halogen-, C 1 -C 6 -alkyl-, C 1 -C 6 -alkoxy-, C 1 -C 6 -haloalkyl- and cyano-substituted C 3 -C 6 -cycloalkylcarbonyl, or represents a cation or an optionally C 1 -C 6 -alkyl- or aryl-C 1 -C 6 -alkyl-substituted ammonium ion, 
         R 9  represents a radical from the group consisting of in each case optionally halogen-, C 1 -C 4 -alkoxy-, C 1 -C 4 -haloalkoxy-, C 1 -C 4 -alkylthio-, C 1 -C 4 -haloalkylthio-, C 1 -C 4 -alkylsulfinyl-, C 1 -C 4 -haloalkylsulfinyl-, C 1 -C 4 -alkylsulfonyl- and C 1 -C 4 -haloalkylsulfonyl-substituted C 1 -C 4 -alkyl, C 2 -C 4 -alkenyl and C 2 -C 4 -alkynyl, in each case optionally halogen-, C 1 -C 4 -alkyl-, C 1 -C 4 -haloalkyl-, C 1 -C 4 -alkoxy-, C 1 -C 4 -haloalkoxy-substituted C 3 -C 6 -cycloalkyl, C 3 -C 6 -cycloalkyl-C 1 -C 4 -alkyl and C 3 -C 4 -cycloalkenyl, in which one or two ring members may in each case be replaced by a heteroatom from the group consisting of sulfur, oxygen (where oxygen atoms must not be directly adjacent to one another) and nitrogen (and here in particular represent 
       
    
     
       
         
         
             
             
         
       
         
         
           
             where the arrow in each case marks the bond to the sulfur atom in the radical (C-1) and in the radical (F-1)), in each case optionally halogen-, cyano- (also in the alkyl moiety), nitro-, C 1 -C 4 -alkyl-, C 1 -C 4 -haloalkyl-, C 3 -C 6 -cycloalkyl-, C 1 -C 4 -alkoxy-, C 1 -C 4 -haloalkoxy-, C 1 -C 4 -alkylthio-, C 1 -C 4 -haloalkylthio-, C 1 -C 4 -alkylsulfinyl-, C 1 -C 4 -haloalkylsulfinyl-, C 1 -C 4 -alkylsulfonyl-, C 1 -C 4 -haloalkylsulfonyl-, amino-, C 1 -C 4 -alkylamino-, di(C 1 -C 4 -alkyl)amino-, C 1 -C 4 -alkylcarbonylamino-, C 1 -C 4 -alkoxycarbonylamino-, C 1 -C 4 -alkoxy-C 1 -C 4 -alkyl-, C 1 -C 4 -haloalkoxy-C 1 -C 4 -alkyl-, C 2 -C 4 -alkenyl-, C 2 -C 4 -alkynyl-, C 3 -C 6 -cycloalkyl-C 1 -C 4 -alkyl-, C 1 -C 4 -alkylcarbonyl-, C 1 -C 4 -alkoxycarbonyl- or aminocarbonyl-substituted aryl, heteroaryl, aryl-C 1 -C 4 -alkyl and heteroaryl-C 1 -C 4 -alkyl or represent NR′R″ in which R′ and R″ independently of one another represent a radical from the group consisting of hydrogen and C 1 -C 4 -alkyl, 
           
         
         R 8  and R 9  in the radical (C-1) and in the radical (F-1), together with the N—S(O)n group to which they are attached, may also form a saturated or unsaturated and optionally halogen-, C 1 -C 6 -alkyl-, C 1 -C 6 -haloalkyl-, C 1 -C 6 -alkoxy-, C 1 -C 6 -haloalkoxy-substituted 5- to 7-membered ring which may contain one or two heteroatoms from the group consisting of sulfur, oxygen (where oxygen atoms must not be directly adjacent to one another) and nitrogen and/or at least one and preferably one carbonyl group; in particular, R 8  and R 9  together with the N—S(O)n group to which they are attached may represent a radical from the group consisting of 
       
    
     
       
         
         
             
             
         
       
         
         
           
             (in which the arrow in each case marks the bond to the C(X) group), 
           
         
         R 17  represents a radical from the group consisting of in each case optionally halogen-, C 1 -C 4 -alkoxy-, C 1 -C 4 -haloalkoxy-, C 1 -C 4 -alkylthio-, C 1 -C 4 -haloalkylthio-, C 1 -C 4 -alkylsulfinyl-, C 1 -C 4 -haloalkylsulfinyl-, C 1 -C 4 -alkylsulfonyl- and C 1 -C 4 -haloalkylsulfonyl-substituted C 1 -C 4 -alkyl, C 2 -C 4 -alkenyl and C 2 -C 4 -alkynyl, in each case optionally halogen-, C 1 -C 4 -alkyl-, C 1 -C 4 -haloalkyl-, C 1 -C 4 -alkoxy-, C 1 -C 4 -haloalkoxy-substituted C 3 -C 6 -cycloalkyl, C 3 -C 6 -cycloalkyl-C 1 -C 4 -alkyl and C 3 -C 4 -cycloalkenyl, N-pyrrolidinyl, N-piperidinyl, N-morpholinyl, N-thiomorpholinyl, N-thiomorpholinyl 1-oxide, N-thiomorpholinyl 1,1-dioxide, N-piperazinyl, N-1-methylpiperazinyl and N-2-oxo-1-methylpiperazinyl, in each case optionally halogen-, cyano- (also in the alkyl moiety), nitro-, C 1 -C 4 -alkyl-, C 1 -C 4 -haloalkyl-, C 3 -C 6 -cycloalkyl-, C 1 -C 4 -alkoxy-, C 1 -C 4 -haloalkoxy-, C 1 -C 4 -alkylthio-, C 1 -C 4 -haloalkylthio-, C 1 -C 4 -alkylsulfinyl-, C 1 -C 4 -haloalkylsulfinyl-, C 1 -C 4 -alkylsulfonyl-, C 1 -C 4 -haloalkylsulfonyl-, amino-, C 1 -C 4 -alkylamino-, di-(C 1 -C 4 -alkyl)amino-, C 1 -C 4 -alkylcarbonylamino-, C 1 -C 4 -alkoxycarbonylamino-, C 1 -C 4 -alkoxy-C 1 -C 4 -alkyl-, C 1 -C 4 -haloalkoxy-C 1 -C 4 -alkyl-, C 2 -C 4 -alkenyl-, C 2 -C 4 -alkynyl-, C 3 -C 6 -cycloalkyl-C 1 -C 4 -alkyl-, C 1 -C 4 -alkylcarbonyl-, C 1 -C 4 -alkoxycarbonyl- or aminocarbonyl-substituted aryl, heteroaryl, aryl-C 1 -C 4 -alkyl and heteroaryl-C 1 -C 4 -alkyl or represents NR′R″ in which R′ and R″ independently of one another represent a radical from the group consisting of hydrogen and C 1 -C 4 -alkyl, 
         W represents a radical from the group consisting of S, SO and SO 2 , 
         Y 3  represents a radical from the group consisting of hydrogen, fluorine, chlorine, bromine, cyano, methyl, ethyl, trifluoromethyl, methoxy, ethoxy, difluoromethoxy and trifluoromethoxy, 
       
    
     R 18  represents a radical from the group consisting of hydrogen, hydroxy, of C 1 -C 4 -alkyl, C 1 -C 4 -alkoxy, C 1 -C 4 -alkoxy-C 1 -C 4 -alkyl, C 1 -C 4 -alkyl-S—C 1 -C 2 -alkyl, C 1 -C 4 -alkyl-S(O)—C 1 -C 2 -alkyl, C 1 -C 4 - alkyl-S(O) 2 —C 1 -C 2 -alkyl, C 1 -C 4 -alkylcarbonyl, C 1 -C 4 -alkoxycarbonyl, C 3 -C 6 -cycloalkyl, C 3 -C 6 -cycloalkyl-C 1 -C 3 -alkyl, heterocyclyl and heterocyclyl-C 1 -C 3 -alkyl, each of which is optionally mono-, di-, tri-, tetra- or pentasubstituted by fluorine, chlorine or mono- or disubstituted by cyano, and of phenyl, benzyl, pyridyl, pyrimidyl, thiazolyl, oxazolyl, pyrazolyl, thienyl, furanyl, pyridinylmethyl and thiazolylmethyl, each of which is optionally mono- to trisubstituted by C 1 -C 4 -alkyl, C 1 -C 3 -haloalkyl, C 1 -C 3 -alkoxy, C 1 -C 3 -haloalkoxy, cyclopropyl, fluorine, chlorine, bromine or cyano, 
     R 19  represents hydrogen, an alkali or alkaline earth metal ion, represents an ammonium ion which is optionally mono- to tetrasubstituted by C 1 -C 4 -alkyl or represents a radical from the group consisting of C 1 -C 4 -alkyl, C 1 -C 4 -alkoxy, C 1 -C 4 -alkoxy-C 1 -C 2 -alkyl and C 1 -C 4 -alkyl-S—C 1 -C 2 -alkyl, C 1 -C 4 -alkyl-S(O)—C 1 -C 2 -alkyl and C 1 -C 4 -alkyl-S(O) 2 —C 1 -C 2 -alkyl, each of which is optionally mono-, di-, tri-, tetra- or pentasubstituted by fluorine, chlorine or mono- or disubstituted by cyano, or
     R 22 , if R 2  represents the radical c), represents a radical from the group consisting of C 1 -C 6 -alkyl, optionally cyano-substituted C 3 -C 6 -cycloalkyl, C 1 -C 6 -haloalkyl, C 1 -C 6 -alkoxy, C 1 -C 4 -haloalkoxy, C 1 -C 6 -alkoxy-C 1 -C 6 -alkyloxy, C 1 -C 4 -alkylthio, C 1 -C 4 -alkylsulfinyl, C 1 -C 4 -alkylsulfonyl, C 1 -C 4 -haloalkylthio, C 1 -C 4 -haloalkylsulfinyl, C 1 -C 4 -haloalkylsulfonyl, C 1 -C 4 -alkylthio-C 1 -C 4 -alkyl, C 1 -C 4 -alkylsulfinyl-C 1 -C 4 -alkyl, C 1 -C 4 -alkylsulfonyl-C 1 -C 4 -alkyl, C 1 -C 4 -alkylthio-C 1 -C 4 -alkyloxy, C 1 -C 4 -alkylsulfinyl-C 1 -C 4 -alkyloxy, C 1 -C 4 -alkylsulfonyl-C 1 -C 4 -alkyloxy, C 1 -C 4 -haloalkylthio-C 1 -C 4 -alkyl, C 1 -C 4 -haloalkylsulfinyl-C 1 -C 4 -alkyl, C 1 -C 4 -haloalkylsulfonyl-C 1 -C 4 -alkyl, C 1 -C 4 -alkylthio-C 2 -C 4 -alkenyl, C 1 -C 4 -alkylsulfinyl-C 2 -C 4 -alkenyl, C 1 -C 4 -alkylsulfonyl-C 2 -C 4 -alkenyl, C 2 -C 4 -alkenylthio-C 1 -C 4 -alkyl, C 2 -C 4 -alkenylsulfinyl-C 1 -C 4 -alkyl, C 2 -C 4 -alkenylsulfonyl-C 1 -C 4 -alkyl, C 1 -C 4 -alkylcarbonyl-C 1 -C 4 -alkyl, C 1 -C 4 -haloalkylcarbonyl-C 1 -C 4 -alkyl, C 1 -C 4 -alkoxy-C 1 -C 4 -alkyl, C 1 -C 4 -haloalkoxy-C 1 -C 4 -alkyl, C 1 -C 4 -alkoxycarbonyl-C 1 -C 4 -alkyl, C 1 -C 4 -haloalkoxycarbonyl-C 1 -C 4 -alkyl, C 1 -C 4 -alkylaminosulfonyl, di-(C 1 -C 4 -alkyl)-aminosulfonyl,   R 23 , if R 2  represents the radical c), represents a radical from the group consisting of hydrogen, C 1 -C 6 -alkyl, C 2 -C 4 -alkenyl, C 2 -C 4 -alkynyl, C 1 -C 4 -alkylthio-C 1 -C 4 -alkyl, C 2 -C 4 -alkenylthio-C 1 -C 4 -alkyl, cyano-C 1 -C 4 -alkyl, C 1 -C 4 -alkoxy-C 1 -C 4 -alkyl,   R 22 , if R 2  represents the radical d), represents a radical from the group consisting of C 1 -C 4 -alkyl, optionally cyano-substituted C 3 -C 6 -cycloalkyl, C 1 -C 4 -haloalkyl, C 1 -C 4 -alkylthio-C 1 -C 4 -alkyl, C 1 -C 4 -alkylsulfinyl-C 1 -C 4 -alkyl, C 1 -C 4 -alkylsulfonyl-C 1 -C 4 -alkyl, C 1 -C 4 -haloalkylthio-C 1 -C 4 -alkyl, C 1 -C 4 -haloalkylsulfinyl-C 1 -C 4 -alkyl, C 1 -C 4 -haloalkylsulfonyl-C 1 -C 4 -alkyl, C 1 -C 4 -alkylthio-C 2 -C 4 -alkenyl, C 1 -C 4 -alkylsulfinyl-C 2 -C 4 -alkenyl, C 1 -C 4 -alkylsulfonyl-C 2 -C 4 -alkenyl, C 2 -C 4 -alkenylthio-C 1 -C 4 -alkyl, C 2 -C 4 -alkenylsulfinyl-C 1 -C 4 -alkyl, C 2 -C 4 -alkenylsulfonyl-C 1 -C 4 -alkyl, C 1 -C 4 -alkylcarbonyl-C 1 -C 4 -alkyl, C 1 -C 4 -haloalkylcarbonyl-C 1 -C 4 -alkyl, C 1 -C 4 -alkoxy-C 1 -C 4 -alkyl, C 1 -C 4 -haloalkoxy-C 1 -C 4 -alkyl, C 1 -C 4 -alkoxycarbonyl-C 1 -C 4 -alkyl, C 1 -C 4 -haloalkoxycarbonyl-C 1 -C 4 -alkyl, C 1 -C 4 -alkylaminosulfonyl, di-(C 1 -C 4 -alkyl)-aminosulfonyl,   R 23 , if R 2  represents the radical d) or e), represents a radical from the group consisting of hydrogen, C 1 -C 6 -alkyl, C 2 -C 4 -alkenyl, C 2 -C 4 -alkynyl, C 3 -C 6 -cycloalkyl, C 3 -C 6 -cycloalkenyl, C 1 -C 6 -alkoxy, C 2 -C 6 -alkenyloxy, C 2 -C 6 -alkynyloxy, C 3 -C 6 -cycloalkyloxy, C 1 -C 4 -alkylthio-C 1 -C 4 -alkyl, C 2 -C 4 -alkenylthio-C 1 -C 4 -alkyl, cyano-C 1 -C 4 -alkyl, C 1 -C 4 -alkoxy-C 1 -C 4 alkyl, and
       in the case R 2 =d),   
       R 22  also represents optionally halogen-, cyano-, nitro-, amino-, hydroxy-, C 1 -C 6 -alkyl-, C 1 -C 6 -haloalkyl-, C 2 -C 6 -alkenyl-, C 2 -C 6 -alkynyl-, C 3 -C 6 -cycloalkyl-, C 1 -C 6 -alkoxy-, C 1 -C 6 -haloalkoxy-, C 3 -C 6 -alkenyloxy-, C 3 -C 6 -alkynyloxy-, C 1 -C 6 -alkoxycarbonyloxy-, C 1 -C 6 -alkylamino-, C 3 -C 6 -alkenylamino-, C 3 -C 6 -alkynylamino-, C 3 -C 6 -cycloalkylamino-, C 1 -C 6 -alkylthio-, C 1 -C 6 -haloalkylthio-, C 3 -C 6 -alkenylthio-, C 3 -C 6 -alkynylthio-, C 3 -C 6 -cycloalkylthio-, C 1 -C 6 -alkylsulfinyl-, C 1 -C 6 -alkylsulfonyl-, C 1 -C 6 -alkylcarbonyl-, aminocarbonyl-, C 1 -C 6 -alkylaminocarbonyl-, di-(C 1 -C 6 -alkyl)-aminocarbonyl-, C 1 -C 6 -alkylcarbonylamino-substituted phenyl or represents one of the E radicals below   

     
       
         
         
             
             
         
       
       
         
         
             
             
         
       
       
         
         
             
             
         
       
         
         R 27  represents hydrogen or methyl and 
         R 26  represents a radical from the group consisting of hydrogen, methyl, 2,2,2-trifluoroethyl, 2,2-difluoroethyl, propenyl, propargyl, cyclopropyl, cyclopropylmethyl, methoxymethyl, methylthioethyl, methylsulfinylethyl, methylsulfonylethyl and cyanomethyl. 
       
    
     Range of preference (4): A particular group of compounds of the formula (I) is that of those in which
     A represents a radical from the group consisting of (A-a), (A-b) and (A-f)   

     
       
         
         
             
             
         
       
         
         
           
             where the broken line represents the bond to the nitrogen atom of the bicyclic system of the formula (I), 
           
         
         G 1  represents N or C—B 1 , 
         B 1  represents a radical from the group consisting of hydrogen and fluorine, 
         B 2  represents hydrogen, 
         T represents an electron pair, 
         R 2  c) represents the radical of the formula 
       
    
     
       
         
         
             
             
         
       
         
         
           
             where the broken line denotes the bond to the carbon atom of the bicyclic system of the formula (I), 
           
         
         X represents oxygen, 
         R 3  represents C 1 -C 4 -alkyl, 
         R 22  represents a radical from the group consisting of C 1 -C 6 -alkyl, C 3 -C 6 -cycloalkyl, C 1 -C 6 -haloalkyl, C 1 -C 6 -alkoxy, C 1 -C 4 -alkylsulfonyl and di-(C 1 -C 4 -alkyl)-aminosulfonyl and 
         R 23  represents hydrogen or C 1 -C 6 -alkyl. 
       
    
     When sulfur and/or nitrogen occur in rings in the above definitions, for example in expressions such as “in which the rings may contain at least one heteroatom from the group of sulfur, oxygen (where oxygen and sulfur atoms must not be directly adjacent to one another) and nitrogen” or “in which one or two ring members may each be replaced by a heteroatom from the group of sulfur, oxygen (where oxygen atoms must not be directly adjacent to one another) and nitrogen”, unless stated otherwise, the sulfur may also be present in the form of SO or SO 2 ; the nitrogen, if it is not in the form of —N═, as well as NH, may also be present in the form of N-alkyl (in particular N—C 1 -C 6 -alkyl). 
     In the preferred definitions whose combination forms the range of preference (1), unless stated otherwise, 
     cation represents an alkali metal ion selected from the group consisting of lithium, sodium, potassium, rubidium, caesium, preferably from the group consisting of lithium, sodium, potassium, or an 
     alkaline earth metal ion selected from the group consisting of beryllium, magnesium, calcium, strontium, barium, preferably from the group consisting of magnesium and calcium, 
     halogen is selected from the group consisting of fluorine, chlorine, bromine and iodine, preferably in turn from the group consisting of fluorine, chlorine and bromine, 
     aryl (including as part of a larger unit, for example arylalkyl) is selected from the group consisting of phenyl, naphthyl, anthryl, phenanthrenyl, and preferably in turn represents phenyl, 
     hetaryl (synonymous with heteroaryl, including as part of a larger unit, for example hetarylalkyl) is selected from the group consisting of furyl, thienyl, pyrrolyl, pyrazolyl, imidazolyl, 1,2,3-triazolyl, 1,2,4-triazolyl, oxazolyl, isoxazolyl, thiazolyl, isothiazolyl, 1,2,3-oxadiazolyl, 1,2,4-oxadiazolyl, 1,3,4-oxadiazolyl, 1,2,5-oxadiazolyl, 1,2,3-thiadiazolyl, 1,2,4-thiadiazolyl, 1,3,4-thiadiazolyl, 1,2,5-thiadiazolyl, pyridyl, pyrimidinyl, pyridazinyl, pyrazinyl, 1,2,3-triazinyl, 1,2,4-triazinyl, 1,3,5-triazinyl, benzofuryl, benzoisofuryl, benzothienyl, benzoisothienyl, indolyl, isoindolyl, indazolyl, benzothiazolyl, benzoisothiazolyl, benzoxazolyl, benzisoxazolyl, benzimidazolyl, 2,1,3-benzoxadiazole, quinolinyl, isoquinolinyl, cinnolinyl, phthalazinyl, quinazolinyl, quinoxalinyl, naphthyridinyl, benzotriazinyl, purinyl, pteridinyl and indolizinyl,
 
heterocyclyl represents a saturated 4-, 5- or 6-membered ring containing 1 or 2 nitrogen atoms and/or one oxygen atom and/or one sulfur atom, for example azetidinyl, azolidinyl, azinanyl, oxetanyl, oxolanyl, oxanyl, dioxanyl, thiethanyl, thiolanyl, thianyl, tetrahydrofuryl, piperazinyl, morpholinyl.
 
     In the particularly preferred definitions whose combination forms the range of preference (2), unless stated otherwise, 
     cation represents an alkali metal ion selected from the group consisting of lithium, sodium, potassium, rubidium, caesium, preferably from the group consisting of lithium, sodium, potassium, or an 
     alkaline earth metal ion selected from the group consisting of beryllium, magnesium, calcium, strontium, barium, preferably from the group consisting of magnesium and calcium, 
     halogen is selected from the group consisting of fluorine, chlorine, bromine and iodine, preferably in turn from the group consisting of fluorine, chlorine and bromine, 
     aryl (including as part of a larger unit, for example arylalkyl) is selected from the group consisting of phenyl, naphthyl, anthryl, phenanthrenyl, and preferably in turn represents phenyl, 
     hetaryl (synonymous with heteroaryl, also as part of a larger unit such as, for example, hetarylalkyl) is selected from the group consisting of pyrazolyl, imidazolyl, 1,2,3-triazolyl, 1,2,4-triazolyl, oxazolyl, isoxazolyl, thiazolyl, isothiazolyl, pyridyl, pyrimidinyl, pyridazinyl, pyrazinyl, 1,2,3-triazinyl, 1,2,4-triazinyl, 1,3,5-triazinyl,
 
heterocyclyl is selected from the group consisting of azetidinyl, azolidinyl, azinanyl, oxetanyl, oxolanyl, oxanyl, dioxanyl, thiethanyl, thiolanyl, thianyl, tetrahydrofuryl, piperazinyl, morpholinyl.
 
     In the very particularly preferred definitions and the especially preferred definitions whose combination forms the range of preference (3), unless stated otherwise, 
     cation represents an alkali metal ion from the group consisting of lithium, sodium, potassium, rubidium, caesium, preferably from the group consisting of lithium, sodium, potassium, or an 
     alkaline earth metal ion from the group consisting of beryllium, magnesium, calcium, strontium, barium, preferably from the group consisting of magnesium and calcium, 
     heterocyclyl represents oxetanyl, thiethanyl, tetrahydrofuryl and morpholinyl. 
     Aryl represents phenyl, 
     hetaryl (synonymous with heteroaryl, including as part of a larger unit such as, for example, hetarylalkyl) represents a radical from the group consisting of pyridyl, pyrimidyl, pyrazinyl, pyridazinyl, thiazolyl and pyrazolyl. 
     In the definitions which form the range of preference (4), 
     halogen represents fluorine, chlorine, bromine and iodine, preferably in turn fluorine, chlorine and bromine. 
     Halogen-substituted radicals, for example haloalkyl, are mono- or polyhalogenated, up to the maximum number of possible substituents. In the case of polyhalogenation, the halogen atoms may be identical or different. In this case, halogen represents fluorine, chlorine, bromine or iodine, in particular fluorine, chlorine or bromine. 
     Saturated or unsaturated hydrocarbon radicals, such as alkyl or alkenyl, may each be straight-chain or branched if possible, including in combination with heteroatoms, as, for example, in alkoxy. 
     Unless stated otherwise, optionally substituted radicals may be mono- or polysubstituted, where the substituents in the case of poly substitutions may be the same or different. 
     If T in the radical A of the formula (A-a) 
                         
represents an electron pair, the radical is present as a pyridine derivative of the formula
 
     
       
         
         
             
             
         
       
     
     If T in the radical A of the formula (A-a) 
                         
represents oxygen, the radical is present as a pyridine N-oxide derivative of the formula
 
     
       
         
         
             
             
         
       
     
     Here, the formal charges (+ at nitrogen and − at oxygen) were omitted from the illustration. 
     The radical definitions or elucidations given in general terms or listed within areas of preference apply correspondingly to end products and to starting materials and intermediates. These radical definitions can be combined with one another as desired, i.e. including combinations between the respective ranges of preference. 
     According to the invention, preference is given to compounds of the formula (I) which contain a combination of the definitions listed above as being preferred (range of preference (1)). 
     According to the invention, particular preference is given to compounds of the formula (I) which contain a combination of the definitions listed above as being particularly preferred (range of preference (2)). 
     According to the invention, very particular preference is given to compounds of the formula (I) which contain a combination of the definitions listed above as being very particularly preferred (range of preference (3)). 
     According to the invention, special preference is given to compounds of the formula (I) which contain a combination of the definitions listed above as being special (range of preference (4)). 
     A preferred embodiment of the invention relates to compounds of the formula (I) in which A represents the radical of the formula (A-a) 
     
       
         
         
             
             
         
       
     
     A further preferred embodiment of the invention relates to compounds of the formula (I) in which A represents the radical of the formula (A-b) 
     
       
         
         
             
             
         
       
     
     A further preferred embodiment of the invention relates to compounds of the formula (I) in which A represents the radical of the formula (A-f) 
     
       
         
         
             
             
         
       
     
     A further preferred embodiment of the invention relates to compounds of the formula (I) in which A represents pyridin-3-yl. 
     A further preferred embodiment of the invention relates to compounds of the formula (I) in which A represents 5-fluoropyridin-3-yl. 
     A further preferred embodiment of the invention relates to compounds of the formula (I) in which A represents pyrimidin-5-yl. 
     A further preferred embodiment of the invention relates to compounds of the formula (I) in which A represents pyridazin-4-yl. 
     A further preferred embodiment of the invention relates to compounds of the formula (I) in which R 2  has the meanings given under a). 
     A further preferred embodiment of the invention relates to compounds of the formula (I) in which R 2  has the meanings given under b). 
     A further preferred embodiment of the invention relates to compounds of the formula (I) in which R 2  has the meanings given under c). 
     A further preferred embodiment of the invention relates to compounds of the formula (I) in which R 2  has the meanings given under d). 
     A further preferred embodiment of the invention relates to compounds of the formula (I) in which R 2  has the meanings given under e). 
     A further preferred embodiment of the invention relates to compounds of the formula (I) in which R 2  has the meanings given under f). 
     A further preferred embodiment of the invention relates to compounds of the formula (I) in which R 2  represents the radical (D-2) 
     
       
         
         
             
             
         
       
     
     The radical definitions or elucidations given above in general terms or within preferred ranges apply correspondingly to the end products (including the compounds of the formulae (I-A) to (I-N) shown later), and to the starting materials and intermediates. These radical definitions can be combined with one another as desired, i.e. including combinations between the respective ranges of preference. 
     In a preferred embodiment, the invention relates to compounds of the formula (I-A) 
     
       
         
         
             
             
         
       
     
     In a further preferred embodiment, the invention relates to compounds of the formula (I-B) 
     
       
         
         
             
             
         
       
     
     In a further preferred embodiment, the invention relates to compounds of the formula (I-C) 
     
       
         
         
             
             
         
       
     
     In a further preferred embodiment, the invention relates to compounds of the formula (I-D) 
     
       
         
         
             
             
         
       
     
     In a further preferred embodiment, the invention relates to compounds of the formula (I-E) 
     
       
         
         
             
             
         
       
     
     In a further preferred embodiment, the invention relates to compounds of the formula (I-F) 
     
       
         
         
             
             
         
       
     
     In a further preferred embodiment, the invention relates to compounds of the formula (I-G) 
     
       
         
         
             
             
         
       
     
     In a further preferred embodiment, the invention relates to compounds of the formula (I-H) 
     
       
         
         
             
             
         
       
     
     In a further preferred embodiment, the invention relates to compounds of the formula (I-I) 
     
       
         
         
             
             
         
       
     
     In a further preferred embodiment, the invention relates to compounds of the formula (I-J) 
     
       
         
         
             
             
         
       
     
     In a further preferred embodiment, the invention relates to compounds of the formula (I-K) 
     
       
         
         
             
             
         
       
     
     In a further preferred embodiment, the invention relates to compounds of the formula (I-L) 
     
       
         
         
             
             
         
       
     
     In a further preferred embodiment, the invention relates to compounds of the formula (I-M) 
     
       
         
         
             
             
         
       
     
     In a further preferred embodiment, the invention relates to compounds of the formula (I-N) 
     
       
         
         
             
             
         
       
     
     In the formulae (I-A) to (I-N), the variables G 2 , R, R 3 , R 8 , R 22 , R 23 W, X 1 , Y 2  and n have the meanings mentioned above. 
     The compounds of the formula (I) according to the invention and their acid addition salts and metal salt complexes are highly active, in particular in the control of animal pests including arthropods and in particular insects. 
     The compounds of the formula (I) may possibly also, depending on the nature of the substituents, be in the form of stereoisomers, i.e. in the form of geometric and/or optical isomers or isomer mixtures of varying composition. This invention provides both the pure stereoisomers and any desired mixtures of these isomers, even though it is generally only compounds of the formula (I) that are discussed here. 
     The invention therefore relates both to the pure enantiomers and diastereomers and to mixtures thereof for controlling animal pests, including arthropods and particularly insects. 
     However, preference is given in accordance with the invention to using the optically active, stereoisomeric forms of the compounds of the formula (I) and salts thereof. 
     Suitable salts of the compounds of the general formula (I) include customary nontoxic salts, i.e. salts with appropriate bases and salts with added acids. Preference is given to salts with inorganic bases, such as alkali metal salts, for example sodium, potassium or caesium salts, alkaline earth metal salts, for example calcium or magnesium salts, ammonium salts, salts with organic bases and with inorganic amines, for example triethylammonium, dicyclohexylammonium, N,N′-dibenzylethylenediammonium, pyridinium, picolinium or ethanolammonium salts, salts with inorganic acids, for example hydrochlorides, hydrobromides, dihydrosulfates, trihydrosulfates, or phosphates, salts with organic carboxylic acids or organic sulfonic acids, for example formates, acetates, trifluoroacetates, maleates, tartrates, methanesulfonates, benzenesulfonates or para-toluenesulfonates, salts with basic amino acids, for example arginates, aspartates or glutamates, and the like. 
     It has additionally been found that the compounds of the formula (I) can be prepared by the processes described below. 
     Compounds of the formula (I) in which the heterocycle A represents optionally B 2 -substituted pyrimidin-5-yl (A-a; G 1 =N), pyridin-3-yl (A-a; G 1 =C—B 1 ), pyrazin-2-yl (A-b), pyridazin-3-yl (A-c), thiazol-5-yl (A-d), isothiazol-4-yl (A-e) and pyrazol-4-yl (A-f) can, for example, be prepared according to Reaction Scheme I in two steps. 
     
       
         
         
             
             
         
       
     
     In Reaction Scheme I, A and R 2 , unless indicated otherwise, have the meanings mentioned above. 
     For example, the 2-substituted 5-nitro-4-pyridinecarboxaldehydes of the formula (A-1) can be reacted with the corresponding 3-amino-substituted heterocycles of the formula (A-2) in the presence of acidic reaction auxiliaries in a first reaction step to give compounds of the formula (A-3) which are then, in a second reaction step, subjected to reductive cyclization in the presence of a suitable phosphorus(III) reagent, for example triethyl phosphite, with formation of the compounds (A-4). 
     If, in the process according to the invention for preparing the compounds of the formula (I), the compound of the formula (A-1) employed is methyl 4-formyl-5-nitro-2-pyridinecarboxylate (R 2 ═COOCH 3 ) and the compound of the formula (A-2) employed is 3-pyridineamine (A=pyridin-3-yl), initially the methyl 4-[(1E)-2-(dimethylamino)ethenyl]-5-nitro-2-pyridinecarboxylate (A=3-pyridin-3-yl, R 2 ═COOCH 3 ) is formed as so-called “Schiff base”. Subsequent reduction and cyclization then leads to the 5-substituted 2-(pyridin-3-yl)-2H-pyrazolo[3,4-b]pyridine-5-carboxylic acid (A-4, A=pyridin-3-yl, R 2 ═COOCH 3 ), which can be used as starting material for the compounds of the formula (I) (cf. preparation examples). 
     Azomethine derivatives or so-called “Schiff bases” of amino-substitutes heterocycles have various applications (they form, for example, metal complexes or are biologically active) and can be obtained by customary processes (cf. also V. Shama, et al.,  Intern. J. Univ. Pharm. Bio Science  2013, 2, 241-57 and the literature cited therein). 
     Some of the compounds of the formula (A-1) are known and commercially available (e.g. for R 2 ═Br, 2-bromo-5-nitroisonicotinaldehyde/Anichem Product List), or they can be obtained by preparation processes known in principle (for R 2 ═Cl; 2-chloro-5-nitro-4-pyridinecarboxaldehyde, WO 2010/026121 A1; R 2 =NH 2 ; 2-amino-5-nitro-4-pyridinecarboxaldehyde, M. Andaloussi et al.,  Tetrahedron Lett.  48, 8392-8395, 2007). 
     For example, methyl 4-formyl-5-nitro-2-pyridinecarboxylate (R 2 ═COOCH 3 ) can be synthesized from methyl 4-methyl-5-nitro-2-pyridinecarboxylate via N,N-dimethylformamide O,O-dimethyl acetal reaction and subsequent sodium periodate oxidation according to Reaction Scheme II (cf. preparation examples, synthesis of intermediates). 
     
       
         
         
             
             
         
       
     
     Some of the compounds of the formula (A-2) are known and commercially available and/or they can be prepared by preparation processes known in principle, cf., for example, for A=5-fluoropyridin-3-yl (A-a; B 2 ═H, G 1 =C—F; T=electron pair) (WO 2011/123751 A2); pyrazin-2-yl (A-b; B 2 ═H) (WO 2012/151567 A1); pyridazin-4-yl (A-c; B 2 ═H) (WO 2011/038572 A1); thiazol-5-yl (A-d; B 2 ═H) (JP 4600 6049 B4); isothiazol-4-yl (A-e; B 2 ═H) (U.S. Pat. No. 2,839,529) or 1-methyl-1H-pyrazol-4-yl (A-f; B 2 ═H, R 3 ═CH 3 ). 
     The compounds of the formula (A-3) can be obtained by step 1 of the preparation process mentioned, or by synthesis methods known in principle, cf., for example, the preparation of 4-methyl-N-[(3-nitro-4-pyridinyl)methylene]benzamine (H. E. Baumgarten et al.,  J. Amer. Chem. Soc.  77, 2438-2440, 1955). 
     Finally, the compounds of the formula (I) can be obtained by Step 2 of the preparation process mentioned by reductive cyclization of the 4-imino-5-nitropyridines of the formula (A-3), for example by the Candogan indazole synthesis in the presence of triethyl phosphite (cf. J. I. G. Candogan et al.,  J. Chem. Soc.  1965, 4831; N. E. Genung et al.,  Org. Lett.  16, 3114-3117, 2014 and synthesis of azaindoles: WO 2008/147822 A1 and WO 2010/056999). 
     Alternatively, it is also possible to utilize modified Candogan et al. reductive cyclization reaction conditions or to employ alternative reaction conditions, for example the transition metal-catalyzed reductive cyclization of iminonitroaromatics and the thermal transition metal-catalyzed cyclization of 2-azidoimines (cf. N. E. Genung et al.,  Org. Lett.  2014, 16, 3114-3117 and the literature cited therein). 
     In the presence of the phosphorus(III) reagent, initially the nitro group in substrate (A-3) is reduced with formation of a nitroso group (cf. N. E. Genung et al.,  Org. Lett.  2014, 16, 3114-3117) which subsequently forms a nitrene or a nitrene-like intermediate which then causes intramolecular cyclization. Besides triethyl phosphite, it is also possible to use tricyclohexylphosphine, tri(n-butyl)phosphine or tri(tert-butyl)phosphine (M.-A. Armour et al.,  J. Chem. Soc., Perkin Trans.  2 1975, 1185-1189; N. E. Genung et al.,  Org. Lett.  2014, 16, 3114-3117) as alternative phosphorus(III) reagents. 
     Compounds of the formula (I) in which R 2  represents a radical from the group consisting of (B-1) to (B-36) can be prepared, for example, from compounds of the formula (I) in which R 2  represents halogen from the group consisting of bromine and iodine, by known methods (Method A: cf. J. C. Antilla et al.,  J. Org. Chem.,  2004, 69, 5578-5587 and Method B: cf. H. Dong et al.,  Org. Lett.,  2011, 13, 2726-2729; Ch. O. Ndubaku et al.,  J. Med. Chem.,  2013, 56, 4597-4610; T. Furuya et al.,  J. Am. Chem. Soc.,  2010, 132, 3793-3807). 
     Compounds of the formula (I) in which R 2  represents halogen, for example bromine or iodine, can be obtained according to Reaction Scheme I from the corresponding 2-halogenated 6-formyl-5-nitropyridines (A-1). 
     For example, the compounds of the formula (I) in which R 2  represents a radical (B-2), (B-21) or (B-23) can be obtained according to Reaction Scheme III. 
     
       
         
         
             
             
         
       
     
     In Reaction Scheme III, the compounds (I-e) and (B-21) in which G 2  has the meaning mentioned further above have a nucleofugic leaving group LG, which is optionally generated in situ. 
     Compounds of the formula (I) in which R 2  represents a radical (B-1), (B-2), (B-10), (B-29) or (B-30) can be prepared by Method A, which is known from the literature, preferably in the presence of copper(I) iodide and basic reaction auxiliaries, for example trans-N,N′-dimethylcyclohexane-1,2-diamine and potassium carbonate, in a suitable solvent or diluent. Useful solvents or diluents include all inert organic solvents, for example aliphatic or aromatic hydrocarbons. 
     Preference is given to using aromatic hydrocarbons such as, for example, toluene. 
     The preparation of the compounds of the formula (I) in which R 2  represents a radical (B-3) to (B-9), (B-11) to (B-28) and (B-31) to (B-33) can take place similar to Methods B and C shown in Reaction Scheme III. 
     For example, the compounds (B-3) to (B-9), (B-11) to (B-28) and (B-31) to (B-33) having a suitable leaving group (LG=B(OH) 2 ) or (hetero)arylboronic ester (LG=B(OR) 2 ) can be reacted with the appropriate compounds of the formula (I-a) according to known methods (cf.  Chem. Rev.  1995, 95, 2457-2483 ; Tetrahedron  2002, 58, 9633-9695 ; Metal - Catalyzed Cross - Coupling Reactions  (Eds.: A. de Meijere, F. Diederich), 2nd ed., Wiley-VCH, Weinheim, 2004) in the presence of suitable catalysts from the group of the transition metal salts to give compounds of the formula (I-B-3) to (I-B-9), (I-B-11) to (I-B-28) and (I-B-31) to (I-B-33). 
     Some of the compounds (B-3) to (B-9), (B-11) to (B-13) and (B-21) to (B-33) having a suitable leaving group (LG=B(OH) 2  or (hetero)arylboronic ester, LG=B(OR) 2 ) are known or they can be prepared by generally known methods: e.g. 1-(methyl-1H-pyrazol-4-yl)boronic acid [(B-3), LG=B(OH) 2 , G 2 =hydrogen, WO 2009/155527], 2-phenyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)oxazole [(B-6), LG=B(OCMe 2 ) 2 , G 2 =phenyl, WO 2010/094755]; thiazol-2-ylboronic acid [(B-7), LG=B(OH) 2 , G 2 =hydrogen, U.S. Pat. No. 6,310,095 B1]; 5-phenyl-1,2,4-thiadiazol-3-ylboronic acid [(B-13), LG=B(OH) 2 , G 2 =phenyl, DE 19710614 A1], pyridin-3-ylboronic acid [(B-21) vs (B-22), LG=B(OH) 2 , G 2 =hydrogen, WO 2013/186089]; 1,3,5-triazin-2-ylboronic acid [(B-28), LG=B(OH) 2 , G 2 =hydrogen, KR 2011/079401]. 
     Alternatively, the compounds of the formula (I-a) can initially be converted by methods known from the literature into compounds of the formula (I-e) which are then reacted further with halogen-activated heterocycles according to Reaction Scheme III by Method C (cf. T. Ishiyama et al.,  J. Org. Chem.,  1995, 60, 7508-7510; WO 2010/151601). 
     Some halogen-activated compounds (B-3) to (B-9), (B-11) to (B-13) and (B-21) to (B-33) are known or can be prepared by generally known methods: e.g. 3-bromo-4,5-dihydro-1-phenyl-1H-pyrazole [(B-18), LG=Br, G 2 =phenyl, J. Elguero et al.,  Bull. Soc. Chim. France  1996, 5, 1683-1686]. 
     The preparation of compounds of the formula (I) in which R 2  represents a radical (B-21) or (B-23) can be carried out similar to Methods B and C, which are known from the literature and shown in Reaction Scheme III, preferably in the presence of suitable coupling catalysts, basic reaction auxiliaries and in a suitable solvent or diluent. Useful solvents or diluents include all inert organic solvents, for example aliphatic or aromatic hydrocarbons. 
     Preference is given to using aromatic hydrocarbons such as, for example, toluene. 
     The preparation of compounds of the formula (I) in which R 2  represents a radical (B-3) to (B-9), (B-11) to (B-28) and (B-31) to (B-33) can be carried out similar to Methods B and C, which are shown in Reaction Scheme III, preferably in the presence of suitable coupling catalysts, basic reaction auxiliaries and in a suitable solvent or diluent. 
     Examples of preferred coupling catalysts include palladium catalysts such as [1,1′-bis(diphenylphosphino)ferrocene]dichloropalladium(II) or tetrakis(triphenylphosphine)palladium. 
     Suitable basic reaction auxiliaries used for carrying out the processes according to Reaction Scheme III are preferably carbonates of sodium or potassium. 
     Preference is given to using nitriles such as acetonitrile, benzonitrile, in particular acetonitrile, or ethers such as diethyl ether, dioxane, tetrahydrofuran, 1,2-dimethoxyethane, in particular 1,2-dimethoxyethane in combination with water. 
     Compounds of the formula (I) in which R 2  represents a radical from the group consisting of (C-1) to (C-9) or represents CX—NR 22 R 23  can be prepared, for example, from compounds of the formula (I) in which R 2  represents a carboxyl group, following suitable activation (i.e. LG represents a nucleofugic leaving group optionally generated in situ) by known methods. 
     For example, the compounds of the formula (I) in which R 2  represents a radical (C-1) or represents CX—NR 22 R 23  can be obtained according to Reaction Scheme IV (cf. also preparation examples for (I-C-1): A=5-fluoropyridin-3-yl; R 8 ═H, R 9 ═N(CH 3 ) 2 , n=2 in Example 10; (I-d): A=pyridin-3-yl; R 22 , R 23 ═CH 3  in Example 7). 
     
       
         
         
             
             
         
       
     
     Compounds of the formula (I) in which R 2  represents carboxyl can be obtained according to Reaction Scheme I from corresponding methyl 4-formyl-5-nitro-2-pyridinecarboxylates (A-1; R 2 ═COOR). Subsequent ester hydrolysis by customary methods then leads to the compounds of the formula (I-b). 
     Suitable condensing agents for activating the carboxylic acids of the formula (I-b) are all condensing agents customarily used for such amidation reactions. Examples include acid halide formers such as phosgene, phosgene derivatives such as carbonyldiimidazole (CDI), phosphorus trichloride, oxalyl chloride or thionyl chloride; carbodiimides such as N,N′-dicyclohexylcarbodiimide (DCC) and 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide (EDCI), or other customary condensing agents such as phosphorus pentoxide, polyphosphoric acid, N,N′-carbonyldiimidazole, 2-chloropyridine 1-methoiodide (Mukaiyama&#39;s reagent), 2-ethoxy-N-ethoxycarbonyl-1,2-dihydroquinoline (EEDQ), triphenylphosphine/carbon tetrachloride, bromotripyrrolidinophosphonium hexafluorophosphate (BROP), O-(1H-benzotriazol-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate (BOP), bis(2-oxo-3-oxazolidinyl)phosphinic chloride (BOP-Cl), N,N,N′,N′-bis(tetramethylene)chlorouronium tetrafluoroborate, O-(1H-benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate (HBTU), O-(1H-benzotriazol-1-yl)-N,N,N′,N′-bis(tetramethylene)uronium hexafluorophosphate, O-(1H-benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate (TBTU), O-(1H-benzotriazol-1-yl)-N,N,N′,N′-bis(tetramethylene)uronium tetrafluoroborate, O-(7-azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate (HATU), 1-hydroxybenzotriazole (HOBt) and 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium salt (DMT.MM), usually available as chloride. These reagents can be used separately or, if appropriate, in combination. 
     However, for the targeted activation of the compounds of the formula (I-b) it is also possible to use mixed anhydrides (LG=COOR), which lead to the preparation of compounds of the formulae (I-C-1) and (I-d) (cf. G. W. Anderson et al.  J. Am. Chem. Soc.  1967, 89, 5012-5017). Various chloroformic esters can be employed in this process, such as, for example, isobutyl chloroformate (LG=COOR where R=isobutyl) and isopropyl chloroformate (LG=COOR where R=isopropyl). Likewise, it is possible for this purpose to use diethylacetyl chloride, trimethylacetyl chloride and similar compounds. 
     The subsequent reaction of the activated compounds of the formula (I-c) with the respective amine components according to Reaction Scheme IV is optionally carried out in the presence of a suitable reaction auxiliary and in the presence of a suitable solvent or diluent. 
     Suitable reaction auxiliaries for carrying out the processes according to Reaction Scheme IV are basic reaction auxiliaries. 
     Examples which may be mentioned are the hydroxides, hydrides, oxides and carbonates of lithium, sodium, potassium, magnesium, calcium and barium, furthermore further basic compounds such as amidine bases or guanidine bases, such as 7-methyl-1,5,7-triazabicyclo[4.4.0]dec-5-ene (MTBD); diazabicyclo[4.3.0]nonene (DBN), diazabicyclo[2.2.2]octane (DABCO), 1,8-diazabicyclo[5.4.0]undecene (DBU), cyclohexyltetrabutylguanidine (CyTBG), cyclohexyltetramethylguanidine (CyTMG), N,N,N,N-tetramethyl-1,8-naphthalenediamine, pentamethylpiperidine, tertiary amines, such as triethylamine, trimethylamine, tribenzylamine, triisopropylamine, tributylamine, tricyclohexylamine, triamylamine, trihexylamine, N,N-dimethylaniline, N,N-dimethyltoluidine, N,N-dimethyl-p-aminopyridine, N-methylpyrrolidine, N-methylpiperidine, N-methylimidazole, N-methylpyrazole, N-methylmorpholine, N-methylhexamethylenediamine, pyridine, 4-pyrrolidinopyridine, 4-dimethylaminopyridine, quinoline, α-picoline, β-picoline, isoquinoline, pyrimidine, acridine, N,N,N′,N′-tetramethylenediamine, N,N′,′-tetraethylenediamine, quinoxaline, N-propyldiisopropylamine, N-ethyldiisopropylamine (“Hünig&#39;s Base”), N,N′-dimethylcyclohexylamine, 2,6-lutidine, 2,4-lutidine or triethylenediamine. 
     Suitable for use as basic reaction auxiliaries for carrying out the processes according to Reaction Scheme IV are all suitable acid binders, for example amines, in particular tertiary amines, and alkali metal and alkaline earth metal compounds. 
     For preparing the compounds of the formula (I-C-1) or (I-d), use is preferably made of tertiary amines such as N-propyldiisopropylamine or N-ethyldiisopropylamine (DIEA; Hünig&#39;s base). 
     Suitable solvents or diluents include all inert organic solvents, for example aliphatic or aromatic hydrocarbons (such as petroleum ether, toluene), halogenated hydrocarbons (such as chlorotoluene, dichloromethane, chloroform, 1,2-dichloroethane), ethers (such as diethyl ether, dioxane, tetrahydrofuran, 1,2-dimethoxyethane), esters (such as ethyl or methyl acetate), nitrohydrocarbons (such as nitromethane, nitroethane, nitrobenzene), nitriles (such as acetonitrile, benzonitrile), amides (such as N,N-dimethylformamide, N,N-dimethylacetamide, N-methylformanilide, N-methylpyrrolidone, hexamethylphosphoramide), and also dimethyl sulfoxide or water or mixtures of the solvents mentioned. 
     Preference is given to using amides as solvents, for example N,N-dimethylformamide. 
     Compounds of the formula (I) in which R 2  represents a radical from the group consisting of (D-1) to (D-3) can be prepared, for example, from compounds of the formula (I) in which R 2  represents halogen from the group consisting of bromine and iodine, by methods known in principle. 
     For example, the compounds of the formula (I) in which R 2  represents a radical from the group consisting of (D-1) to (D-3) can be obtained according to Reaction Scheme V by methods known from the literature (cf. US2013/0267493; T. Furuya et al.,  J. Am. Chem. Soc.,  2010, 132, 3793-3807). 
     
       
         
         
             
             
         
       
     
     In Reaction Scheme V, the compounds (D-2) in which W represents S, SO or SO 2  have a nucleofugic leaving group LG, which is optionally generated in situ. 
     For example, the compounds (D-1) to (D-3) having a suitable leaving group (LG=B(OH) 2 ) or (hetero)arylboronic ester (LG=B(OR) 2 ) can be reacted with the appropriate compounds of the formula (I-a) according to known methods (cf.  Chem. Rev.  1995, 95, 2457-2483 ; Tetrahedron  2002, 58, 9633-9695 ; Metal - Catalyzed Cross - Coupling Reactions  (Eds.: A. de Meijere, F. Diederich), 2nd ed., Wiley-VCH, Weinheim, 2004) in the presence of suitable catalysts from the group of the transition metal salts to give compounds of the formulae (I-D-1) to (I-D-3). 
     The preparation of compounds of the formula (I) in which R 2  represents a radical (D-1) to (D-3) can be carried out similar to Reaction Scheme V, preferably in the presence of suitable coupling catalysts, basic reaction auxiliaries and in a suitable solvent or diluent. 
     Examples of preferred coupling catalysts include palladium catalysts such as [1,1′-bis(diphenylphosphino)ferrocene]dichloropalladium(II) or tetrakis(triphenylphosphine)palladium. 
     Suitable basic reaction auxiliaries used for carrying out the processes according to Reaction Scheme III are preferably carbonates of sodium or potassium. 
     Preference is given to using nitriles such as acetonitrile, benzonitrile, in particular acetonitrile, or ethers such as diethyl ether, dioxane, tetrahydrofuran, 1,2-dimethoxyethane, in particular 1,2-dimethoxyethane in combination with water. 
     Subsequent oxidation of the sulfur in the compounds of the formula (I-D-2) in which W represents sulfur leads to compounds of the formula (I-D-2) in which W represents SO or SO 2  (cf. Reaction Scheme V) 
     Compounds of the formula (I) in which W is SO (sulfoxides) or SO 2  (sulfones) can be prepared from compounds of the formula (I) in which W is S (thioethers) by oxidation by processes known from the literature, for example by means of an oxidizing agent in a suitable solvent or diluent. Suitable oxidizing agents are, for example, diluted nitric acid, hydrogen peroxide, Oxone® and peroxycarboxylic acids, for example meta-chloroperbenzoic acid. Suitable solvents or diluents are inert organic solvents, typically acetonitrile and halogenated solvents such as dichloromethane, chloroform or dichloroethane, and water and alcohols such as methanol for the reaction with Oxone®. 
     A variety of methods are suitable for producing enantiomerically enriched sulfoxides, as described by G. E. O&#39;Mahony et al., in  ARKIVOC  ( Gainesville, Fla., United States ), 2011, 1, 1-110: metal-catalysed asymmetric oxidations of thioethers, for example with titanium or vanadium as the most frequently utilized catalyst sources, in the form of Ti(O i Pr 4 ) or VO(acac) 2 , together with a chiral ligand and an oxidizing agent such as tert-butyl hydroperoxide (TBHP), 2-phenylpropan-2-yl hydroperoxide (CHP) or hydrogen peroxide; non-metal-catalysed asymmetric oxidations through use of chiral oxidizing agents or chiral catalysts; electrochemical or biological asymmetric oxidations and also kinetic resolution of sulfoxides and nucleophilic displacement (by Andersen&#39;s method). 
     Compounds of the formula (I) in which R 2  represents —NR 23 —C(X)—R 22  can be obtained, for example, from compounds of the formula (I) in which R 2  represents —NHR 23  via N-acylation reaction using activated compounds of the formula LG-CX—R 22  in which LG represents a nucleofugic leaving group which is optionally generated in situ. 
     These compounds of the formula (I) in which R 2  represents —NHR 23  can be prepared from compounds of the formula (I) in which R 2  represents a carboxyl group according to Reaction Scheme VI, by known methods. 
     
       
         
         
             
             
         
       
     
     For example, compounds of the formula (I-f) can be obtained by Curtius degradation as described, for example, in Houben-Weyl,  Methoden der Organischen Chemie  [Methods of Organic Chemistry], Volume XI/1 (Georg Thieme Verlag Stuttgart), p. 865. 
     Here, the compounds of the formula (I-b) can, for example, be reacted directly with diphenylphosphoryl azide (DPPA) in the presence of tert-butanol to give compounds of the formula (I-f). 
     From the compounds of the formula (I-f), it is possible to obtain the compounds of the formula (I-g) by N-alkylation in a first reaction step, N-deblocking (i.e. cleavage of the Boc group) in a second reaction step and subsequent N-acylation in a third reaction step. 
     The compounds of the formula (I-h) can be prepared by N-deblocking (i.e. cleavage of the Boc group) in a first reaction step and subsequent N-acylation in a second reaction step. 
     In general, for the removal of the protecting group, it is possible to use suitable acidic or basic reaction auxiliaries according to the literature procedure. When protecting groups of the carbamate type are used, preference is given to using acidic reaction auxiliaries. When the tert-butyl carbamate protective group (Boc group) is used, for example, mixtures of mineral acids such as hydrochloric acid, hydrobromic acid, nitric acid, sulfuric acid, phosphoric acid or of organic acids such as benzoic acid, formic acid, acetic acid, trifluoroacetic acid, methanesulfonic acid, benzenesulfonic acid or toluenesulfonic acid, in a suitable diluent such as water and/or an organic solvent such as tetrahydrofuran, dioxane, dichloromethane, chloroform, ethyl acetate, ethanol or methanol are used. Preference is given to mixtures of hydrochloric acid or acetic acid with water and/or an organic solvent such as ethyl acetate. 
     Isomers 
     Depending on the nature of the substituents, the compounds of the formula (I) may be in the form of geometric and/or optically active isomers or corresponding isomer mixtures in different compositions. These stereoisomers are, for example, enantiomers, diastereomers, atropisomers or geometric isomers. The invention therefore encompasses pure stereoisomers and any desired mixtures of these isomers. 
     Methods and Uses 
     The invention also relates to methods for controlling animal pests, in which compounds of the formula (I) are allowed to act on animal pests and/or their habitat. The control of the animal pests is preferably conducted in agriculture and forestry, and in material protection. This preferably excludes methods for surgical or therapeutic treatment of the human or animal body and diagnostic methods carried out on the human or animal body. 
     The invention further relates to the use of the compounds of the formula (I) as pesticides, especially crop protection agents. 
     In the context of the present application, the term “pesticide” also always encompasses the term “crop protection agent”. 
     The compounds of the formula (I), given good plant tolerance, favourable homeotherm toxicity and good environmental compatibility, are suitable for protecting plants and plant organs against biotic and abiotic stress factors, for increasing harvest yields, for improving the quality of the harvested material and for controlling animal pests, especially insects, arachnids, helminths, nematodes and molluscs, which are encountered in agriculture, in horticulture, in animal husbandry, in aquatic cultures, in forests, in gardens and leisure facilities, in the protection of stored products and of materials, and in the hygiene sector. They can preferably be used as pesticides. They are active against normally sensitive and resistant species and also against all or specific stages of development. The abovementioned pests include: 
     pests from the phylum of the Arthropoda, especially from the class of the Arachnida, for example  Acarus  spp., for example  Acarus siro, Aceria kuko, Aceria sheldoni, Aculops  spp.,  Aculus  spp., for example  Aculus fockeui, Aculus schlechtendali, Amblyomma  spp.,  Amphitetranychus viennensis, Argas  spp.,  Boophilus  spp.,  Brevipalpus  spp., for example  Brevipalpus phoenicis, Bryobia graminum, Bryobia praetiosa, Centruroides  spp.,  Chorioptes  spp.,  Dermanyssus gallinae, Dermatophagoides pteronyssinus, Dermatophagoides farinae, Dermacentor  spp.,  Eotetranychus  spp., for example  Eotetranychus hicoriae, Epitrimerus pyri, Eutetranychus  spp., for example  Eutetranychus banksi, Eriophyes  spp., for example  Eriophyes pyri, Glycyphagus domesticus, Halotydeus destructor, Hemitarsonemus  spp., for example  Hemitarsonemus latus  (= Polyphagotarsonemus latus ),  Hyalomma  spp.,  Ixodes  spp.,  Latrodectus  spp.,  Loxosceles  spp.,  Neutrombicula autumnalis, Nuphersa  spp.,  Oligonychus  spp., for example  Oligonychus coffeae, Oligonychus coniferarum, Oligonychus ilicis, Oligonychus indicus, Oligonychus mangiferus, Oligonychus pratensis, Oligonychus punicae, Oligonychus yothersi, Ornithodorus  spp.,  Ornithonyssus  spp.,  Panonychus  spp., for example  Panonychus citri  (= Metatetranychus citri ),  Panonychus ulmi  (= Metatetranychus ulmi ),  Phyllocoptruta oleivora, Platytetranychus multidigituli, Polyphagotarsonemus latus, Psoroptes  spp.,  Rhipicephalus  spp.,  Rhizoglyphus  spp.,  Sarcoptes  spp.,  Scorpio maurus, Steneotarsonemus  spp.,  Steneotarsonemus spinki, Tarsonemus  spp., for example  Tarsonemus confusus, Tarsonemus pallidus, Tetranychus  spp., for example  Tetranychus canadensis, Tetranychus cinnabarinus, Tetranychus turkestani, Tetranychus urticae, Trombicula alfreddugesi, Vaejovis  spp.,  Vasates lycopersici;    
     from the class of the Chilopoda, for example  Geophilus  spp.,  Scutigera  spp.; 
     from the order or the class of the Collembola, for example  Onychiurus armatus; Sminthurus viridis;    
     from the class of the Diplopoda, for example  Blaniulus guttulatus;    
     from the class of the Insecta, for example from the order of the Blattodea, for example  Blatta orientalis, Blattella asahinai, Blattella germanica, Leucophaea maderae, Loboptera decipiens, Neostylopyga rhombifolia, Panchlora  spp.,  Parcoblatta  spp.,  Periplaneta  spp., for example  Periplaneta americana, Periplaneta australasiae, Pycnoscelus surinamensis, Supella longipalpa;    
     from the order of the Coleoptera, for example  Acalymma vittatum, Acanthoscelides obtectus, Adoretus  spp.,  Aethina tumida, Agelastica alni, Agriotes  spp., for example  Agriotes linneatus, Agriotes mancus, Alphitobius diaperinus, Amphimallon solstitialis, Anobium punctatum, Anoplophora  spp.,  Anthonomus  spp., for example  Anthonomus grandis, Anthrenus  spp.,  Apion  spp.,  Apogonia  spp.,  Atomaria  spp., for example  Atomaria linearis, Attagenus  spp.,  Baris caerulescens, Bruchidius obtectus, Bruchus  spp., for example  Bruchus pisorum, Bruchus rufimanus, Cassida  spp.,  Cerotoma trifurcata, Ceutorrhynchus  spp., for example  Ceutorrhynchus assimilis, Ceutorrhynchus quadridens, Ceutorrhynchus rapae, Chaetocnema  spp., for example  Chaetocnema confinis, Chaetocnema denticulata, Chaetocnema ectypa, Cleonus mendicus, Conoderus  spp.,  Cosmopolites  spp., for example  Cosmopolites sordidus, Costelytra zealandica, Ctenicera  spp.,  Curculio  spp., for example  Curculio caryae, Curculio caryatrypes, Curculio obtusus, Curculio sayi, Cryptolestes ferrugineus, Cryptolestes pusillus, Cryptorhynchus lapathi, Cryptorhynchus mangiferae, Cylindrocopturus  spp.,  Cylindrocopturus adspersus, Cylindrocopturus furnissi, Dermestes  spp.,  Diabrotica  spp., for example  Diabrotica balteata, Diabrotica barberi, Diabrotica undecimpunctata howardi, Diabrotica undecimpunctata undecimpunctata, Diabrotica virgifera virgifera, Diabrotica virgifera zeae, Dichocrocis  spp.,  Dicladispa armigera, Diloboderus  spp.,  Epicaerus  spp.,  Epilachna  spp., for example  Epilachna borealis, Epilachna varivestis, Epitrix  spp., for example  Epitrix cucumeris, Epitrix fuscula, Epitrix hirtipennis, Epitrix subcrinita, Epitrix tuberis, Faustinus  spp.,  Gibbium psylloides, Gnathocerus cornutus, Hellula undalis, Heteronychus arator, Heteronyx  spp.,  Hylamorpha elegans, Hylotrupes bajulus, Hypera postica, Hypomeces squamosus, Hypothenemus  spp., for example  Hypothenemus hampei, Hypothenemus obscurus, Hypothenemus pubescens, Lachnosterna consanguinea, Lasioderma serricorne, Latheticus oryzae, Lathridius  spp.,  Lema  spp.,  Leptinotarsa decemlineata, Leucoptera  spp., for example  Leucoptera coffeella, Lissorhoptrus oryzophilus, Listronotus  (=Hyperodes) spp.,  Lixus  spp.,  Luperomorpha xanthodera, Luperodes  spp.,  Lyctus  spp.,  Megascelis  spp.,  Melanotus  spp., for example  Melanotus longulus oregonensis, Meligethes aeneus, Melolontha  spp., for example  Melolontha melolontha, Migdolus  spp.,  Monochamus  spp.,  Naupactus xanthographus, Necrobia  spp.,  Neogalerucella  spp.,  Niptus hololeucus, Oryctes rhinoceros, Oryzaephilus surinamensis, Oryzaphagus oryzae, Otiorhynchus  spp., for example  Otiorhynchus cribricollis, Otiorhynchus ligustici, Otiorhynchus ovatus, Otiorhynchus rugosostriarus, Otiorhynchus sulcatus, Oulema  spp., z.B.  Oulema melanopus, Oulema oryzae, Oxycetonia jucunda, Phaedon cochleariae, Phyllophaga  spp.,  Phyllophaga helleri, Phyllotreta  spp., for example  Phyllotreta armoraciae, Phyllotreta pusilla, Phyllotreta ramosa, Phyllotreta striolata, Popillia japonica, Premnotrypes  spp.,  Prostephanus truncatus, Psylliodes  spp., for example  Psylliodes affinis, Psylliodes chrysocephala, Psylliodes punctulata, Ptinus  spp.,  Rhizobius ventralis, Rhizopertha dominica, Rhynchophorus  spp.,  Rhynchophorus ferrugineus, Rhynchophorus palmarum, Sinoxylon perforans, Sitophilus  spp., for example  Sitophilus granarius, Sitophilus linearis, Sitophilus oryzae, Sitophilus zeamais, Sphenophorus  spp.,  Stegobium paniceum, Sternechus  spp., for example  Sternechus paludatus, Symphyletes  spp.,  Tanymecus  spp., for example  Tanymecus dilaticollis, Tanymecus indicus, Tanymecus palliatus, Tenebrio molitor, Tenebrioides mauretanicus, Tribolium  spp., for example  Tribolium audax, Tribolium castaneum, Tribolium confusum, Trogoderma  spp.,  Tychius  spp.,  Xylotrechus  spp.,  Zabrus  spp., for example  Zabrus tenebrioides;    
     from the order of the Dermaptera, for example  Anisolabis maritime, Forficula auricularia, Labidura riparia;    
     from the order of the Diptera, for example  Aedes  spp., for example  Aedes aegypti, Aedes albopictus, Aedes sticticus, Aedes vexans, Agromyza  spp., for example  Agromyza frontella, Agromyza parvicornis, Anastrepha  spp.,  Anopheles  spp., for example  Anopheles quadrimaculatus, Anopheles gambiae, Asphondylia  spp.,  Bactrocera  spp., for example  Bactrocera cucurbitae, Bactrocera dorsalis, Bactrocera oleae, Bibio hortulanus, Calliphora erythrocephala, Calliphora vicina, Ceratitis capitata, Chironomus  spp.,  Chrysomya  spp.,  Chrysops  spp.,  Chrysozona pluvialis, Cochliomya  spp.,  Contarinia  spp., for example  Contarinia johnsoni, Contarinia nasturtii, Contarinia pyrivora, Contarinia schulzi, Contarinia sorghicola, Contarinia tritici, Cordylobia anthropophaga, Cricotopus sylvestris, Culex  spp., for example  Culex pipiens, Culex quinquefasciatus, Culicoides  spp.,  Culiseta  spp.,  Cuterebra  spp.,  Dacus oleae, Dasineura  spp., for example  Dasineura brassicae, Delia  spp., for example  Delia antiqua, Delia coarctata, Delia florilega, Delia platura, Delia radicum, Dermatobia hominis, Drosophila  spp., for example  Drosphila melanogaster, Drosophila suzukii, Echinocnemus  spp.,  Euleia heraclei, Fannia  spp.,  Gasterophilus  spp.,  Glossina  spp.,  Haematopota  spp.,  Hydrellia  spp.,  Hydrellia griseola, Hylemya  spp.,  Hippobosca  spp.,  Hypoderma  spp.,  Liriomyza  spp., for example  Liriomyza brassicae, Liriomyza huidobrensis, Liriomyza sativae, Lucilia  spp., for example  Lucilia cuprina, Lutzomyia  spp.,  Mansonia  spp.,  Musca  spp., for example  Musca domestica, Musca domestica vicina, Oestrus  spp.,  Oscinella frit, Paratanytarsus  spp.,  Paralauterborniella subcincta, Pegomya  spp., for example  Pegomya betae, Pegomya hyoscyami, Pegomya rubivora, Phlebotomus  spp.,  Phorbia  spp.,  Phormia  spp.,  Piophila casei, Platyparea poeciloptera, Prodiplosis  spp.,  Psila rosae, Rhagoletis  spp., for example  Rhagoletis cingulata, Rhagoletis completa, Rhagoletis fausta, Rhagoletis indifferens, Rhagoletis mendax, Rhagoletis pomonella, Sarcophaga  spp.,  Simulium  spp., for example  Simulium meridionale, Stomoxys  spp.,  Tabanus  spp.,  Tetanops  spp.,  Tipula  spp., for example  Tipula paludosa, Tipula simplex, Toxotrypana curvicauda;    
     from the order of the Hemiptera for example  Acizzia acaciaebaileyanae, Acizzia dodonaeae, Acizzia uncatoides, Acrida turrita, Acyrthosipon  spp., for example  Acyrthosiphon pisum, Acrogonia  spp.,  Aeneolamia  spp.,  Agonoscena  spp.,  Aleurocanthus  spp.,  Aleyrodes proletella, Aleurolobus barodensis, Aleurothrixus floccosus, Allocaridara malayensis, Amrasca  spp., for example  Amrasca bigutulla, Amrasca devastans, Anuraphis cardui, Aonidiella  spp., for example  Aonidiella aurantii, Aonidiella citrina, Aonidiella inornata, Aphanostigma piri, Aphis  spp., for example  Aphis citricola, Aphis craccivora, Aphis fabae, Aphis forbesi, Aphis glycines, Aphis gossypii, Aphis hederae, Aphis illinoisensis, Aphis middletoni, Aphis nasturtii, Aphis nerii, Aphis pomi, Aphis spiraecola, Aphis viburniphila, Arboridia apicalis, Arytainilla  spp.,  Aspidiella  spp.,  Aspidiotus  spp., for example  Aspidiotus nerii, Atanus  spp.,  Aulacorthum solani, Bemisia tabaci, Blastopsylla occidentalis, Boreioglycaspis melaleucae, Brachycaudus helichrysi, Brachycolus  spp.,  Brevicoryne brassicae, Cacopsylla  spp., for example  Cacopsylla pyricola, Calligypona marginata, Capulinia  spp.,  Carneocephala fulgida, Ceratovacuna lanigera, Cercopidae, Ceroplastes  spp.,  Chaetosiphon fragaefolii, Chionaspis tegalensis, Chlorita onukii, Chondracris rosea, Chromaphis juglandicola, Chrysomphalus aonidum, Chrysomphalus ficus, Cicadulina mbila, Coccomytilus halli, Coccus  spp., for example  Coccus hesperidum, Coccus longulus, Coccus pseudomagnoliarum, Coccus viridis, Cryptomyzus ribis, Cryptoneossa  spp.,  Ctenarytaina  spp.,  Dalbulus  spp.,  Dialeurodes chittendeni, Dialeurodes citri, Diaphorina citri, Diaspis  spp.,  Diuraphis  spp.,  Doralis  spp.,  Drosicha  spp.,  Dysaphis  spp., for example  Dysaphis apiifolia, Dysaphis plantaginea, Dysaphis tulipae, Dysmicoccus  spp.,  Empoasca  spp., for example  Empoasca abrupta, Empoasca fabae, Empoasca maligna, Empoasca solana, Empoasca stevensi, Eriosoma  spp., for example  Eriosoma americanum, Eriosoma lanigerum, Eriosoma pyricola, Erythroneura  spp.,  Eucalyptolyma  spp.,  Euphyllura  spp.,  Euscelis bilobatus, Ferrisia  spp.,  Fiorinia  spp.,  Furcaspis oceanica, Geococcus coffeae, Glycaspis  spp.,  Heteropsylla cubana, Heteropsylla spinulosa, Homalodisca coagulata, Hyalopterus arundinis, Hyalopterus pruni, Icerya  spp., for example  Icerya purchasi, Idiocerus  spp.,  Idioscopus  spp.,  Laodelphax striatellus, Lecanium  spp., for example  Lecanium corni  (=Parthenolecanium corni),  Lepidosaphes  spp., for example  Lepidosaphes ulmi, Lipaphis erysimi, Lopholeucaspis japonica, Lycorma delicatula, Macrosiphum  spp., for example  Macrosiphum euphorbiae, Macrosiphum lilii, Macrosiphum rosae, Macrosteles facifrons, Mahanarva  spp.,  Melanaphis sacchari, Metcalfiella  spp.,  Metcalfa pruinosa, Metopolophium dirhodum, Monellia costalis, Monelliopsis pecanis, Myzus  spp., for example  Myzus ascalonicus, Myzus cerasi, Myzus ligustri, Myzus ornatus, Myzus persicae, Myzus nicotianae, Nasonovia ribisnigri, Neomaskellia  spp.,  Nephotettix  spp., for example  Nephotettix cincticeps, Nephotettix nigropictus, Nettigoniclla spectra, Nilaparvata lugens, Oncometopia  spp.,  Orthezia praelonga, Oxya chinensis, Pachypsylla  spp.,  Parabemisia myricae, Paratrioza  spp., for example  Paratrioza cockerelli, Parlatoria  spp.,  Pemphigus  spp., for example  Pemphigus bursarius, Pemphigus populivenae, Peregrinus maidis, Perkinsiella  spp.,  Phenacoccus  spp., for example  Phenacoccus madeirensis, Phloeomyzus passerinii, Phorodon humuli, Phylloxera  spp., for example  Phylloxera devastatrix, Phylloxera notabilis, Pinnaspis aspidistrae, Planococcus  spp., for example  Planococcus citri, Prosopidopsylla flava, Protopulvinaria pyriformis, Pseudaulacaspis pentagona, Pseudococcus  spp., for example  Pseudococcus calceolariae, Pseudococcus comstocki, Pseudococcus longispinus, Pseudococcus maritimus, Pseudococcus viburni, Psyllopsis  spp.,  Psylla  spp., for example  Psylla buxi, Psylla mali, Psylla pyri, Pteromalus  spp.,  Pulvinaria  spp.,  Pyrilla  spp.,  Quadraspidiotus  spp., for example  Quadraspidiotus juglansregiae, Quadraspidiotus ostreaeformis, Quadraspidiotus perniciosus, Quesada gigas, Rastrococcus  spp.,  Rhopalosiphum  spp., for example  Rhopalosiphum maidis, Rhopalosiphum oxyacanthae, Rhopalosiphum padi, Rhopalosiphum rufiabdominale, Saissetia  spp., for example  Saissetia coffeae, Saissetia miranda, Saissetia neglecta, Saissetia oleae, Scaphoideus titanus, Schizaphis graminum, Selenaspidus articulatus, Sipha flava, Sitobion avenae, Sogata  spp.,  Sogatella furcifera, Sogatodes  spp.,  Stictocephala festina, Siphoninus phillyreae, Tenalaphara malayensis, Tetragonocephela  spp.,  Tinocallis caryaefoliae, Tomaspis  spp.,  Toxoptera  spp., for example  Toxoptera aurantii, Toxoptera citricidus, Trialeurodes vaporariorum, Trioza  spp., for example  Trioza diospyri, Typhlocyba  spp.,  Unaspis  spp.,  Viteus vitifolii, Zygina  spp.; 
     from the suborder of the Heteroptera, for example  Aelia  spp.,  Anasa tristis, Antestiopsis  spp.,  Boisea  spp.,  Blissus  spp.,  Calocoris  spp.,  Campylomma livida, Cavelerius  spp.,  Cimex  spp., for example  Cimex adjunctus, Cimex hemipterus, Cimex lectularius, Cimex pilosellus, Collaria  spp.,  Creontiades dilutus, Dasynus piperis, Dichelops furcatus, Diconocoris hewetti, Dysdercus  spp.,  Euschistus  spp., for example  Euschistus heros, Euschistus servus, Euschistus tristigmus, Euschistus variolarius, Eurydema  spp.,  Eurygaster  spp.,  Halyomorpha halys, Heliopeltis  spp.,  Horcias nobilellus, Leptocorisa  spp.,  Leptocorisa varicornis, Leptoglossus occidentalis, Leptoglossus phyllopus, Lygocoris  spp., for example  Lygocoris pabulinus, Lygus  spp., for example  Lygus elisus, Lygus hesperus, Lygus lineolaris, Macropes excavatus, Megacopta cribraria, Miridae, Monalonion atratum, Nezara  spp., for example  Nezara viridula, Nysius  spp.,  Oebalus  spp., Pentomidae,  Piesma quadrata, Piezodorus  spp., for example  Piezodorus guildinii, Psallus  spp.,  Pseudacysta persea, Rhodnius  spp.,  Sahlbergella singularis, Scaptocoris castanea, Scotinophora  spp.,  Stephanitis nashi, Tibraca  spp.,  Triatoma  spp.; 
     from the order of the Hymenoptera, for example  Acromyrmex  spp.,  Athalia  spp., for example  Athalia rosae, Atta  spp.,  Camponotus  spp.,  Dolichovespula  spp.,  Diprion  spp., for example  Diprion similis, Hoplocampa  spp., for example  Hoplocampa cookei, Hoplocampa testudinea, Lasius  spp.,  Linepithema  (Iridiomyrmex)  humile, Monomorium pharaonis, Paratrechina  spp.,  Paravespula  spp.,  Plagiolepis  spp.,  Sirex  spp.,  Solenopsis invicta, Tapinoma  spp.,  Technomyrmex albipes, Urocerus  spp.,  Vespa  spp., for example  Vespa crabro, Wasmannia auropunctata, Xeris  spp.; 
     from the order of the Isopoda, for example  Armadillidium vulgare, Oniscus asellus, Porcellio scaber;    
     from the order of the Isoptera, for example  Coptotermes  spp., for example  Coptotermes formosanus, Cornitermes cumulans, Cryptotermes  spp.,  Incisitermes  spp.,  Kalotermes  spp.,  Microtermes obesi, Nasutitermes  spp.,  Odontotermes  spp.,  Reticulitermes  spp., for example  Reticulitermes flavipes, Reticulitermes hesperus;    
     from the order of the Lepidoptera, for example  Achroia grisella, Acronicta major, Adoxophyes  spp., for example  Adoxophyes orana, Aedia leucomelas, Agrotis  spp., for example  Agrotis segetum, Agrotis ipsilon, Alabama  spp., for example  Alabama argillacea, Amyelois transitella, Anarsia  spp.,  Anticarsia  spp., for example  Anticarsia gemmatalis, Argyroploce  spp.,  Autographa  spp.,  Barathra brassicae, Blastodacna atra, Borbo cinnara, Bucculatrix thurberiella, Bupalus piniarius, Busseola  spp.,  Cacoecia  spp.,  Caloptilia theivora, Capua reticulana, Carpocapsa pomonella, Carposina niponensis, Cheimatobia brumata, Chilo  spp., for example  Chilo plejadellus, Chilo suppressalis, Choreutis pariana, Choristoneura  spp.,  Chrysodeixis chalcites, Clysia ambiguella, Cnaphalocerus  spp.,  Cnaphalocrocis medinalis, Cnephasia  spp.,  Conopomorpha  spp.,  Conotrachelus  spp.,  Copitarsia  spp.,  Cydia  spp., for example  Cydia nigricana, Cydia pomonella, Dalaca noctuides, Diaphania  spp.,  Diparopsis  spp.,  Diatraea saccharalis, Earias  spp.,  Ecdytolopha aurantium, Elasmopalpus lignosellus, Eldana saccharina, Ephestia  spp., for example  Ephestia elutella, Ephestia kuehniella, Epinotia  spp.,  Epiphyas postvittana, Erannis  spp.,  Erschoviella musculana, Etiella  spp.,  Eudocima  spp.,  Eulia  spp.,  Eupoecilia ambiguella, Euproctis  spp., for example  Euproctis chrysorrhoea, Euxoa  spp.,  Feltia  spp.,  Galleria mellonella, Gracillaria  spp.,  Grapholitha  spp., for example  Grapholita molesta, Grapholita prunivora, Hedylepta  spp.,  Helicoverpa  spp., for example  Helicoverpa armigera, Helicoverpa zea, Heliothis  spp., for example  Heliothis virescens, Hofmannophila pseudospretella, Homoeosoma  spp.,  Homona  spp.,  Hyponomeuta padella, Kakivoria flavofasciata, Lampides  spp.,  Laphygma  spp.,  Laspeyresia molesta, Leucinodes orbonalis, Leucoptera  spp., for example  Leucoptera coffeella, Lithocolletis  spp., for example  Lithocolletis blancardella, Lithophane antennata, Lobesia  spp., for example  Lobesia botrana, Loxagrotis albicosta, Lymantria  spp., for example  Lymantria dispar, Lyonetia  spp., for example  Lyonetia clerkella, Malacosoma neustria, Maruca testulalis, Mamestra brassicae, Melanitis leda, Mocis  spp.,  Monopis obviella, Mythimna separata, Nemapogon cloacellus, Nymphula  spp.,  Oiketicus  spp.,  Omphisa  spp.,  Operophtera  spp.,  Oria  spp.,  Orthaga  spp.,  Ostrinia  spp., for example  Ostrinia nubilalis, Panolis flammea, Parnara  spp.,  Pectinophora  spp., for example  Pectinophora gossypiella, Perileucoptera  spp.,  Phthorimaea  spp., for example  Phthorimaea operculella, Phyllocnistis citrella, Phyllonorycter  spp., for example  Phyllonorycter blancardella, Phyllonorycter crataegella, Pieris  spp., for example  Pieris rapae, Platynota stultana, Plodia interpunctella, Plusia  spp.,  Plutella xylostella  (= Plutella maculipennis ),  Prays  spp.,  Prodenia  spp.,  Protoparce  spp.,  Pseudaletia  spp., for example  Pseudaletia unipuncta, Pseudoplusia includens, Pyrausta nubilalis, Rachiplusia nu, Schoenobius  spp., for example  Schoenobius bipunctifer, Scirpophaga  spp., for example  Scirpophaga innotata, Scotia segetum, Sesamia  spp., for example  Sesamia inferens, Sparganothis  spp.,  Spodoptera  spp., for example  Spodoptera eradiana, Spodoptera exigua, Spodoptera frugiperda, Spodoptera praefica, Stathmopoda  spp.,  Stenoma  spp.,  Stomopteryx subsecivella, Synanthedon  spp.,  Tecia solanivora, Thaumetopoea  spp.,  Thermesia gemmatalis, Tinea cloacella, Tinea pellionella, Tineola bisselliella, Tortrix  spp.,  Trichophaga tapetzella, Trichoplusia  spp.,  for example Trichoplusia ni, Tryporyza incertulas, Tuta absoluta, Virachola  spp.; 
     from the order of the Orthoptera or Saltatoria, for example  Acheta domesticus, Dichroplus  spp.,  Gryllotalpa  spp., for example  Gryllotalpa gryllotalpa, Hieroglyphus  spp.,  Locusta  spp., for example  Locusta migratoria, Melanoplus  spp., for example  Melanoplus devastator, Paratlanticus ussuriensis, Schistocerca gregaria;    
     from the order of the Phthiraptera, for example  Damalinia  spp.,  Haematopinus  spp.,  Linognathus  spp.,  Pediculus  spp.,  Phylloxera vastatrix, Phthirus pubis, Trichodectes  spp.; 
     from the order of the Psocoptera, for example  Lepinotus  spp.,  Liposcelis  spp.; 
     from the order of the Siphonaptera, for example  Ceratophyllus  spp.,  Ctenocephalides  spp., for example  Ctenocephalides canis, Ctenocephalides felis, Pulex irritans, Tunga penetrans, Xenopsylla cheopis;    
     from the order of the Thysanoptera, for example  Anaphothrips obscurus, Baliothrips biformis, Chaetanaphothrips leeuweni, Drepanothrips reuteri, Enneothrips flavens, Frankliniella  spp., for example  Frankliniella fusca, Frankliniella occidentalis, Frankliniella schultzei, Frankliniella tritici, Frankliniella vaccinii, Frankliniella williamsi, Haplothrips  spp.,  Heliothrips  spp.,  Hercinothrips femoralis, Kakothrips  spp.,  Rhipiphorothrips cruentatus, Scirtothrips  spp.,  Taeniothrips cardamomi, Thrips  spp., for example  Thrips palmi, Thrips tabaci;    
     from the order of the Zygentoma (=Thysanura), for example  Ctenolepisma  spp.,  Lepisma saccharina, Lepismodes inquilinus, Thermobia domestica;    
     from the class of the Symphyla, for example  Scutigerella  spp., for example  Scutigerella immaculata;    
     pests from the phylum of the Mollusca, in particular from the class of the Bivalvia, for example  Dreissena  spp.; 
     and also from the class of the Gastropoda, for example  Anion  spp., for example  Anion ater rufus, Biomphalaria  spp.,  Bulinus  spp.,  Deroceras  spp., for example  Deroceras laeve, Galba  spp.,  Lymnaea  spp.,  Oncomelania  spp.,  Pomacea  spp.,  Succinea  spp.; 
     animal and human parasites from the phyla of the Platyhelminthes and Nematoda, for example  Aelurostrongylus  spp.,  Amidostomum  spp.,  Ancylostoma  spp, for example  Ancylostoma duodenale, Ancylostoma ceylanicum, Acylostoma braziliensis, Angiostrongylus  spp.,  Anisakis  spp.,  Anoplocephala  spp.,  Ascaris  spp.,  Ascaridia  spp.,  Baylisascaris  spp.,  Brugia  spp., for example  Brugia malayi, Brugia timori, Bunostomum  spp.,  Capillaria  spp.,  Chabertia  spp.,  Clonorchis  spp.,  Cooperia  spp.,  Crenosoma  spp.,  Cyathostoma  spp.,  Dicrocoelium  spp.,  Dictyocaulus  spp., for example  Dictyocaulus filaria, Diphyllobothrium  spp., for example  Diphyllobothrium latum, Dipylidium  spp.,  Dirofilaria  spp.,  Dracunculus  spp., for example  Dracunculus medinensis, Echinococcus  spp., for example  Echinococcus granulosus, Echinococcus multilocularis, Echinostoma  spp.,  Enterobius  spp., for example  Enterobius vermicularis, Eucoleus  spp.,  Fasciola  spp.,  Fascioloides  spp.,  Fasciolopsis  spp.,  Filaroides  spp.,  Gongylonema  spp.,  Gyrodactylus  spp.,  Habronema  spp.,  Haemonchus  spp.,  Heligmosomoides  spp.,  Heterakis  spp.,  Hymenolepis  spp., for example  Hymenolepis nana, Hyostrongylus  spp.,  Litomosoides  spp.,  Loa  spp., for example  Loa Loa, Metastrongylus  spp.,  Metorchis  spp.,  Mesocestoides  spp.,  Moniezia  spp.,  Muellerius  spp.,  Necator  spp.,  Nematodirus  spp.,  Nippostrongylus  spp.,  Oesophagostomum  spp.,  Ollulanus  spp.,  Onchocerca  spp, for example  Onchocerca volvulus, Opisthorchis  spp.,  Oslerus  spp.,  Ostertagia  spp.,  Oxyuris  spp.,  Paracapillaria  spp.,  Parafilaria  spp.,  Paragonimus  spp.,  Paramphistomum  spp.,  Paranoplocephala  spp.,  Parascaris  spp.,  Passalurus  spp.,  Protostrongylus  spp.,  Schistosoma  spp.,  Setaria  spp.,  Spirocerca  spp.,  Stephanofilaria  spp.,  Stephanurus  spp.,  Strongyloides  spp., for example  Strongyloides fuelleborni, Strongyloides stercoralis, Strongylus  spp.,  Syngamus  spp.,  Taenia  spp., for example  Taenia saginata, Taenia solium, Teladorsagia  spp.,  Thelazia  spp.,  Toxascaris  spp.,  Toxocara  spp.,  Trichinella  spp., for example  Trichinella spiralis, Trichinella nativa, Trichinella britovi, Trichinella nelsoni, Trichinella pseudopsiralis, Trichobilharzia  spp.,  Trichostrongylus  spp.,  Trichuris  spp., for example  Trichuris trichiura, Uncinaria  spp.,  Wuchereria  spp., for example  Wuchereria bancrofti;    
     plant pests from the phylum of the Nematoda, i.e. phytoparasitic nematodes, especially  Aglenchus  spp., for example  Aglenchus agricola, Anguina  spp., for example  Anguina tritici, Aphelenchoides  spp., for example  Aphelenchoides arachidis, Aphelenchoides fragariae, Belonolaimus  spp., for example  Belonolaimus gracilis, Belonolaimus longicaudatus, Belonolaimus nortoni, Bursaphelenchus  spp., for example  Bursaphelenchus cocophilus, Bursaphelenchus eremus, Bursaphelenchus xylophilus, Cacopaurus  spp., for example  Cacopaurus pestis, Criconemella  spp., for example  Criconemella curvata, Criconemella onoensis, Criconemella ornata, Criconemella rusium, Criconemella xenoplax  (=Mesocriconema xenoplax),  Criconemoides  spp., for example  Criconemoides ferniae, Criconemoides onoense, Criconemoides ornatum, Ditylenchus  spp., for example  Ditylenchus dipsaci, Dolichodorus  spp.,  Globodera  spp., for example  Globodera pallida, Globodera rostochiensis, Helicotylenchus  spp., for example  Helicotylenchus dihystera, Hemicriconemoides  spp.,  Hemicycliophora  spp.,  Heterodera  spp.,  for example Heterodera avenae, Heterodera glycines, Heterodera schachtii, Hirschmaniella  spp.,  Hoplolaimus  spp.,  Longidorus  spp., for example  Longidorus africanus, Meloidogyne  spp., for example  Meloidogyne chitwoodi, Meloidogyne fallax, Meloidogyne hapla, Meloidogyne incognita, Meloinema  spp.,  Nacobbus  spp.,  Neotylenchus  spp.,  Paralongidorus  spp.,  Paraphelenchus  spp.,  Paratrichodorus  spp.,  for example Paratrichodorus minor, Paratylenchus  spp.,  Pratylenchus  spp., for example  Pratylenchus penetrans, Pseudohalenchus  spp.,  Psilenchus  spp.,  Punctodera  spp.,  Quinisulcius  spp.,  Radopholus  spp.,  for example Radopholus citrophilus, Radopholus similis, Rotylenchulus  spp.,  Rotylenchus  spp.,  Scutellonema  spp.,  Subanguina  spp.,  Trichodorus  spp., for example  Trichodorus obtusus, Trichodorus primitivus, Tylenchorhynchus  spp., for example  Tylenchorhynchus annulatus, Tylenchulus  spp., for example  Tylenchulus semipenetrans, Xiphinema  spp., for example  Xiphinema  index. 
     In addition, it is possible to control, from the sub-kingdom of the Protozoa, the order of the Coccidia, for example  Eimeria  spp. 
     The compounds of the formula (I) can optionally, at certain concentrations or application rates, also be used as herbicides, safeners, growth regulators or agents to improve plant properties, as microbicides or gametocides, for example as fungicides, antimycotics, bactericides, virucides (including agents against viroids) or as agents against MLO ( mycoplasma -like organisms) and RLO ( rickettsia -like organisms). They can, as the case may be, also be used as intermediates or precursors for the synthesis of other active compounds. 
     Formulations 
     The present invention further relates to formulations and use forms prepared therefrom as pesticides, for example drench, drip and spray liquors, comprising at least one compound of the formula (I). Optionally, the use forms comprise further pesticides and/or adjuvants which improve action, such as penetrants, e.g. vegetable oils, for example rapeseed oil, sunflower oil, mineral oils, for example paraffin oils, alkyl esters of vegetable fatty acids, for example rapeseed oil methyl ester or soya oil methyl ester, or alkanol alkoxylates and/or spreaders, for example alkylsiloxanes and/or salts, for example organic or inorganic ammonium or phosphonium salts, for example ammonium sulfate or diammonium hydrogenphosphate and/or retention promoters, for example dioctyl sulfosuccinate or hydroxypropylguar polymers and/or humectants, for example glycerol and/or fertilizers, for example ammonium-, potassium- or phosphorus-containing fertilizers. 
     Customary formulations are, for example, water-soluble liquids (SL), emulsion concentrates (EC), emulsions in water (EW), suspension concentrates (SC, SE, FS, OD), water-dispersible granules (WG), granules (GR) and capsule concentrates (CS); these and further possible formulation types are described, for example, by Crop Life International and in Pesticide Specifications, Manual on development and use of FAO and WHO specifications for pesticides, FAO Plant Production and Protection Papers-173, prepared by the FAO/WHO Joint Meeting on Pesticide Specifications, 2004, ISBN: 9251048576. The formulations, in addition to one or more compounds of the formula (I), optionally comprise further agrochemically active compounds. 
     Preference is given to formulations or use forms comprising auxiliaries, for example extenders, solvents, spontaneity promoters, carriers, emulsifiers, dispersants, frost protection agents, biocides, thickeners and/or further auxiliaries, for example adjuvants. An adjuvant in this context is a component which enhances the biological effect of the formulation, without the component itself having any biological effect. Examples of adjuvants are agents which promote retention, spreading, attachment to the leaf surface or penetration. 
     These formulations are prepared in a known way, for example by mixing the compounds of the formula (I) with auxiliaries such as, for example, extenders, solvents and/or solid carriers and/or other auxiliaries such as, for example, surfactants. The formulations are produced either in suitable facilities or else before or during application. 
     The auxiliaries used may be substances suitable for imparting special properties, such as certain physical, technical and/or biological properties, to the formulation of the compounds of the formula (I), or to the use forms prepared from these formulations (for example ready-to-use pesticides such as spray liquors or seed dressing products). 
     Suitable extenders are, for example, water, polar and nonpolar organic chemical liquids, for example from the classes of the aromatic and non-aromatic hydrocarbons (such as paraffins, alkylbenzenes, alkylnaphthalenes, chlorobenzenes), the alcohols and polyols (which, if appropriate, may also be substituted, etherified and/or esterified), the ketones (such as acetone, cyclohexanone), esters (including fats and oils) and (poly)ethers, the simple and substituted amines, amides, lactams (such as N-alkylpyrrolidones) and lactones, the sulfones and sulfoxides (such as dimethyl sulfoxide). 
     If the extender utilized is water, it is also possible to use, for example, organic solvents as auxiliary solvents. Useful liquid solvents are essentially: aromatics such as xylene, toluene or alkylnaphthalenes, chlorinated aromatics or chlorinated aliphatic hydrocarbons such as chlorobenzenes, chloroethylenes or methylene chloride, aliphatic hydrocarbons such as cyclohexane or paraffins, for example mineral oil fractions, mineral and vegetable oils, alcohols such as butanol or glycol and their ethers and esters, ketones such as acetone, methyl ethyl ketone, methyl isobutyl ketone or cyclohexanone, strongly polar solvents such as dimethylformamide and dimethyl sulfoxide, and water. 
     In principle, it is possible to use all suitable solvents. Examples of suitable solvents are aromatic hydrocarbons, such as xylene, toluene or alkylnaphthalenes, chlorinated aromatic or aliphatic hydrocarbons, such as chlorobenzene, chloroethylene or methylene chloride, aliphatic hydrocarbons, such as cyclohexane, paraffins, mineral oil fractions, mineral and vegetable oils, alcohols, such as methanol, ethanol, isopropanol, butanol or glycol and their ethers and esters, ketones such as acetone, methyl ethyl ketone, methyl isobutyl ketone or cyclohexanone, strongly polar solvents, such as dimethyl sulfoxide, and also water. 
     In principle, it is possible to use all suitable carriers. Useful carriers especially include: for example ammonium salts and ground natural minerals such as kaolins, clays, talc, chalk, quartz, attapulgite, montmorillonite or diatomaceous earth, and ground synthetic minerals such as finely divided silica, alumina and natural or synthetic silicates, resins, waxes and/or solid fertilizers. It is likewise possible to use mixtures of such carriers. Useful carriers for granules include: for example crushed and fractionated natural rocks such as calcite, marble, pumice, sepiolite, dolomite, and synthetic granules of inorganic and organic flours, and also granules of organic material such as sawdust, paper, coconut shells, maize cobs and tobacco stalks. 
     It is also possible to use liquefied gaseous extenders or solvents. Especially suitable are those extenders or carriers which are gaseous at standard temperature and under atmospheric pressure, for example aerosol propellants such as halogenated hydrocarbons, and also butane, propane, nitrogen and carbon dioxide. 
     Examples of emulsifiers and/or foam formers, dispersants or wetting agents having ionic or nonionic properties or mixtures of these surface-active substances are salts of polyacrylic acid, salts of lignosulfonic acid, salts of phenolsulfonic acid or naphthalenesulfonic acid, polycondensates of ethylene oxide with fatty alcohols or with fatty acids or with fatty amines, with substituted phenols (preferably alkylphenols or arylphenols), salts of sulfosuccinic esters, taurine derivatives (preferably alkyl taurates), phosphoric esters of polyethoxylated alcohols or phenols, fatty acid esters of polyols, and derivatives of the compounds containing sulfates, sulfonates and phosphates, for example alkylaryl polyglycol ethers, alkylsulfonates, alkyl sulfates, arylsulfonates, protein hydrolysates, lignosulfite waste liquors and methylcellulose. The presence of a surfactant is advantageous if one of the compounds of the formula (I) and/or one of the inert carriers is insoluble in water and if the application takes place in water. 
     Further auxiliaries which may be present in the formulations and the use forms derived therefrom are dyes such as inorganic pigments, for example iron oxide, titanium oxide and Prussian Blue, and organic dyes such as alizarin dyes, azo dyes and metal phthalocyanine dyes, and nutrients and trace nutrients such as salts of iron, manganese, boron, copper, cobalt, molybdenum and zinc. 
     Additional components which may be present are stabilizers, such as cold stabilizers, preservatives, antioxidants, light stabilizers, or other agents which improve chemical and/or physical stability. Foam generators or antifoams may also be present. 
     In addition, the formulations and the use forms derived therefrom may also comprise, as additional auxiliaries, stickers such as carboxymethylcellulose and natural and synthetic polymers in the form of powders, granules or latices, such as gum arabic, polyvinyl alcohol and polyvinyl acetate, or else natural phospholipids such as cephalins and lecithins and synthetic phospholipids. Further auxiliaries may be mineral and vegetable oils. 
     It is possible if appropriate for still further auxiliaries to be present in the formulations and the use forms derived therefrom. Examples of such additives are fragrances, protective colloids, binders, adhesives, thickeners, thixotropic agents, penetrants, retention promoters, stabilizers, sequestrants, complexing agents, humectants, spreaders. In general, the compounds of the formula (I) can be combined with any solid or liquid additive commonly used for formulation purposes. 
     Useful retention promoters include all those substances which reduce dynamic surface tension, for example dioctyl sulfosuccinate, or increase viscoelasticity, for example hydroxypropylguar polymers. 
     Useful penetrants in the present context are all those substances which are typically used to improve the penetration of agrochemically active compounds into plants. Penetrants are defined in this context by their ability to penetrate from the (generally aqueous) application liquor and/or from the spray coating into the cuticle of the plant and hence increase the mobility of the active compounds in the cuticle. The method described in the literature (Baur et al., 1997, Pesticide Science 51, 131-152) can be used for determining this property. Examples include alcohol alkoxylates such as coconut fatty ethoxylate (10) or isotridecyl ethoxylate (12), fatty acid esters, for example rapeseed oil methyl ester or soya oil methyl ester, fatty amine alkoxylates, for example tallowamine ethoxylate (15), or ammonium and/or phosphonium salts, for example ammonium sulfate or diammonium hydrogenphosphate. 
     The formulations preferably comprise between 0.00000001% and 98% by weight of the compound of the formula (I), more preferably between 0.01% and 95% by weight of the compound of the formula (I), most preferably between 0.5% and 90% by weight of the compound of the formula (I), based on the weight of the formulation. 
     The content of the compound of the formula (I) in the use forms prepared from the formulations (in particular pesticides) may vary within wide ranges. The concentration of the compound of the formula (I) in the use forms may typically be between 0.00000001% and 95% by weight of the compound of the formula (I), preferably between 0.00001% and 1% by weight, based on the weight of the use form. Application is accomplished in a customary manner appropriate for the use forms. 
     Mixtures 
     The compounds of the formula (I) can also be used in a mixture with one or more suitable fungicides, bactericides, acaricides, molluscicides, nematicides, insecticides, microbiological agents, beneficial organisms, herbicides, fertilizers, bird repellents, phytotonics, sterilants, safeners, semiochemicals and/or plant growth regulators, in order thus, for example, to broaden the spectrum of action, prolong the period of action, enhance the rate of action, prevent repellency or prevent evolution of resistance. In addition, active compound combinations of this kind can improve plant growth and/or tolerance to abiotic factors, for example high or low temperatures, to drought or to elevated water content or soil salinity. It is also possible to improve flowering and fruiting performance, optimize germination capacity and root development, facilitate harvesting and improve yields, influence maturation, improve the quality and/or the nutritional value of the harvested products, prolong storage life and/or improve the processability of the harvested products. 
     In addition, the compounds of the formula (I) may be present in a mixture with other active compounds or semiochemicals such as attractants and/or bird repellents and/or plant activators and/or growth regulators and/or fertilizers. Likewise, the compounds of the formula (I) can be used in mixtures with agents to improve plant properties, for example growth, yield and quality of the harvested material. 
     In a particular embodiment according to the invention, the compounds of the formula (I) are present in formulations or in the use forms prepared from these formulations in a mixture with further compounds, preferably those as described below. 
     If one of the compounds mentioned below can occur in different tautomeric forms, these forms are also included even if not explicitly mentioned in each case. 
     Insecticides/Acaricides/Nematicides 
     The active compounds specified here with their common names are known and are described for example in “The Pesticide Manual”, 16th ed., British Crop Protection Council 2012, or can be searched for on the Internet (e.g. http://www.alanwood.net/pesticides). 
     (1) Acetylcholinesterase (AChE) inhibitors, for example carbamates, e.g. alanycarb, aldicarb, bendiocarb, benfuracarb, butocarboxim, butoxycarboxim, carbaryl, carbofuran, carbosulfan, ethiofencarb, fenobucarb, formetanate, furathiocarb, isoprocarb, methiocarb, methomyl, metolcarb, oxamyl, pirimicarb, propoxur, thiodicarb, thiofanox, triazamate, trimethacarb, XMC and xylylcarb; or organophosphates, e.g. acephate, azamethiphos, azinphos-ethyl, azinphos-methyl, cadusafos, chlorethoxyfos, chlorfenvinphos, chlormephos, chloropyrifos, chloropyrifos-methyl, coumaphos, cyanophos, demeton-S-methyl, diazinon, dichlorvos/DDVP, dicrotophos, dimethoate, dimethylvinphos, disulfoton, EPN, ethion, ethoprophos, famphur, fenamiphos, fenitrothion, fenthion, fosthiazate, heptenophos, imicyafos, isofenphos, isopropyl O-(methoxyaminothiophosphoryl) salicylate, isoxathion, malathion, mecarbam, methamidophos, methidathion, mevinphos, monocrotophos, naled, omethoate, oxydemeton-methyl, parathion, parathion-methyl, phenthoate, phorate, phosalone, phosmet, phosphamidon, phoxim, pirimiphos-methyl, profenofos, propetamphos, prothiofos, pyraclofos, pyridaphenthion, quinalphos, sulfotep, tebupirimfos, temephos, terbufos, tetrachlorvinphos, thiometon, triazophos, triclorfon and vamidothion.
 
(2) GABA-gated chloride channel antagonists, for example cyclodiene-organochlorines, e.g. chlordane and endosulfan or phenylpyrazoles (fiproles), e.g. ethiprole and fipronil.
 
(3) Sodium channel modulators/voltage-gated sodium channel blockers, for example pyrethroids, e.g. acrinathrin, allethrin, d-cis-trans allethrin, d-trans allethrin, bifenthrin, bioallethrin, bioallethrin S-cyclopentenyl isomer, bioresmethrin, cycloprothrin, cyfluthrin, beta-cyfluthrin, cyhalothrin, lambda-cyhalothrin, gamma-cyhalothrin, cypermethrin, alpha-cypermethrin, beta-cypermethrin, theta-cypermethrin, zeta-cypermethrin, cyphenothrin [(1R)-trans isomers], deltamethrin, empenthrin [(EZ)-(1R) isomers], esfenvalerate, etofenprox, fenpropathrin, fenvalerate, flucythrinate, flumethrin, tau-fluvalinate, halfenprox, imiprothrin, kadethrin, momfluorothrin, permethrin, phenothrin [(1R)-trans isomer], prallethrin, pyrethrins (pyrethrum), resmethrin, silafluofen, tefluthrin, tetramethrin, tetramethrin [(1R) isomers)], tralomethrin and transfluthrin or DDT or methoxychlor.
 
(4) Nicotinergic acetylcholine receptor (nAChR) agonists, for example neonicotinoids, e.g. acetamiprid, clothianidin, dinotefuran, imidacloprid, nitenpyram, thiacloprid and thiamethoxam or nicotine or sulfoxaflor or flupyradifurone.
 
(5) Allosteric activators of the nicotinergic acetylcholine receptor (nAChR), for example spinosyns, e.g. spinetoram and spinosad.
 
(6) Chloride channel activators, for example avermectins/milbemycins, e.g. abamectin, emamectin benzoate, lepimectin and milbemectin.
 
(7) Juvenile hormone imitators, for example, juvenile hormone analogues, e.g. hydroprene, kinoprene and methoprene or fenoxycarb or pyriproxyfen.
 
(8) Active compounds having unknown or nonspecific mechanisms of action, for example
 
alkyl halides, e.g. methyl bromide and other alkyl halides; or chloropicrine or sulfuryl fluoride or borax or tartar emetic.
 
(9) Selective antifeedants, e.g. pymetrozine or flonicamid.
 
(10) Mite growth inhibitors, e.g. clofentezine, hexythiazox and diflovidazin or etoxazole.
 
(11) Microbial disruptors of the insect gut membrane, e.g.  Bacillus thuringiensis  subspecies  israelensis, Bacillus sphaericus, Bacillus thuringiensis  subspecies  aizawai, Bacillus thuringiensis  subspecies  kurstaki, Bacillus thuringiensis  subspecies  tenebrionis , and BT plant proteins: CrylAb, CrylAc, CrylFa, Cry2Ab, mCry3A, Cry3Ab, Cry3Bb, Cry34/35Ab1.
 
(12) Oxidative phosphorylation inhibitors, ATP disruptors, for example diafenthiuron or organotin compounds, e.g. azocyclotin, cyhexatin and fenbutatin oxide or propargite or tetradifon.
 
(13) Oxidative phosphorylation decouplers that interrupt the H proton gradient, for example chlorfenapyr, DNOC and sulfluramid.
 
(14) Nicotinergic acetylcholine receptor antagonists, for example bensultap, cartap hydrochloride, thiocyclam, and thiosultap-sodium.
 
(15) Inhibitors of chitin biosynthesis, type 0, for example bistrifluron, chlorfluazuron, diflubenzuron, flucycloxuron, flufenoxuron, hexaflumuron, lufenuron, novaluron, noviflumuron, teflubenzuron and triflumuron.
 
(16) Inhibitors of chitin biosynthesis, type 1, for example buprofezin.
 
(17) Moulting inhibitors (especially for Diptera, i.e. dipterans), for example cyromazine.
 
(18) Ecdysone receptor agonists, for example chromafenozide, halofenozide, methoxyfenozide and tebufenozide.
 
(19) Octopaminergic agonists, for example amitraz.
 
(20) Complex-III electron transport inhibitors, for example hydramethylnon or acequinocyl or fluacrypyrim.
 
(21) Complex-I electron transport inhibitors, for example METI acaricides, e.g. fenazaquin, fenpyroximate, pyrimidifen, pyridaben, tebufenpyrad and tolfenpyrad or rotenone (Derris).
 
(22) Voltage-gated sodium channel blockers, for example indoxacarb or metaflumizone.
 
(23) Inhibitors of acetyl-CoA carboxylase, for example tetronic and tetramic acid derivatives, e.g. spirodiclofen, spiromesifen and spirotetramat.
 
(24) Complex-IV electron transport inhibitors, for example phosphines, e.g. aluminium phosphide, calcium phosphide, phosphine and zinc phosphide or cyanide.
 
(25) Complex-II electron transport inhibitors, for example cyenopyrafen and cyflumetofen.
 
(28) Ryanodine receptor effectors, for example diamides, e.g. chlorantraniliprole, cyantraniliprole and flubendiamide.
 
     Further active ingredients having an unknown or unclear mechanism of action, for example afidopyropen, afoxolaner, azadirachtin, benclothiaz, benzoximate, bifenazate, bromopropylate, chinomethionat, cryolite, cyclaniliprole, cycloxaprid, cyhalodiamide, dicloromezotiaz, dicofol, diflovidazin, flometoquin, fluensulfone, flufenerim, flufenoxystrobin, flufiprole, fluhexafon, fluopyram, fluralaner, fufenozide, guadipyr, heptafluthrin, imidaclothiz, iprodione, meperfluthrin, paichongding, pyflubumide, pyridalyl, pyrifluquinazon, pyriminostrobin, tetramethylfluthrin, tetraniliprole, tetrachlorantraniliprole, tioxazafen, triflumezopyrim and iodomethane; and additionally preparations based on  Bacillus firmus  (I-1582, BioNeem, Votivo), and the following known active compounds: 1-{2-fluoro-4-methyl-5-[(2,2,2-trifluoroethyl)sulfinyl]phenyl}-3-(trifluoromethyl)-1H-1,2,4-triazole-5-amine (known from WO2006/043635), {1′-[(2E)-3-(4-chlorophenyl)prop-2-en-1-yl]-5-fluorospiro[indol-3,4′-piperidin]-1(2H)-yl}(2-chloropyridin-4-yl)methanone (known from WO2003/106457), 2-chloro-N-[2-{1-[(2E)-3-(4-chlorophenyl)prop-2-en-1-yl]piperidin-4-yl}-4-(trifluoromethyl)phenyl]isonicotinamide (known from WO2006/003494), 3-(2,5-dimethylphenyl)-4-hydroxy-8-methoxy-1,8-diazaspiro[4.5]dec-3-en-2-one (known from WO2009/049851), 3-(2,5-dimethylphenyl)-8-methoxy-2-oxo-1,8-diazaspiro[4.5]dec-3-en-4-ylethyl carbonate (known from WO2009/049851), 4-(but-2-yn-1-yloxy)-6-(3,5-dimethylpiperidin-1-yl)-5-fluoropyrimidine (known from WO2004/099160), 4-(but-2-yn-1-yloxy)-6-(3-chlorophenyl)pyrimidine (known from WO2003/076415), PF1364 (CAS Reg. No. 1204776-60-2), methyl 2-[2-({[3-bromo-1-(3-chloropyridin-2-yl)-1H-pyrazol-5-yl]carbonyl}amino)-5-chloro-3-methylbenzoyl]-2-methylhydrazinecarboxylate (known from WO2005/085216), methyl 2-[2-({[3-bromo-1-(3-chloropyridin-2-yl)-1H-pyrazol-5-yl]carbonyl}amino)-5-cyano-3-methylbenzoyl]-2-ethylhydrazinecarboxylate (known from WO2005/085216), methyl 2-[2-({[3-bromo-1-(3-chloropyridin-2-yl)-1H-pyrazol-5-yl]carbonyl}amino)-5-cyano-3-methylbenzoyl]-2-methylhydrazinecarboxylate (known from WO2005/085216), methyl 2-[3,5-dibromo-2-({[3-bromo-1-(3-chloropyridin-2-yl)-1H-pyrazol-5-yl]carbonyl}amino)benzoyl]-2-ethylhydrazinecarboxylate (known from WO2005/085216), N-[2-(5-amino-1,3,4-thiadiazol-2-yl)-4-chloro-6-methylphenyl]-3-bromo-1-(3-chloropyridin-2-yl)-1H-pyrazole-5-carboxamide (known from CN102057925), 8-chloro-N-[(2-chloro-5-methoxyphenyl)sulfonyl]-6-(trifluoromethyl)imidazo[1,2-a]pyridine-2-carboxamide (known from WO2010/129500), 4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4,5-dihydro-1,2-oxazol-3-yl]-2-methyl-N-(1-oxidothietan-3-yl)benzamide (known from WO2009/080250), N-[(2E)-1-[(6-chloropyridin-3-yl)methyl]pyridin-2(1H)-ylidene]-2,2,-3-trifluoroacetamide (known from WO2012/029672), 1-[(2-chloro-1,3-thiazol-5-yl)methyl]-4-oxo-3-phenyl-4H-pyrido[1,2-a]pyrimidin-1-ium-2-olate (known from WO2009/099929), 1-[(6-chloropyridin-3-yl)methyl]-4-oxo-3-phenyl-4H-pyrido[1,2-a]pyrimidin-1-ium-2-olate (known from WO2009/099929), 4-(3-{2,6-dichloro-4-[(3,3-dichloroprop-2-en-1-yl)oxy]phenoxy}propoxy)-2-methoxy-6-(trifluoromethyl)pyrimidine (known from CN101337940), N-[2-(tert-butylcarbamoyl)-4-chloro-6-methylphenyl]-1-(3-chloropyridin-2-yl)-3-(fluoromethoxy)-1H-pyrazole-5-carboxamide (known from WO2008/134969, 3-[benzoyl(methyl)amino]-N-[2-bromo-4-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]-6-(trifluoromethyl)phenyl]-2-fluorobenzamide (known from WO 2010018714), butyl[2-(2,4-dichlorophenyl)-3-oxo-4-oxaspiro[4.5]dec-1-en-1-yl]carbonate (known from CN 102060818), 4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-isoxazol-3-yl]-N—[(Z)-methoxyiminomethyl]-2-methylbenzamide (known from WO2007/026965), 3E)-3-[1-[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]-1,1,1-trifluoropropan-2-one (known from WO2013/144213, N-(methylsulfonyl)-6-[2-(pyridin-3-yl)-1,3-thiazol-5-yl]pyridine-2-carboxamide (known from WO2012/000896), N-[3-(benzylcarbamoyl)-4-chlorophenyl]-1-methyl-3-(pentafluoroethyl)-4-(trifluoromethyl)-1H-pyrazole-5-carboxamide (known from WO2010/051926). 
     Fungicides 
     The active ingredients specified herein by their common name are known and described, for example, in “Pesticide Manual” or on the Internet (for example: http://www.alanwood.net/pesticides). 
     All the fungicidal mixing components listed in classes (1) to (15) may optionally form salts with corresponding bases or acids if suitable functional groups are present. In addition, the fungicidal mixing components listed in classes (1) to (15) also include tautomeric forms if tautomerism is possible. 
     1) inhibitors of the ergosterol biosynthesis, for example (1.01) aldimorph, (1.02) azaconazole, (1.03) bitertanol, (1.04) bromuconazole, (1.05) cyproconazole, (1.06) diclobutrazole, (1.07) difenoconazole, (1.08) diniconazole, (1.09) diniconazole-M, (1.10) dodemorph, (1.11) dodemorph acetate, (1.12) epoxiconazole, (1.13) etaconazole, (1.14) fenarimol, (1.15) fenbuconazole, (1.16) fenhexamide, (1.17) fenpropidin, (1.18) fenpropimorph, (1.19) fluquinconazole, (1.20) flurprimidol, (1.21) flusilazole, (1.22) flutriafol, (1.23) furconazole, (1.24) furconazole-cis, (1.25) hexaconazole, (1.26) imazalil, (1.27) imazalil sulfate, (1.28) imibenconazole, (1.29) ipconazole, (1.30) metconazole, (1.31) myclobutanil, (1.32) naftifine, (1.33) nuarimol, (1.34) oxpoconazole, (1.35) paclobutrazole, (1.36) pefurazoate, (1.37) penconazole, (1.38) piperalin, (1.39) prochloraz, (1.40) propiconazole, (1.41) prothioconazole, (1.42) pyributicarb, (1.43) pyrifenox, (1.44) quinconazole, (1.45) simeconazole, (1.46) spiroxamine, (1.47) tebuconazole, (1.48) terbinafin, (1.49) tetraconazole, (1.50) triadimefon, (1.51) triadimenol, (1.52) tridemorph, (1.53) triflumizole, (1.54) triforin, (1.55) triticonazole, (1.56) uniconazole, (1.57) uniconazole-p, (1.58) viniconazole, (1.59) voriconazole, (1.60) 1-(4-chlorophenyl)-2-(1H-1,2,4-triazol-1-yl)cycloheptanol, (1.61) 1-(2,2-dimethyl-2,3-dihydro-1H-inden-1-yl)-1H-imidazole-5-carboxylic acid methyl ester, (1.62) N′-{5-(difluoromethyl)-2-methyl-4-[3-(trimethylsilyl)propoxy]phenyl}-N-ethyl-N-methylimidoformamide, (1.63) N-ethyl-N-methyl-N′-{2-methyl-5-(trifluoromethyl)-4-[3-(trimethylsilyl)propoxy]phenyl}imidoformamide, (1.64) O-[1-(4-methoxyphenoxy)-3,3-dimethylbutan-2-yl]-1H-imidazole-1-carbothioate, (1.65) pyrisoxazole, (1.66) 2-{[3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-2,4-dihydro-3H-1,2,4-triazole-3-thione, (1.67) 1-{[3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-1H-1,2,4-triazol-5-ylthiocyanate, (1.68) 5-(allylsulfanyl)-1-{[3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-1H-1,2,4-triazole, (1.69) 2-[1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione, (1.70) 2-{[rel(2R,3S)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-2,4-dihydro-3H-1,2,4-triazole-3-thione, (1.71) 2-{[rel(2R,3R)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-2,4-dihydro-3H-1,2,4-triazole-3-thione, (1.72) 1-{[rel(2R,3S)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-1H-1,2,4-triazol-5-ylthiocyanate, (1.73) 1-{[rel(2R,3R)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-1H-1,2,4-triazol-5-ylthiocyanate, (1.74) 5-(allylsulfanyl)-1-{[rel(2R,3S)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-1H-1,2,4-triazole, (1.75) 5-(allylsulfanyl)-1-{[rel(2R,3R)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-1H-1,2,4-triazole, (1.76) 2-[(2S,4S,5S)-1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione, (1.77) 2-[(2R,4S,5S)-1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione, (1.78) 2-[(2R,4R,5R)-1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione, (1.79) 2-[(2S,4R,5R)-1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione, (1.80) 2-[(2S,4S,5R)-1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione, (1.81) 2-[(2R,4S,5R)-1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione, (1.82) 2-[(2R,4R,5S)-1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione, (1.83) 2-[(2S,4R,5S)-1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione, (1.84) 2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1H-1,2,4-triazol-1-yl)propan-2-ol, (1.85) 2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1H-1,2,4-triazol-1-yl)butan-2-ol, (1.86) 2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1H-1,2,4-triazol-1-yl)pentan-2-ol, (1.87) 2-[2-chloro-4-(4-chlorophenoxy)phenyl]-1-(1H-1,2,4-triazol-1-yl)butan-2-ol, (1.88) 2-[2-chloro-4-(2,4-dichlorophenoxy)phenyl]-1-(1H-1,2,4-triazol-1-yl)propan-2-ol, (1.89) (2R)-2-(1-chlorocyclopropyl)-4-[(1R)-2,2-dichlorocyclopropyl]-1-(1H-1,2,4-triazol-1-yl)butan-2-ol, (1.90) (2R)-2-(1-chlorocyclopropyl)-4-[(1S)-2,2-dichlorocyclopropyl]-1-(1H-1,2,4-triazol-1-yl)butan-2-ol, (1.91) (2S)-2-(1-chlorocyclopropyl)-4-[(1S)-2,2-dichlorocyclopropyl]-1-(1H-1,2,4-triazol-1-yl)butan-2-ol, (1.92) (2S)-2-(1-chlorocyclopropyl)-4-[(1R)-2,2-dichlorocyclopropyl]-1-(1H-1,2,4-triazol-1-yl)butan-2-ol, (1.93) (1S,2R,5R)-5-(4-chlorobenzyl)-2-(chloromethyl)-2-methyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol, (1.94) (1R,2S,5S)-5-(4-chlorobenzyl)-2-(chloromethyl)-2-methyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol, (1.95) 5-(4-chlorobenzyl)-2-(chloromethyl)-2-methyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol.
 
2) Inhibitors of the respiratory chain on complex I or II, for example (2.01) bixafen, (2.02) boscalid, (2.03) carboxin, (2.04) diflumetorim, (2.05) fenfuram, (2.06) fluopyram, (2.07) flutolanil, (2.08) fluxapyroxad, (2.09) furametpyr, (2.10) furmecyclox, (2.11) isopyrazam (mixture of syn-epimeric racemate 1RS,4SR,9RS and anti-epimeric racemate 1RS,4SR,9SR), (2.12) isopyrazam (anti-epimeric racemate 1RS,4SR,9SR), (2.13) isopyrazam (anti-epimeric enantiomer 1R,4S,9S), (2.14) isopyrazam (anti-epimeric enantiomer 1S,4R,9R), (2.15) isopyrazam (syn-epimeric racemate 1RS,4SR,9RS), (2.16) isopyrazam (syn-epimeric enantiomer 1R,4S,9R), (2.17) isopyrazam (syn-epimeric enantiomer 1S,4R,9S), (2.18) mepronil, (2.19) oxycarboxin, (2.20) penflufen, (2.21) penthiopyrad, (2.22) sedaxane, (2.23) thifluzamide, (2.24) 1-methyl-N-[2-(1,1,2,2-tetrafluoroethoxy)phenyl]-3-(trifluoromethyl)-1H-pyrazole-4-carboxamide, (2.25) 3-(difluoromethyl)-1-methyl-N-[2-(1,1,2,2-tetrafluoroethoxy)phenyl]-1H-pyrazole-4-carboxamide, (2.26) 3-(difluoromethyl)-N-[4-fluoro-2-(1,1,2,3,3,3-hexafluoropropoxy)phenyl]-1-methyl-1H-pyrazole-4-carboxamide, (2.27) N-[1-(2,4-dichlorophenyl)-1-methoxypropan-2-yl]-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide, (2.28) 5,8-difluoro-N-[2-(2-fluoro-4-{[4-(trifluoromethyl)pyridin-2-yl]oxy}phenyl)ethyl]quinazoline-4-amine, (2.29) benzovindiflupyr, (2.30) N-[(1S,4R)-9-(dichloromethylene)-1,2,3,4-tetrahydro-1,4-methanonaphthalin-5-yl]-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide, (2.31) N-[(1R,4S)-9-(dichloromethylene)-1,2,3,4-tetrahydro-1,4-methanonaphthalin-5-yl]-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide, (2.32) 3-(difluoromethyl)-1-methyl-N-(1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl)-1H-pyrazole-4-carboxamide, (2.33) 1,3,5-trimethyl-N-(1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl)-1H-pyrazole-4-carboxamide, (2.34) 1-methyl-3-(trifluoromethyl)-N-(1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl)-1H-pyrazole-4-carboxamide, (2.35) 1-methyl-3-(trifluoromethyl)-N-[(3R)-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1H-pyrazole-4-carboxamide, (2.36) 1-methyl-3-(trifluoromethyl)-N-[(3S)-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1H-pyrazole-4-carboxamide, (2.37) 3-(difluoromethyl)-1-methyl-N-[(3S)-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1H-pyrazole-4-carboxamide, (2.38) 3-(difluoromethyl)-1-methyl-N-[(3R)-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1H-pyrazole-4-carboxamide, (2.39) 1,3,5-trimethyl-N-[(3R)-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1H-pyrazole-4-carboxamide, (2.40) 1,3,5-trimethyl-N-[(3S)-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1H-pyrazole-4-carboxamide, (2.41) benodanil, (2.42) 2-chloro-N-(1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl)pyridine-3-carboxamide, (2.43) isofetamid, (2.44) 1-methyl-3-(trifluoromethyl)-N-[2′-(trifluoromethyl)biphenyl-2-yl]-1H-pyrazole-4-carboxamide, (2.45) N-(4′-chlorobiphenyl-2-yl)-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide, (2.46) N-(2′,4′-dichlorobiphenyl-2-yl)-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide, (2.47) 3-(difluoromethyl)-1-methyl-N-[4′-(trifluoromethyl)biphenyl-2-yl]-1H-pyrazole-4-carboxamide, (2.48) N-(2′,5′-difluorobiphenyl-2-yl)-1-methyl-3-(trifluoromethyl)-1H-pyrazole-4-carboxamide, (2.49) 3-(difluoromethyl)-1-methyl-N-[4′-(prop-1-yn-1-yl)biphenyl-2-yl]-1H-pyrazole-4-carboxamide, (2.50) 5-fluoro-1,3-dimethyl-N-[4′-(prop-1-yn-1-yl)biphenyl-2-yl]-1H-pyrazole-4-carboxamide, (2.51) 2-chloro-N-[4′-(prop-1-yn-1-yl)biphenyl-2-yl]nicotinamide, (2.52) 3-(difluoromethyl)-N-[4′-(3,3-dimethylbut-1-yn-1-yl)biphenyl-2-yl]-1-methyl-1H-pyrazole-4-carboxamide, (2.53) N-[4′-(3,3-dimethylbut-1-yn-1-yl)biphenyl-2-yl]-5-fluoro-1,3-dimethyl-1H-pyrazole-4-carboxamide, (2.54) 3-(difluoromethyl)-N-(4′-ethynylbiphenyl-2-yl)-1-methyl-1H-pyrazole-4-carboxamide, (2.55) N-(4′-ethynylbiphenyl-2-yl)-5-fluoro-1,3-dimethyl-1H-pyrazole-4-carboxamide, (2.56) 2-chloro-N-(4′-ethynylbiphenyl-2-yl)nicotinamide, (2.57) 2-chloro-N-[4′-(3,3-dimethylbut-1-yn-1-yl)biphenyl-2-yl]nicotinamide, (2.58) 4-(difluoromethyl)-2-methyl-N-[4′-(trifluoromethyl)biphenyl-2-yl]-1,3-thiazole-5-carboxamide, (2.59) 5-fluoro-N-[4′-(3-hydroxy-3-methylbut-1-yn-1-yl)biphenyl-2-yl]-1,3-dimethyl-1H-pyrazole-4-carboxamide, (2.60) 2-chloro-N-[4′-(3-hydroxy-3-methylbut-1-yn-1-yl)biphenyl-2-yl]nicotinamide, (2.61) 3-(difluoromethyl)-N-[4′-(3-methoxy-3-methylbut-1-yn-1-yl)biphenyl-2-yl]-1-methyl-1H-pyrazole-4-carboxamide, (2.62) 5-fluoro-N-[4′-(3-methoxy-3-methylbut-1-yn-1-yl)biphenyl-2-yl]-1,3-dimethyl-1H-pyrazole-4-carboxamide, (2.63) 2-chloro-N-[4′-(3-methoxy-3-methylbut-1-yn-1-yl)biphenyl-2-yl]nicotinamide, (2.64) 1,3-dimethyl-N-(1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl)-1H-pyrazole-4-carboxamide, (2.65) 1,3-dimethyl-N-[(3R)-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1H-pyrazole-4-carboxamide, (2.66) 1,3-dimethyl-N-[(3S)-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1H-pyrazole-4-carboxamide, (2.67) 3-(difluoromethyl)-N-methoxy-1-methyl-N-[1-(2,4,6-trichlorophenyl)propan-2-yl]-1H-pyrazole-4-carboxamide, (2.68) 3-(difluoromethyl)-N-(7-fluoro-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl)-1-methyl-1H-pyrazole-4-carboxamide, (2.69) 3-(difluoromethyl)-N-[(3R)-7-fluoro-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1-methyl-1H-pyrazole-4-carboxamide, (2.70) 3-(difluoromethyl)-N-[(3S)-7-fluoro-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1-methyl-1H-pyrazole-4-carboxamide.
 
3) Inhibitors of the respiratory chain on complex III, for example (3.01) ametoctradin, (3.02) amisulbrom, (3.03) azoxystrobin, (3.04) cyazofamid, (3.05) coumethoxystrobin, (3.06) coumoxystrobin, (3.07) dimoxystrobin, (3.08) enoxastrobin, (3.09) famoxadon, (3.10) fenamidon, (3.11) flufenoxystrobin, (3.12) fluoxastrobin, (3.13) kresoxim-methyl, (3.14) metominostrobin, (3.15) orysastrobin, (3.16) picoxystrobin, (3.17) pyraclostrobin, (3.18) pyrametostrobin, (3.19) pyraoxystrobin, (3.20) pyribencarb, (3.21) triclopyricarb, (3.22) trifloxystrobin, (3.23) (2E)-2-(2-{[6-(3-chloro-2-methylphenoxy)-5-fluoropyrimidin-4-yl]oxy}phenyl)-2-(methoxyimino)-N-methylacetamide, (3.24) (2E)-2-(methoxyimino)-N-methyl-2-(2-{[({(1E)-1-[3-(trifluoromethyl)phenyl]ethyliden}amino)oxy]methyl}phenyl)acetamide, (3.25) (2E)-2-(methoxyimino)-N-methyl-2-{2-[(E)-({1-[3-(trifluoromethyl)phenyl]ethoxy}imino)methyl]phenyl}acetamide, (3.26) (2E)-2-{2-[({[(1E)-1-(3-{[(E)-1-fluoro-2-phenylvinyl]oxy}phenyl)ethyliden]amino}oxy)methyl]phenyl}-2-(methoxyimino)-N-methylacetamide, (3.27) fenaminostrobin, (3.28) 5-methoxy-2-methyl-4-(2-{[({(1E)-1-[3-(trifluoromethyl)phenyl]ethyliden}amino)oxy]methyl}phenyl)-2,4-dihydro-3H-1,2,4-triazol-3-one, (3.29) (2E)-2-{2-[({cyclopropyl[(4-methoxyphenyl)imino]methyl}sulfanyl)methyl]phenyl}-3-methoxyacrylic acid methyl ester, (3.30) N-(3-ethyl-3,5,5-trimethylcyclohexyl)-3-formamido-2-hydroxybenzamide, (3.31) 2-{2-[(2,5-dimethylphenoxy)methyl]phenyl}-2-methoxy-N-methylacetamide, (3.32) 2-{2-[(2,5-dimethylphenoxy)methyl]phenyl}-2-methoxy-N-methylacetamide, (3.33) (2E,3Z)-5-{[1-(4-chlorophenyl)-1H-pyrazol-3-yl]oxy}-2-(methoxyimino)-N,3-dimethylpent-3-enamide.
 
4) Inhibitors of mitosis and cell division, for example (4.01) benomyl, (4.02) carbendazim, (4.03) chlorfenazole, (4.04) diethofencarb, (4.05) ethaboxam, (4.06) fluopicolide, (4.07) fuberidazole, (4.08) pencycuron, (4.09) thiabendazole, (4.10) thiophanate-methyl, (4.11) thiophanate, (4.12) zoxamide, (4.13) 5-chloro-7-(4-methylpiperidin-1-yl)-6-(2,4,6-trifluorophenyl)[1,2,4]triazolo[1,5-a]pyrimidine, (4.14) 3-chloro-5-(6-chloropyridin-3-yl)-6-methyl-4-(2,4,6-trifluorophenyl)pyridazine.
 
5) Compounds capable of having multisite action, for example (5.01) Bordeaux mixture, (5.02) captafol, (5.03) captan, (5.04) chlorothalonil, (5.05) copper hydroxide, (5.06) copper naphthenate, (5.07) copper oxide, (5.08) copper oxychloride, (5.09) copper(2+) sulfate, (5.10) dichlofluanid, (5.11) dithianon, (5.12) dodine, (5.13) dodine free base, (5.14) ferbam, (5.15) fluorofolpet, (5.16) folpet, (5.17) guazatine, (5.18) guazatine acetate, (5.19) iminoctadine, (5.20) iminoctadine albesilate, (5.21) iminoctadine triacetate, (5.22) mancopper, (5.23) mancozeb, (5.24) maneb, (5.25) metiram, (5.26) metiram zinc, (5.27) oxine-copper, (5.28) propamidine, (5.29) propineb, (5.30) sulfur and sulfur preparations including calcium polysulfide, (5.31) thiram, (5.32) tolylfluanid, (5.33) zineb, (5.34) ziram, (5.35) anilazine.
 
6) Compounds capable of inducing host defence, for example (6.01) acibenzolar-S-methyl, (6.02) isotianil, (6.03) probenazole, (6.04) tiadinil, (6.05) laminarin.
 
7) Inhibitors of the amino acid and/or protein biosynthesis, for example (7.01) andoprim, (7.02) blasticidin-S, (7.03) cyprodinil, (7.04) kasugamycin, (7.05) kasugamycin hydrochloride hydrate, (7.06) mepanipyrim, (7.07) pyrimethanil, (7.08) 3-(5-fluoro-3,3,4,4-tetramethyl-3,4-dihydroisoquinolin-1-yl)quinoline, (7.09) oxytetracycline, (7.10) streptomycin.
 
8) Inhibitors of ATP production, for example (8.01) fentin acetate, (8.02) fentin chloride, (8.03) fentin hydroxide, (8.04) silthiofam.
 
9) Inhibitors of cell wall synthesis, for example (9.01) benthiavalicarb, (9.02) dimethomorph, (9.03) flumorph, (9.04) iprovalicarb, (9.05) mandipropamid, (9.06) polyoxins, (9.07) polyoxorim, (9.08) validamycin A, (9.09) valifenalate, (9.10) polyoxin B, (9.11) (2E)-3-(4-tert-butylphenyl)-3-(2-chloropyridin-4-yl)-1-(morpholin-4-yl)prop-2-en-1-one, (9.12) (2Z)-3-(4-tert-butylphenyl)-3-(2-chloropyridin-4-yl)-1-(morpholin-4-yl)prop-2-en-1-one.
 
10) Inhibitors of lipid and membrane synthesis, for example (10.01) biphenyl, (10.02) chloroneb, (10.03) dicloran, (10.04) edifenphos, (10.05) etridiazole, (10.06) iodocarb, (10.07) iprobenfos, (10.08) isoprothiolane, (10.09) propamocarb, (10.10) propamocarb hydrochloride, (10.11) prothiocarb, (10.12) pyrazophos, (10.13) quintozene, (10.14) tecnazene, (10.15) tolclofos-methyl.
 
11) Inhibitors of melanin biosynthesis, for example (11.01) carpropamid, (11.02) diclocymet, (11.03) fenoxanil, (11.04) phthalide, (11.05) pyroquilon, (11.06) tricyclazole, (11.07) 2,2,2-trifluoroethyl {3-methyl-1-[(4-methylbenzoyl)amino]butan-2-yl}carbamate.
 
12) Inhibitors of nucleic acid synthesis, for example (12.01) benalaxyl, (12.02) benalaxyl-M (kiralaxyl), (12.03) bupirimate, (12.04) clozylacon, (12.05) dimethirimol, (12.06) ethirimol, (12.07) furalaxyl, (12.08) hymexazole, (12.09) metalaxyl, (12.10) metalaxyl-M (mefenoxam), (12.11) ofurace, (12.12) oxadixyl, (12.13) oxolinic acid, (12.14) octhilinone.
 
13) Inhibitors of signal transduction, for example (13.01) chlozolinate, (13.02) fenpiclonil, (13.03) fludioxonil, (13.04) iprodione, (13.05) procymidone, (13.06) quinoxyfen, (13.07) vinclozolin, (13.08) proquinazid.
 
14) Compounds capable of acting as uncouplers, for example (14.01) binapacryl, (14.02) dinocap, (14.03) ferimzone, (14.04) fluazinam, (14.05) meptyldinocap.
 
15) Further compounds, for example (15.001) benthiazole, (15.002) bethoxazin, (15.003) capsimycin, (15.004) carvone, (15.005) quinomethionate, (15.006) pyriofenone (chlazafenone), (15.007) cufraneb, (15.008) cyflufenamid, (15.009) cymoxanil, (15.010) cyprosulfamide, (15.011) dazomet, (15.012) debacarb, (15.013) dichlorophen, (15.014) diclomezin, (15.015) difenzoquat, (15.016) difenzoquat metilsulfate, (15.017) diphenylamine, (15.018) Ecomate, (15.019) fenpyrazamine, (15.020) flumetover, (15.021) fluoroimide, (15.022) flusulfamide, (15.023) flutianil, (15.024) fosetyl-aluminium, (15.025) fosetyl-calcium, (15.026) fosetyl-sodium, (15.027) hexachlorobenzene, (15.028) irumamycin, (15.029) methasulfocarb, (15.030) methyl isothiocyanate, (15.031) metrafenone, (15.032) mildiomycin, (15.033) natamycin, (15.034) nickel dimethyldithiocarbamate, (15.035) nitrothal-isopropyl, (15.036) oxamocarb, (15.037) oxyfenthiin, (15.038) pentachlorophenol and salts, (15.039) phenothrin, (15.040) phosphorous acid and salts thereof, (15.041) propamocarb-fosetylate, (15.042) propanosin-sodium, (15.043) pyrimorph, (15.044) pyrrolnitrin, (15.045) tebufloquin, (15.046) tecloftalam, (15.047) tolnifanid, (15.048) triazoxide, (15.049) trichlamid, (15.050) zarilamid, (15.051) 2-methylpropanoic acid (3S,6S,7R,8R)-8-benzyl-3-[({3-[(isobutyryloxy)methoxy]-4-methoxypyridin-2-yl}carbonyl)amino]-6-methyl-4,9-dioxo-1,5-dioxonan-7-yl ester, (15.052) 1-(4-{4-[(5R)-5-(2,6-difluorophenyl)-4,5-dihydro-1,2-oxazol-3-yl]-1,3-thiazol-2-yl}piperidin-1-yl)-2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]ethanone, (15.053) 1-(4-{4-[(5S)-5-(2,6-difluorophenyl)-4,5-dihydro-1,2-oxazol-3-yl]-1,3-thiazol-2-yl}piperidin-1-yl)-2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]ethanone, (15.054) oxathiapiproline, (15.055) 1H-imidazole-1-carboxylic acid 1-(4-methoxyphenoxy)-3,3-dimethylbutan-2-yl ester, (15.056) 2,3,5,6-tetrachloro-4-(methylsulfonyl)pyridine, (15.057) 2,3-dibutyl-6-chlorothieno[2,3-d]pyrimidin-4(3H)-one, (15.058) 2,6-dimethyl-1H,5H-[1,4]dithiino[2,3-c:5,6-c′]dipyrrole-1,3,5,7(2H,6H)-tetrone, (15.059) 2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]-1-(4-{4-[(5R)-5-phenyl-4,5-dihydro-1,2-oxazol-3-yl]-1,3-thiazol-2-yl}piperidin-1-yl)ethanone, (15.060) 2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]-1-(4-{4-[(5S)-5-phenyl-4,5-dihydro-1,2-oxazol-3-yl]-1,3-thiazol-2-yl}piperidin-1-yl)ethanone, (15.061) 2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]-1-{4-[4-(5-phenyl-4,5-dihydro-1,2-oxazol-3-yl)-1,3-thiazol-2-yl]piperidin-1-yl}ethanone, (15.062) 2-butoxy-6-iodo-3-propyl-4H-chromen-4-one, (15.063) 2-chloro-5-[2-chloro-1-(2,6-difluoro-4-methoxyphenyl)-4-methyl-1H-imidazol-5-yl]pyridine, (15.064) 2-phenylphenol and salts, (15.065) 3-(4,4,5-trifluoro-3,3-dimethyl-3,4-dihydroisoquinolin-1-yl)quinoline, (15.066) 3,4,5-trichloropyridine-2,6-dicarboxylic acid nitrile, (15.067) 3-chloro-5-(4-chlorophenyl)-4-(2,6-difluorophenyl)-6-methylpyridazine, (15.068) 4-(4-chlorophenyl)-5-(2,6-difluorophenyl)-3,6-dimethylpyridazine, (15.069) 5-amino-1,3,4-thiadiazole-2-thiol, (15.070) 5-chloro-N′-phenyl-N′-(prop-2-in-1-yl)thiophene-2-sulfonohydrazide, (15.071) 5-fluoro-2-[(4-fluorobenzyl)oxy]pyrimidine-4-amine, (15.072) 5-fluoro-2-[(4-methylbenzyl)oxy]pyrimidine-4-amine, (15.073) 5-methyl-6-octyl[1,2,4]triazolo[1,5-a]pyrimidine-7-amine, (15.074) (2Z)-3-amino-2-cyano-3-phenylacrylic acid ethyl ester, (15.075) N′-(4-{[3-(4-chlorobenzyl)-1,2,4-thiadiazol-5-yl]oxy}-2,5-dimethylphenyl)-N-ethyl-N-methylimidoformamide, (15.076) N-(4-chlorobenzyl)-3-[3-methoxy-4-(prop-2-in-1-yloxy)phenyl]propanamide, (15.077) N-[(4-chlorophenyl)(cyano)methyl]-3-[3-methoxy-4-(prop-2-in-1-yloxy)phenyl]propanamide, (15.078) N-[(5-bromo-3-chloropyridin-2-yl)methyl]-2,4-dichloronicotinamide, (15.079) N-[1-(5-bromo-3-chloropyridin-2-yl)ethyl]-2,4-dichloronicotinamide, (15.080) N-[1-(5-bromo-3-chloropyridin-2-yl)ethyl]-2-fluoro-4-iodonicotinamide, (15.081) N-{(E)-[(cyclopropylmethoxy)imino][6-(difluoromethoxy)-2,3-difluorophenyl]methyl}-2-phenylacetamide, (15.082) N—{(Z)-[(cyclopropylmethoxy)imino][6-(difluoromethoxy)-2,3-difluorophenyl]methyl}-2-phenylacetamide, (15.083) N′-{4-[(3-tert-butyl-4-cyano-1,2-thiazol-5-yl)oxy]-2-chloro-5-methylphenyl}-N-ethyl-N-methylimidoformamide, (15.084) N-methyl-2-(1-{[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-N-(1,2,3,4-tetrahydronaphthalin-1-yl)-1,3-thiazole-4-carboxamide, (15.085) N-methyl-2-(1-{[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-N-[(1R)-1,2,3,4-tetrahydronaphthalin-1-yl]-1,3-thiazole-4-carboxamide, (15.086) N-methyl-2-(1-{[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-N-[(1S)-1,2,3,4-tetrahydronaphthalin-1-yl]-1,3-thiazole-4-carboxamide, (15.087) {6-[({[(1-methyl-1H-tetrazol-5-yl)(phenyl)methylen]amino}oxy)methyl]pyridin-2-yl}carbamic acid pentyl ester, (15.088) phenazine-1-carboxylic acid, (15.089) quinolin-8-ol, (15.090) quinolin-8-ol sulfate (2:1), (15.091) {6-[({[(1-methyl-1H-tetrazol-5-yl)(phenyl)methylen]amino}oxy)methyl]pyridin-2-yl}carbamic acid tert-butyl ester, (15.092) (5-bromo-2-methoxy-4-methylpyridin-3-yl)(2,3,4-trimethoxy-6-methylphenyl)methanone, (15.093) N-[2-(4-{[3-(4-chlorophenyl)prop-2-yn-1-yl]oxy}-3-methoxyphenyl)ethyl]-N2-(methylsulfonyl)valinamide, (15.094) 4-oxo-4-[(2-phenylethyl)amino]butanoic acid, (15.095) {6-[({[(Z)-(1-methyl-1H-tetrazol-5-yl)(phenyl)methylen]amino}oxy)methyl]pyridin-2-yl}carbamic acid but-3-yn-1-yl ester, (15.096) 4-amino-5-fluoropyrimidin-2-ol (tautomeric form: 4-amino-5-fluoropyrimidin-2(1H)-one), (15.097) 3,4,5-trihydroxybenzoic acid propyl ester, (15.098) [3-(4-chloro-2-fluorophenyl)-5-(2,4-difluorophenyl)-1,2-oxazol-4-yl](pyridin-3-yl)methanol, (15.099) (S)-[3-(4-chloro-2-fluorophenyl)-5-(2,4-difluorophenyl)-1,2-oxazol-4-yl](pyridin-3-yl)methanol, (15.100) (R)-[3-(4-chloro-2-fluorophenyl)-5-(2,4-difluorophenyl)-1,2-oxazol-4-yl](pyridin-3-yl)methanol, (15.101) 2-fluoro-6-(trifluoromethyl)-N-(1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl)benzamide, (15.102) 2-(6-benzylpyridin-2-yl)quinazoline, (15.103) 2-[6-(3-fluoro-4-methoxyphenyl)-5-methylpyridin-2-yl]quinazoline, (15.104) 3-(4,4-difluoro-3,3-dimethyl-3,4-dihydroisoquinolin-1-yl)quinoline, (15.105) abscisic acid, (15.106) N-[5-bromo-6-(2,3-dihydro-1H-inden-2-yloxy)-2-methylpyridin-3-yl]-N-ethyl-N-methylimidoformamide, (15.107) N′-{5-bromo-6-[1-(3,5-difluorophenyl)ethoxy]-2-methylpyridin-3-yl}-N-ethyl-N-methylimidoformamide, (15.108) N′-{5-bromo-6-[(1R)-1-(3,5-difluorophenyl)ethoxy]-2-methylpyridin-3-yl}-N-ethyl-N-methylimidoformamide, (15.109) N′-{5-bromo-6-[(1S)-1-(3,5-difluorophenyl)ethoxy]-2-methylpyridin-3-yl}-N-ethyl-N-methylimidoformamide, (15.110) N′-{5-bromo-6-[(cis-4-isopropylcyclohexyl)oxy]-2-methylpyridin-3-yl}-N-ethyl-N-methylimidoformamide, (15.111) N′-{5-bromo-6-[(trans-4-isopropylcyclohexyl)oxy]-2-methylpyridin-3-yl}-N-ethyl-N-methylimidoformamide, (15.112) N-cyclopropyl-3-(difluoromethyl)-5-fluoro-N-(2-isopropylbenzyl)-1-methyl-1H-pyrazole-4-carboxamide, (15.113) N-cyclopropyl-N-(2-cyclopropylbenzyl)-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, (15.114) N-(2-tert-butylbenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, (15.115) N-(5-chloro-2-ethylbenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, (15.116) N-(5-chloro-2-isopropylbenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, (15.117) N-cyclopropyl-3-(difluoromethyl)-N-(2-ethyl-5-fluorobenzyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, (15.118) N-cyclopropyl-3-(difluoromethyl)-5-fluoro-N-(5-fluoro-2-isopropylbenzyl)-1-methyl-1H-pyrazole-4-carboxamide, (15.119) N-cyclopropyl-N-(2-cyclopropyl-5-fluorobenzyl)-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, (15.120) N-(2-cyclopentyl-5-fluorobenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, (15.121) N-cyclopropyl-3-(difluoromethyl)-5-fluoro-N-(2-fluoro-6-isopropylbenzyl)-1-methyl-1H-pyrazole-4-carboxamide, (15.122) N-cyclopropyl-3-(difluoromethyl)-N-(2-ethyl-5-methylbenzyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, (15.123) N-cyclopropyl-3-(difluoromethyl)-5-fluoro-N-(2-isopropyl-5-methylbenzyl)-1-methyl-1H-pyrazole-4-carboxamide, (15.124) N-cyclopropyl-N-(2-cyclopropyl-5-methylbenzyl)-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, (15.125) N-(2-tert-butyl-5-methylbenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, (15.126) N-[5-chloro-2-(trifluoromethyl)benzyl]-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, (15.127) N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-N-[5-methyl-2-(trifluoromethyl)benzyl]-1H-pyrazole-4-carboxamide, (15.128) N-[2-chloro-6-(trifluoromethyl)benzyl]-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, (15.129) N-[3-chloro-2-fluoro-6-(trifluoromethyl)benzyl]-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, (15.130) N-cyclopropyl-3-(difluoromethyl)-N-(2-ethyl-4,5-dimethylbenzyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, (15.131) N-cyclopropyl-3-(difluoromethyl)-5-fluoro-N-(2-isopropylbenzyl)-1-methyl-1H-pyrazole-4-carbothioamide, (15.132) N′-(2,5-dimethyl-4-phenoxyphenyl)-N-ethyl-N-methylimidoformamide, (15.133) N′-{4-[(4,5-dichloro-1,3-thiazol-2-yl)oxy]-2,5-dimethylphenyl}-N-ethyl-N-methylimidoformamide, (15.134) N-(4-chloro-2,6-difluorophenyl)-4-(2-chloro-4-fluorophenyl)-1,3-dimethyl-1H-pyrazole-5-amine, (15.135) 9-fluoro-2,2-dimethyl-5-(quinolin-3-yl)-2,3-dihydro-1,4-benzoxazepine, (15.136) 2-{2-fluoro-6-[(8-fluoro-2-methylquinolin-3-yl)oxy]phenyl}propan-2-ol, (15.137) 2-{2-[(7,8-difluoro-2-methylquinolin-3-yl)oxy]-6-fluorophenyl}propan-2-ol, (15.138) 4-(2-chloro-4-fluorophenyl)-N-(2-fluorophenyl)-1,3-dimethyl-1H-pyrazole-5-amine, (15.139) 4-(2-chloro-4-fluorophenyl)-N-(2,6-difluorophenyl)-1,3-dimethyl-1H-pyrazole-5-amine, (15.140) 4-(2-chloro-4-fluorophenyl)-N-(2-chloro-6-fluorophenyl)-1,3-dimethyl-1H-pyrazole-5-amine, (15.141) 4-(2-bromo-4-fluorophenyl)-N-(2-chloro-6-fluorophenyl)-1,3-dimethyl-1H-pyrazole-5-amine, (15.142) N-(2-bromo-6-fluorophenyl)-4-(2-chloro-4-fluorophenyl)-1,3-dimethyl-1H-pyrazole-5-amine, (15.143) 4-(2-bromo-4-fluorophenyl)-N-(2-bromophenyl)-1,3-dimethyl-1H-pyrazole-5-amine, (15.144) 4-(2-bromo-4-fluorophenyl)-N-(2-bromo-6-fluorophenyl)-1,3-dimethyl-1H-pyrazole-5-amine, (15.145) 4-(2-bromo-4-fluorophenyl)-N-(2-chlorophenyl)-1,3-dimethyl-1H-pyrazole-5-amine, (15.146) N-(2-bromphenyl)-4-(2-chloro-4-fluorophenyl)-1,3-dimethyl-1H-pyrazole-5-amine, (15.147) 4-(2-chloro-4-fluorophenyl)-N-(2-chlorophenyl)-1,3-dimethyl-1H-pyrazole-5-amine, (15.148) 4-(2-bromo-4-fluorophenyl)-N-(2,6-difluorophenyl)-1,3-dimethyl-1H-pyrazole-5-amine, (15.149) 4-(2-bromo-4-fluorophenyl)-N-(2-fluorophenyl)-1,3-dimethyl-1H-pyrazole-5-amine, (15.150) N′-(4-{3-[(difluoromethyl)sulfanyl]phenoxy}-2,5-dimethylphenyl)-N-ethyl-N-methylimidoformamide, (15.151) N′-(2,5-dimethyl-4-{3-[(1,1,2,2-tetrafluoroethyl)sulfanyl]phenoxy}phenyl)-N-ethyl-N-methylimidoformamide, (15.152) N′-(2,5-dimethyl-4-{3-[(2,2,2-trifluoroethyl)sulfanyl]phenoxy}phenyl)-N-ethyl-N-methylimidoformamide, (15.153) N′-(2,5-dimethyl-4-{3-[(2,2,3,3-tetrafluoropropyl)sulfanyl]phenoxyl}phenyl)-N-ethyl-N-methylimidoformamide, (15.154) N′-(2,5-dimethyl-4-{3-[(pentafluoroethyl)sulfanyl]phenoxy}phenyl)-N-ethyl-N-methylimidoformamide, (15.155) N′-(4-{[3-(difluoromethoxy)phenyl]sulfanyl}-2,5-dimethylphenyl)-N-ethyl-N-methylimidoformamide, (15.156) N′-(2,5-dimethyl-4-{[3-(1,1,2,2-tetrafluoroethoxy)phenyl]sulfanyl}phenyl)-N-ethyl-N-methylimidoformamide, (15.157) N′-(2,5-dimethyl-4-{[3-(2,2,2-trifluoroethoxy)phenyl]sulfanyl}phenyl)-N-ethyl-N-methylimidoformamide, (15.158) N′-(2,5-dimethyl-4-{[3-(2,2,3,3-tetrafluoropropoxy)phenyl]sulfanyl}phenyl)-N-ethyl-N-methylimidoformamide, (15.159) N′-(2,5-dimethyl-4-{[3-(pentafluoroethoxy)phenyl]sulfanyl}phenyl)-N-ethyl-N-methylimidoformamide, (15.160) 2-[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]-1-[4-(4-{5-[2-(prop-2-yn-1-yloxy)phenyl]-4,5-dihydro-1,2-oxazol-3-yl}-1,3-thiazol-2-yl)piperidin-1-yl]ethanone, (15.161) 2-[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]-1-[4-(4-{5-[2-fluoro-6-(prop-2-yn-1-yloxy)phenyl]-4,5-dihydro-1,2-oxazol-3-yl}-1,3-thiazol-2-yl)piperidin-1-yl]ethanone, (15.162) 2-[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]-1-[4-(4-{5-[2-chloro-6-(prop-2-yn-1-yloxy)phenyl]-4,5-dihydro-1,2-oxazol-3-yl}-1,3-thiazol-2-yl)piperidin-1-yl]ethanone, (15.163) 2-{3-[2-(1-{[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxazol-5-yl}phenylmethanesulfonate, (15.164) 2-{3-[2-(1-{[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxazol-5-yl}-3-chlorophenylmethanesulfonate, (15.165) 2-[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]-1-[4-(4-{(5S)-5-[2-(prop-2-yn-1-yloxy)phenyl]-4,5-dihydro-1,2-oxazol-3-yl}-1,3-thiazol-2-yl)piperidin-1-yl]ethanone, (15.166) 2-[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]-1-[4-(4-{(5R)-5-[2-(prop-2-yn-1-yloxy)phenyl]-4,5-dihydro-1,2-oxazol-3-yl}-1,3-thiazol-2-yl)piperidin-1-yl]ethanone, (15.167) 2-[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]-1-[4-(4-{(5S)-5-[2-fluoro-6-(prop-2-yn-1-yloxy)phenyl]-4,5-dihydro-1,2-oxazol-3-yl}-1,3-thiazol-2-yl)piperidin-1-yl]ethanone, (15.168) 2-[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]-1-[4-(4-{(5R)-5-[2-fluoro-6-(prop-2-yn-1-yloxy)phenyl]-4,5-dihydro-1,2-oxazol-3-yl}-1,3-thiazol-2-yl)piperidin-1-yl]ethanone, (15.169) 2-[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]-1-[4-(4-{(5S)-5-[2-chloro-6-(prop-2-yn-1-yloxy)phenyl]-4,5-dihydro-1,2-oxazol-3-yl}-1,3-thiazol-2-yl)piperidin-1-yl]ethanone, (15.170) 2-[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]-1-[4-(4-{(5R)-5-[2-chloro-6-(prop-2-yn-1-yloxy)phenyl]-4,5-dihydro-1,2-oxazol-3-yl}-1,3-thiazol-2-yl)piperidin-1-yl]ethanone, (15.171) 2-{(5S)-3-[2-(1-{[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxazol-5-yl}phenylmethane sulfonate, (15.172) 2-{(5R)-3-[2-(1-{[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxazol-5-yl}phenylmethanesulfonate, (15.173) 2-{(5S)-3-[2-(1-{[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxazol-5-yl}-3-chlorophenylmethanesulfonate, (15.174) 2-{(5R)-3-[2-(1-{[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxazol-5-yl}-3-chlorophenylmethanesulfonate.
 
Biological Pesticides as Mixing Components
 
     The compounds of the formula (I) can be combined with biological pesticides. 
     Biological pesticides include especially bacteria, fungi, yeasts, plant extracts and products formed by microorganisms, including proteins and secondary metabolites. 
     Biological pesticides include bacteria such as spore-forming bacteria, root-colonizing bacteria and bacteria which act as biological insecticides, fungicides or nematicides. 
     Examples of such bacteria which are used or can be used as biological pesticides are: 
       Bacillus amyloliquefaciens , strain FZB42 (DSM 231179), or  Bacillus cereus , especially  B. cereus  strain CNCM I-1562 or  Bacillus firmus , strain I-1582 (Accession number CNCM I-1582) or  Bacillus pumilus , especially strain GB34 (Accession No. ATCC 700814) and strain QST2808 (Accession No. NRRL B-30087), or  Bacillus subtilis , especially strain GB03 (Accession No. ATCC SD-1397), or  Bacillus subtilis  strain QST713 (Accession No. NRRL B-21661) or  Bacillus subtilis  strain OST 30002 (Accession No. NRRL B-50421)  Bacillus thuringiensis , especially  B. thuringiensis  subspecies  israelensis  (serotype H-14), strain AM65-52 (Accession No. ATCC 1276), or  B. thuringiensis  subsp.  aizawai , especially strain ABTS-1857 (SD-1372), or  B. thuringiensis  subsp. kurstaki strain HD-1, or  B. thuringiensis  subsp.  tenebrionis  strain NB 176 (SD-5428),  Pasteuria penetrans, Pasteuria  spp. ( Rotylenchulus reniformis  nematode)-PR3 (Accession Number ATCC SD-5834),  Streptomyces microflavus  strain AQ6121 (=QRD 31.013, NRRL B-50550),  Streptomyces galbus  strain AQ 6047 (Accession Number NRRL 30232). 
     Examples of fungi and yeasts which are used or can be used as biological pesticides are: 
       Beauveria bassiana , in particular strain ATCC 74040,  Coniothyrium minitans , in particular strain CON/M/91-8 (Accession No. DSM-9660),  Lecanicillium  spp., in particular strain HRO LEC12 , Lecanicillium lecanii , (formerly known as  Verticillium lecanii ), in particular strain KV01, Metarhizium anisopliae, in particular strain F52 (DSM3884/ATCC 90448),  Metschnikowia fructicola , in particular strain NRRL Y-30752,  Paecilomyces fumosoroseus  (new: Isaria fumosorosea), in particular strain IFPC 200613, or strain Apopka 97 (Accession No. ATCC 20874 ),  Paecilomyces lilacinus , in particular  P. lilacinus  strain 251 (AGAL 89/030550),  Talaromyces flavus , in particular strain V117b,  Trichoderma  atroviride, in particular strain SC1 (Accession Number CBS 122089),  Trichoderma harzianum , in particular  T. harzianum  rifai T39 (Accession Number CNCM I-952). 
     Examples of viruses which are used or can be used as biological pesticides are: 
       Adoxophyes orana  (summer fruit  tortrix ) granulosis virus (GV),  Cydia pomonella  (codling moth) granulosis virus (GV),  Helicoverpa armigera  (cotton bollworm) nuclear polyhedrosis virus (NPV),  Spodoptera exigua  (beet armyworm) mNPV,  Spodoptera frugiperda  (fall armyworm) mNPV,  Spodoptera littoralis  (African cotton leafworm) NPV. 
     Also included are bacteria and fungi which are added as ‘inoculant’ to plants or plant parts or plant organs and which, by virtue of their particular properties, promote plant growth and plant health. Examples include: 
       Agrobacterium  spp.,  Azorhizobium caulinodans, Azospirillum  spp.,  Azotobacter  spp.,  Bradyrhizobium  spp.,  Burkholderia  spp., especially  Burkholderia cepacia  (formerly known as  Pseudomonas cepacia ),  Gigaspora  spp., or  Gigaspora monosporum, Glomus  spp.,  Laccaria  spp.,  Lactobacillus buchneri, Paraglomus  spp.,  Pisolithus tinctorus, Pseudomonas  spp.,  Rhizobium  spp., especially  Rhizobium trifolii, Rhizopogon  spp.,  Scleroderma  spp.,  Suillus  spp.,  Streptomyces  spp. 
     Examples of plant extracts and products formed by microorganisms, including proteins and secondary metabolites, which are used or can be used as biological pesticides are: 
       Allium sativum, Artemisia absinthium , azadirachtin, Biokeeper WP,  Cassia nigricans, Celastrus angulatus, Chenopodium anthelminticum , chitin, Armour-Zen, Dryopteris filix-mas,  Equisetum arvense , Fortune Aza, Fungastop, Heads Up ( Chenopodium quinoa  saponin extract), Pyrethrum/Pyrethrins,  Quassia amara, Quercus , Quillaja, Regalia, “Requiem™ Insecticide”, rotenone, ryania/ryanodine,  Symphytum officinale, Tanacetum vulgare , thymol, Triact 70, TriCon,  Tropaeulum majus, Urtica dioica, Veratrin, Viscum album, Brassicaceae extract, especially oilseed rape powder or mustard powder.    
     Safeners as Mixing Components 
     The compounds of the formula (I) can be combined with safeners, for example benoxacor, cloquintocet (-mexyl), cyometrinil, cyprosulfamide, dichlormid, fenchlorazole (-ethyl), fenclorim, flurazole, fluxofenim, furilazole, isoxadifen (-ethyl), mefenpyr (-diethyl), naphthalic anhydride, oxabetrinil, 2-methoxy-N-({4-[(methylcarbamoyl)amino]phenyl}sulfonyl)benzamide (CAS 129531-12-0), 4-(dichloroacetyl)-1-oxa-4-azaspiro[4.5]decane (CAS 71526-07-3), 2,2,5-trimethyl-3-(dichloroacetyl)-1,3-oxazolidine (CAS 52836-31-4). 
     Plants and Plant Parts 
     All plants and plant parts can be treated in accordance with the invention. Plants are understood here to mean all plants and populations of plants, such as desirable and undesirable wild plants or crop plants (including naturally occurring crop plants), for example cereals (wheat, rice, triticale, barley, rye, oats), maize, soya bean, potato, sugar beet, sugar cane, tomatoes, bell peppers and chili peppers, cucumbers, melons, carrots, water melons, onions, lettuce, spinach, leeks, beans,  Brassica oleracea  (e.g. cabbage), peas and other vegetable species, cotton, tobacco, oilseed rape, and also fruit plants (with the fruits apples, pears, citrus fruits and grapes). Crop plants may be plants which can be obtained by conventional breeding and optimization methods or by biotechnological and genetic engineering methods or combinations of these methods, including the transgenic plants and including the plant cultivars which are protectable or non-protectable by plant breeders&#39; rights. Plants shall be understood to mean all developmental stages of the plants, for example seeds, cuttings and young (immature) plants up to mature plants. Plant parts shall be understood to mean all parts and organs of the plants above and below ground, such as shoot, leaf, flower and root, examples given being leaves, needles, stalks, stems, flowers, fruit bodies, fruits and seeds, and also roots, tubers and rhizomes. Plant parts also include harvested material (harvested plants or plant parts) and vegetative and generative propagation material, for example cuttings, tubers, rhizomes, slips and seeds. 
     The inventive treatment of the plants and parts of plants with the compounds of the formula (I) is effected directly or by allowing them to act on the surroundings, habitat or storage space thereof by the customary treatment methods, for example by dipping, spraying, evaporating, fogging, scattering, painting on, injecting, and, in the case of propagation material, especially in the case of seeds, also by applying one or more coats. 
     As already mentioned above, it is possible to treat all plants and parts thereof in accordance with the invention. In a preferred embodiment, wild plant species and plant cultivars, or those obtained by conventional biological breeding methods, such as crossing or protoplast fusion, and parts thereof, are treated. In a further preferred embodiment, transgenic plants and plant cultivars obtained by genetic engineering methods, if appropriate in combination with conventional methods (genetically modified organisms), and parts thereof are treated. The term “parts” or “parts of plants” or “plant parts” has been explained above. Particular preference is given in accordance with the invention to treating plants of the respective commercially customary plant cultivars or those that are in use. Plant cultivars are understood to mean plants having new properties (“traits”) and which have been grown by conventional breeding, by mutagenesis or by recombinant DNA techniques. They may be cultivars, varieties, biotypes or genotypes. 
     Transgenic Plants, Seed Treatment and Integration Events 
     The preferred transgenic plants or plant cultivars (those obtained by genetic engineering) which are to be treated in accordance with the invention include all plants which, through the genetic modification, received genetic material which imparts particular advantageous useful properties (“traits”) to these plants. Examples of such properties are better plant growth, increased tolerance to high or low temperatures, increased tolerance to drought or to levels of water or soil salinity, enhanced flowering performance, easier harvesting, accelerated ripening, higher harvest yields, higher quality and/or higher nutritional value of the harvested products, better capability for storage and/or processability of the harvested products. Further and particularly emphasized examples of such properties are increased resistance of the plants against animal and microbial pests, such as insects, arachnids, nematodes, mites, slugs and snails, owing, for example, to toxins formed in the plants, in particular those formed in the plants by the genetic material from  Bacillus thuringiensis  (for example by the genes CryIA(a), CryIA(b), CryIA(c), CryIIA, CryIIIA, CryIIIB2, Cry9c, Cry2Ab, Cry3Bb and CryIF and also combinations thereof), and also increased resistance of the plants against phytopathogenic fungi, bacteria and/or viruses caused, for example, by systemic acquired resistance (SAR), systemin, phytoalexins, elicitors and resistance genes and correspondingly expressed proteins and toxins, and also increased tolerance of the plants to certain herbicidally active compounds, for example imidazolinones, sulfonylureas, glyphosates or phosphinothricin (for example the “PAT” gene). The genes which impart the desired properties (“traits”) in question may also be present in combinations with one another in the transgenic plants. Examples of transgenic plants include the important crop plants, such as cereals (wheat, rice, triticale, barley, rye, oats), maize, soya beans, potatoes, sugar beet, sugar cane, tomatoes, peas and other types of vegetable, cotton, tobacco, oilseed rape and also fruit plants (with the fruits apples, pears, citrus fruits and grapes), particular emphasis being given to maize, soya beans, wheat, rice, potatoes, cotton, sugar cane, tobacco and oilseed rape. Properties (“traits”) which are particularly emphasized are the increased resistance of the plants to insects, arachnids, nematodes and slugs and snails. 
     Crop Protection—Types of Treatment 
     The plants and plant parts are treated with the compounds of the formula (I) directly or by action on their surroundings, habitat or storage space using customary treatment methods, for example by dipping, spraying, atomizing, irrigating, evaporating, dusting, fogging, broadcasting, foaming, painting, spreading-on, injecting, watering (drenching), drip irrigating and, in the case of propagation material, in particular in the case of seed, additionally by dry seed treatment, liquid seed treatment, slurry treatment, by incrusting, by coating with one or more coats, etc. It is furthermore possible to apply the compounds of the formula (I) by the ultra-low volume method or to inject the application form or the compound of the formula (I) itself into the soil. 
     A preferred direct treatment of the plants is foliar application, i.e. compounds of the formula (I) are applied to the foliage, where treatment frequency and the application rate should be adjusted according to the level of infestation with the pest in question. 
     In the case of systemically active compounds, the compounds of the formula (I) also access the plants via the root system. The plants are then treated by the action of the compounds of the formula (I) on the habitat of the plant. This can be accomplished, for example, by drenching, or by mixing into the soil or the nutrient solution, meaning that the locus of the plant (e.g. soil or hydroponic systems) is impregnated with a liquid form of the compounds of the formula (I), or by soil application, meaning that the compounds of the formula (I) are introduced in solid form (e.g. in the form of granules) into the locus of the plants. In the case of paddy rice crops, this can also be accomplished by metering the compound of the formula (I) in a solid application form (for example as granules) into a flooded paddy field. 
     Seed Treatment 
     The control of animal pests by the treatment of the seed of plants has long been known and is the subject of constant improvements. Nevertheless, the treatment of seed entails a series of problems which cannot always be solved in a satisfactory manner Thus, it is desirable to develop methods for protecting the seed and the germinating plant which dispense with, or at least reduce considerably, the additional application of pesticides during storage, after sowing or after emergence of the plants. It is additionally desirable to optimize the amount of active ingredient used so as to provide optimum protection for the seed and the germinating plant from attack by animal pests, but without damage to the plant itself by the active ingredient used. In particular, methods for the treatment of seed should also take account of the intrinsic insecticidal or nematicidal properties of pest-resistant or -tolerant transgenic plants in order to achieve optimal protection of the seed and the germinating plant with a minimum expenditure on pesticides. 
     The present invention therefore in particular also relates to a method for the protection of seed and germinating plants from attack by pests, by treating the seed with one of the compounds of the formula (I). The method according to the invention for protecting seed and germinating plants against attack by pests further comprises a method in which the seed is treated simultaneously in one operation or sequentially with a compound of the formula (I) and a mixing component. It further also comprises a method where the seed is treated at different times with a compound of the formula (I) and a mixing component. 
     The invention likewise relates to the use of the compounds of the formula (I) for the treatment of seed for protecting the seed and the resulting plant from animal pests. 
     The invention further relates to seed which has been treated with a compound of the formula (I) for protection from animal pests. The invention also relates to seed which has been treated simultaneously with a compound of the formula (I) and a mixing component. The invention further relates to seed which has been treated at different times with a compound of the formula (I) and a mixing component. In the case of seed which has been treated at different times with a compound of the formula (I) and a mixing component, the individual substances may be present on the seed in different layers. In this case, the layers comprising a compound of the formula (I) and a mixing component may optionally be separated by an intermediate layer. The invention also relates to seed in which a compound of the formula (I) and a mixing component have been applied as part of a coating or as a further layer or further layers in addition to a coating. 
     The invention further relates to seed which, after the treatment with a compound of the formula (I), is subjected to a film-coating process to prevent dust abrasion on the seed. 
     One of the advantages encountered with a systemically acting compound of the formula (I) is the fact that, by treating the seed, not only the seed itself but also the plants resulting therefrom are, after emergence, protected against animal pests. In this way, the immediate treatment of the crop at the time of sowing or shortly thereafter can be dispensed with. 
     A further advantage is that the treatment of the seed with a compound of the formula (I) can enhance germination and emergence of the treated seed. 
     It is likewise considered to be advantageous that compounds of the formula (I) can especially also be used for transgenic seed. 
     Furthermore, compounds of the formula (I) can be employed in combination with compositions of signalling technology, leading to better colonization by symbionts such as, for example,  rhizobia , mycorrhizae and/or endophytic bacteria or fungi, and/or to optimized nitrogen fixation. 
     The compounds of the formula (I) are suitable for protection of seed of any plant variety which is used in agriculture, in the greenhouse, in forests or in horticulture. More particularly, this includes seed of cereals (for example wheat, barley, rye, millet and oats), maize, cotton, soya beans, rice, potatoes, sunflowers, coffee, tobacco, canola, oilseed rape, beet (for example sugar beet and fodder beet), peanuts, vegetables (for example tomatoes, cucumbers, beans, cruciferous vegetables, onions and lettuce), fruit plants, lawns and ornamental plants. Of particular significance is the treatment of the seed of cereals (such as wheat, barley, rye and oats), maize, soya beans, cotton, canola, oilseed rape and rice. 
     As already mentioned above, the treatment of transgenic seed with a compound of the formula (I) is also of particular importance. This involves the seed of plants which generally contain at least one heterologous gene which controls the expression of a polypeptide having insecticidal and/or nematicidal properties in particular. The heterologous genes in transgenic seed may originate in this case from microorganisms such as  Bacillus, Rhizobium, Pseudomonas, Serratia, Trichoderma, Clavibacter, Glomus  or  Gliocladium . The present invention is particularly suitable for the treatment of transgenic seed containing at least one heterologous gene originating from  Bacillus  sp. The heterologous gene is more preferably derived from  Bacillus thuringiensis.    
     In the context of the present invention, the compound of the formula (I) is applied to the seed. The seed is preferably treated in a state in which it is sufficiently stable for no damage to occur in the course of treatment. In general, the seed can be treated at any time between harvest and sowing. It is customary to use seed which has been separated from the plant and freed from cobs, shells, stalks, coats, hairs or the flesh of the fruits. For example, it is possible to use seed which has been harvested, cleaned and dried down to a moisture content which allows storage. Alternatively, it is also possible to use seed which, after drying, has been treated with, for example, water and then dried again, for example priming. In the case of rice seed, it is also possible to use seed which has been pre-swollen in water up to a certain stage (pigeon breast stage) for example, which leads to improved germination and more uniform emergence. 
     When treating the seed, care must generally be taken that the amount of the compound of the formula (I) applied to the seed and/or the amount of further additives is chosen in such a way that the germination of the seed is not adversely affected, or that the resulting plant is not damaged. This has to be ensured particularly in the case of active ingredients which can exhibit phytotoxic effects at certain application rates. 
     In general, the compounds of the formula (I) are applied to the seed in the form of a suitable formulation. Suitable formulations and processes for seed treatment are known to the person skilled in the art. 
     The compounds of the formula (I) can be converted to the customary seed-dressing formulations, such as solutions, emulsions, suspensions, powders, foams, slurries or other coating compositions for seed, and also ULV formulations. 
     These formulations are prepared in a known manner, by mixing compounds of the formula (I) with customary additives such as, for example, customary extenders and also solvents or diluents, dyes, wetting agents, dispersants, emulsifiers, antifoams, preservatives, secondary thickeners, adhesives, gibberellins and also water. 
     Dyes which may be present in the seed-dressing formulations usable in accordance with the invention are all dyes which are customary for such purposes. It is possible to use either pigments, which are sparingly soluble in water, or dyes, which are soluble in water. Examples include the dyes known by the names Rhodamine B, C.I. Pigment Red 112 and C.I. Solvent Red 1. 
     Useful wetting agents which may be present in the seed-dressing formulations usable in accordance with the invention are all substances which promote wetting and which are customary for the formulation of active agrochemical ingredients. Alkyl naphthalenesulfonates, such as diisopropyl or diisobutyl naphthalenesulfonates, can be used with preference. 
     Suitable dispersants and/or emulsifiers which may be present in the seed-dressing formulations usable in accordance with the invention are all nonionic, anionic and cationic dispersants customary for the formulation of active agrochemical ingredients. Nonionic or anionic dispersants or mixtures of nonionic or anionic dispersants can be used with preference. Suitable nonionic dispersants include in particular ethylene oxide/propylene oxide block polymers, alkylphenol polyglycol ethers and tristyrylphenol polyglycol ethers, and the phosphated or sulfated derivatives thereof. Suitable anionic dispersants are especially lignosulfonates, polyacrylic acid salts and arylsulfonate-formaldehyde condensates. 
     Antifoams which may be present in the seed-dressing formulations usable in accordance with the invention are all foam-inhibiting substances customary for the formulation of active agrochemical ingredients. Silicone antifoams and magnesium stearate can be used with preference. 
     Preservatives which may be present in the seed-dressing formulations usable in accordance with the invention are all substances usable for such purposes in agrochemical compositions. Examples include dichlorophene and benzyl alcohol hemiformal. 
     Secondary thickeners which may be present in the seed-dressing formulations usable in accordance with the invention are all substances which can be used for such purposes in agrochemical compositions. Preferred examples include cellulose derivatives, acrylic acid derivatives, xanthan, modified clays and finely divided silica. 
     Useful stickers which may be present in the seed-dressing formulations usable in accordance with the invention are all customary binders usable in seed-dressing products. Preferred examples include polyvinylpyrrolidone, polyvinyl acetate, polyvinyl alcohol and tylose. 
     Gibberellins which may be present in the seed-dressing formulations usable in accordance with the invention are preferably the gibberellins A1, A3 (=gibberellic acid), A4 and A7; particular preference is given to using gibberellic acid. The gibberellins are known (cf. R. Wegler “Chemie der Pflanzenschutz- and Schädlingsbekämpfungsmittel”, vol. 2, Springer Verlag, 1970, pp. 401-412). 
     The seed-dressing formulations usable in accordance with the invention can be used to treat a wide variety of different kinds of seed, either directly or after prior dilution with water. For instance, the concentrates or the preparations obtainable therefrom by dilution with water can be used to dress the seed of cereals, such as wheat, barley, rye, oats and triticale, and also the seed of maize, rice, oilseed rape, peas, beans, cotton, sunflowers, soya beans and beets, or else a wide variety of different vegetable seed. The seed-dressing formulations usable in accordance with the invention, or the dilute use forms thereof, can also be used to dress seed of transgenic plants. 
     For the treatment of seed with the seed-dressing formulations usable in accordance with the invention, or use forms prepared therefrom, all mixing units usable customarily for the seed dressing are useful. Specifically, the procedure in seed dressing is to place the seed into a mixer in batchwise or continuous operation, to add the particular desired amount of seed-dressing formulations, either as such or after prior dilution with water, and to mix until the formulation is distributed homogeneously on the seed. If appropriate, this is followed by a drying operation. 
     The application rate of the seed-dressing formulations usable in accordance with the invention can be varied within a relatively wide range. It is guided by the particular content of the compounds of the formula (I) in the formulations and by the seed. The application rates of the compound of the formula (I) are generally between 0.001 and 50 g per kilogram of seed, preferably between 0.01 and 15 g per kilogram of seed. 
     Animal Health 
     In the animal health field, i.e. the field of veterinary medicine, the compounds of the formula (I) are active against animal parasites, in particular ectoparasites or endoparasites. The term “endoparasites” includes especially helminths and protozoa, such as coccidia. Ectoparasites are typically and preferably arthropods, especially insects and acarids. 
     In the field of veterinary medicine, the compounds of the formula (I) having favourable endotherm toxicity are suitable for controlling parasites which occur in animal breeding and animal husbandry in livestock, breeding animals, zoo animals, laboratory animals, experimental animals and domestic animals. They are active against all or specific stages of development of the parasites. 
     Agricultural livestock include, for example, mammals such as sheep, goats, horses, donkeys, camels, buffalo, rabbits, reindeer, fallow deer, and particularly cattle and pigs; poultry such as turkeys, ducks, geese, and particularly chickens; fish and crustaceans, for example in aquaculture, and also insects such as bees. 
     Domestic animals include, for example, mammals, such as hamsters, guinea pigs, rats, mice, chinchillas, ferrets, and particularly dogs, cats, caged birds, reptiles, amphibians and aquarium fish. 
     In a preferred embodiment, the compounds of the formula (I) are administered to mammals. 
     In another preferred embodiment, the compounds of the formula (I) are administered to birds, namely caged birds and particularly poultry. 
     Use of the compounds of the formula (I) for the control of animal parasites is intended to reduce or prevent illness, cases of death and reductions in performance (in the case of meat, milk, wool, hides, eggs, honey and the like), such that more economical and simpler animal husbandry is enabled and better animal well-being is achievable. 
     In relation to the field of animal health, the term “control” or “controlling” means that the compounds of the formula (I) are effective in reducing the incidence of the particular parasite in an animal infected with such parasites to an innocuous degree. More specifically, “controlling” in the present context means that the compound of the formula (I) can kill the respective parasite, inhibit its growth, or inhibit its proliferation. 
     Arthropods include: 
     from the order Anoplurida, for example  Haematopinus  spp.,  Linognathus  spp.,  Pediculus  spp.,  Phtirus  spp.,  Solenopotes  spp.; from the order Mallophagida and the suborders Amblycerina and Ischnocerina, for example  Trimenopon  spp.,  Menopon  spp.,  Trinoton  spp.,  Bovicola  spp.,  Werneckiella  spp.,  Lepikentron  spp.,  Damalina  spp.,  Trichodectes  spp.,  Felicola  spp.; from the order Diptera and the suborders Nematocerina and Brachycerina, for example  Aedes  spp.,  Anopheles  spp.,  Culex  spp.,  Simulium  spp.,  Eusimulium  spp.,  Phlebotomus  spp.,  Lutzomyia  spp.,  Culicoides  spp.,  Chrysops  spp.,  Odagmia  spp.,  Wilhelmia  spp.,  Hybomitra  spp.,  Atylotus  spp.,  Tabanus  spp.,  Haematopota  spp.,  Philipomyia  spp.,  Braula  spp.,  Musca  spp.,  Hydrotaea  spp.,  Stomoxys  spp.,  Haematobia  spp.,  Morellia  spp.,  Fannia  spp.,  Glossina  spp.,  Calliphora  spp.,  Lucilia  spp.,  Chrysomyia  spp.,  Wohlfahrtia  spp.,  Sarcophaga  spp.,  Oestrus  spp.,  Hypoderma  spp.,  Gasterophilus  spp.,  Hippobosca  spp.,  Lipoptena  spp.,  Melophagus  spp.,  Rhinoestrus  spp.,  Tipula  spp.; from the order Siphonapterida, for example  Pulex  spp.,  Ctenocephalides  spp.,  Tunga  spp.,  Xenopsylla  spp.,  Ceratophyllus  spp.; 
     from the order Heteropterida, for example  Cimex  spp.,  Triatoma  spp.,  Rhodnius  spp.,  Panstrongylus  spp.; and also nuisance and hygiene pests from the order Blattarida. 
     Arthropods further include: 
     from the subclass Acari (Acarina) and the order Metastigmata, for example from the family Argasidae like  Argas  spp.,  Ornithodorus  spp.,  Otobius  spp., from the family Ixodidae like  Ixodes  spp.,  Amblyomma  spp.,  Rhipicephalus  ( Boophilus ) spp.,  Dermacentor  spp.,  Haemophysalis  spp.,  Hyalomma  spp.,  Rhipicephalus  spp. (the original genus of multi-host ticks); from the order Mesostigmata like  Dermanyssus  spp.,  Ornithonyssus  spp.,  Pneumonyssus  spp.,  Raillietia  spp.,  Pneumonyssus  spp.,  Sternostoma  spp.,  Varroa  spp.,  Acarapis  spp.; from the order Actinedida (Prostigmata), for example  Acarapis  spp.,  Cheyletiella  spp.,  Ornithocheyletia  spp.,  Myobia  spp.,  Psorergates  spp.,  Demodex  spp.,  Trombicula  spp.,  Neotrombiculla  spp.,  Listrophorus  spp.; and from the order Acaridida (Astigmata), for example  Acarus  spp.,  Tyrophagus  spp.,  Caloglyphus  spp.,  Hypodectes  spp.,  Pterolichus  spp.,  Psoroptes  spp.,  Chorioptes  spp.,  Otodectes  spp.,  Sarcoptes  spp.,  Notoedres  spp.,  Knemidocoptes  spp.,  Cytodites  spp,  Laminosioptes  spp. 
     Parasitic protozoa include: 
     Mastigophora ( Flagellata ), for example Trypanosomatidae, for example  Trypanosoma b. brucei, T.b. gambiense, T.b. rhodesiense, T. congolense, T. cruzi, T. evansi, T. equinum, T. lewisi, T. percae, T. simiae, T. vivax, Leishmania brasiliensis, L. donovani, L. tropica , for example Trichomonadidae, for example  Giardia lamblia, G. canis;    
     Sarcomastigophora (Rhizopoda) such as Entamoebidae, for example  Entamoeba histolytica, Hartmanellidae, for example Acanthamoeba  sp.,  Harmanella  sp.; 
     Apicomplexa (Sporozoa) such as Eimeridae, for example  Eimeria acervulina, E. adenoides, E. alabamensis, E. anatis, E. anserina, E. arloingi, E. ashata, E. auburnensis, E. bovis, E. brunetti, E. canis, E. chinchillae, E. clupearum, E. columbae, E. contorta, E. crandalis, E. debliecki, E. dispersa, E. ellipsoidales, E. falciformis, E. faurei, E. flavescens, E. gallopavonis, E. hagani, E. intestinalis, E. iroquoina, E. irresidua, E. labbeana, E. leucarti, E. magna, E. maxima, E. media, E. meleagridis, E. meleagrimitis, E. mitis, E. necatrix, E. ninakohlyakimovae, E. ovis, E. parva, E. pavonis, E. perforans, E. phasani, E. piriformis, E. praecox, E. residua, E. scabra, E. spec., E. stiedai, E. suis, E. tenella, E. truncata, E. truttae, E. zuernii, Globidium  spec.,  Isospora belli, I. canis, I. felis, I. ohioensis, I. rivolta, I. spec., I. suis, Cystisospora spec., Cryptosporidium  spec., in particular  C. parvum ; such as Toxoplasmadidae, for example  Toxoplasma gondii, Hammondia heydornii, Neospora caninum, Besnoitia besnoitii ; such as Sarcocystidae, for example  Sarcocystis bovicanis, S. bovihominis, S. ovicanis, S. ovifelis, S. neurona , S. spec.,  S. suihominis , such as Leucozoidae, for example  Leucozytozoon simondi , such as Plasmodiidae, for example  Plasmodium berghei, P. falciparum, P. malariae, P. ovale, P. vivax , P. spec., such as Piroplasmea, for example  Babesia argentina, B. bovis, B. canis , B. spec.,  Theileria parva, Theileria  spec., such as Adeleina, for example  Hepatozoon canis , H. spec. 
     Pathogenic endoparasites which are helminths include Platyhelmintha (e.g. Monogenea, cestodes and trematodes), nematodes, Acanthocephala, and Pentastoma. These include: 
     Monogenea: for example:  Gyrodactylus  spp.,  Dactylogyrus  spp.,  Polystoma  spp.; Cestodes: from the order of Pseudophyllidea, for example:  Diphyllobothrium  spp.,  Spirometra  spp.,  Schistocephalus  spp.,  Ligula  spp.,  Bothridium  spp.,  Diphlogonoporus  spp.; 
     from the order Cyclophyllida, for example:  Mesocestoides  spp.,  Anoplocephala  spp.,  Paranoplocephala  spp.,  Moniezia  spp.,  Thysanosoma  spp.,  Thysaniezia  spp.,  Avitellina  spp.,  Stilesia  spp.,  Cittotaenia  spp.,  Andyra  spp.,  Bertiella  spp.,  Taenia  spp.,  Echinococcus  spp.,  Hydatigera  spp.,  Davainea  spp.,  Raillietina  spp.,  Hymenolepis  spp.,  Echinolepis  spp.,  Echinocotyle  spp.,  Diorchis  spp.,  Dipylidium  spp.,  Joyeuxiella  spp.,  Diplopylidium  spp.; 
     Trematodes: from the class of Digenea, for example:  Diplostomum  spp.,  Posthodiplostomum  spp.,  Schistosoma  spp.,  Trichobilharzia  spp.,  Ornithobilharzia  spp.,  Austrobilharzia  spp.,  Gigantobilharzia  spp.,  Leucochloridium  spp.,  Brachylaima  spp.,  Echinostoma  spp.,  Echinoparyphium  spp.,  Echinochasmus  spp.,  Hypoderaeum  spp.,  Fasciola  spp.,  Fascioloides  spp.,  Fasciolopsis  spp.,  Cyclocoelum  spp.,  Typhlocoelum  spp.,  Paramphistomum  spp.,  Calicophoron  spp.,  Cotylophoron  spp.,  Gigantocotyle  spp.,  Fischoederius  spp.,  Gastrothylacus  spp.,  Notocotylus  spp.,  Catatropis  spp.,  Plagiorchis  spp.,  Prosthogonimus  spp.,  Dicrocoelium  spp.,  Eurytrema  spp.,  Troglotrema  spp.,  Paragonimus  spp.,  Collyriclum  spp.,  Nanophyetus  spp.,  Opisthorchis  spp.,  Clonorchis  spp.,  Metorchis  spp.,  Heterophyes  spp.,  Metagonimus  spp.; 
     Nematodes: Trichinellida, for example  Trichuris  spp.,  Capillaria  spp.,  Paracapillaria  spp.,  Eucoleus  spp.,  Trichomosoides  spp.,  Trichinella  spp., 
     from the order Tylenchida, for example:  Micronema  spp.,  Strongyloides  spp.; 
     from the order Rhabditida, for example:  Strongylus  spp.,  Triodontophorus  spp.,  Oesophagodontus  spp.,  Trichonema  spp.,  Gyalocephalus  spp.,  Cylindropharynx  spp.,  Poteriostomum  spp.,  Cyclococercus  spp.,  Cylicostephanus  spp.,  Oesophagostomum  spp.,  Chabertia  spp.,  Stephanurus  spp.,  Ancylostoma  spp.,  Uncinaria  spp.,  Necator  spp.,  Bunostomum  spp.,  Globocephalus  spp.,  Syngamus  spp.,  Cyathostoma  spp.,  Metastrongylus  spp.,  Dictyocaulus  spp.,  Muellerius  spp.,  Protostrongylus  spp.,  Neostrongylus  spp.,  Cy stocaulus  spp.,  Pneumostrongylus  spp.,  Spicocaulus  spp.,  Elaphostrongylus  spp.,  Parelaphostrongylus  spp.,  Crenosoma  spp.,  Paracrenosoma  spp.,  Oslerus  spp.,  Angiostrongylus  spp.,  Aelurostrongylus  spp.,  Filaroides  spp.,  Parafilaroides  spp.,  Trichostrongylus  spp.,  Haemonchus  spp.,  Ostertagia  spp.,  Teladorsagia  spp.,  Marshallagia  spp.,  Cooperia  spp.,  Nippostrongylus  spp.,  Heligmosomoides  spp.,  Nematodirus  spp.,  Hyostrongylus  spp.,  Obeliscoides  spp.,  Amidostomum  spp.,  Ollulanus  spp; 
     from the order Spirurida, for example:  Oxyuris  spp.,  Enterobius  spp.,  Passalurus  spp.,  Syphacia  spp.,  Aspiculuris  spp.,  Heterakis  spp.;  Ascaris  spp.,  Toxascaris  spp.,  Toxocara  spp.,  Baylisascaris  spp.,  Parascaris  spp.,  Anisakis  spp.,  Ascaridia  spp.;  Gnathostoma  spp.,  Physaloptera  spp.,  Thelazia  spp.,  Gongylonema  spp.,  Habronema  spp.,  Parabronema  spp.,  Draschia  spp.,  Dracunculus  spp.;  Stephanofilaria  spp.,  Parafilaria  spp.,  Setaria  spp.,  Loa  spp.,  Dirofilaria  spp.,  Litomosoides  spp.,  Brugia  spp.,  Wuchereria  spp.,  Onchocerca  spp.,  Spirocerca  spp.; 
     Acanthocephala: from the order of Oligacanthorhynchida, for example:  Macracanthorhynchus  spp.,  Prosthenorchis  spp.; from the order Polymorphida for example:  Filicollis  spp.; from the order Moniliformida for example:  Moniliformis  spp.; 
     from the order Echinorhynchida, for example  Acanthocephalus  spp.,  Echinorhynchus  spp.,  Leptorhynchoides  spp.; 
     Pentastoma: from the order Porocephalida, for example  Linguatula  spp. 
     In the veterinary field and in animal husbandry, the compounds of the formula (I) are administered by methods generally known in the art, such as via the enteral, parenteral, dermal or nasal route in the form of suitable preparations. Administration may be prophylactic or therapeutic. 
     Thus, one embodiment of the present invention refers to the use of a compound of the formula (I) as a medicament. 
     A further aspect refers to the use of a compound of the formula (I) as an antiendoparasitic agent, in particular a helminthicidal agent or antiprotozoic agent. Compounds of the formula (I) are suitable for use as an antiendoparasitic agent, especially as a helminthicidal agent or antiprotozoic agent, for example in animal breeding, in animal husbandry, in animal houses and in the hygiene sector. 
     A further aspect in turn relates to the use of a compound of the formula (I) as an antiectoparasitic agent, in particular an arthropodicide such as an insecticide or an acaricide. A further aspect relates to the use of a compound of the formula (I) as an antiectoparasitic agent, in particular an arthropodicide such as an insecticide or an acaricide, for example in animal husbandry, in animal breeding, in animal houses or in the hygiene sector. 
     Vector Control 
     The compounds of the formula (I) can also be used in vector control. In the context of the present invention, a vector is an arthropod, especially an insect or arachnid, capable of transmitting pathogens, for example viruses, worms, single-cell organisms and bacteria, from a reservoir (plant, animal, human, etc.) to a host. The pathogens can be transmitted either mechanically (for example trachoma by non-stinging flies) to a host or after injection (for example malaria parasites by mosquitoes) into a host. 
     Examples of vectors and the diseases or pathogens they transmit are: 
     1) mosquitoes 
     
         
         
           
               Anopheles : malaria, filariasis; 
               Culex : Japanese encephalitis, filariasis, other viral diseases, transmission of worms; 
               Aedes : yellow fever, dengue fever, filariasis, other viral diseases; 
             Simuliidae: transmission of worms, in particular  Onchocerca volvulus;  
 
2) Lice: skin infections, epidemic typhus;
 
3) Fleas: plague, endemic typhus;
 
4) Flies: sleeping sickness (trypanosomiasis); cholera, other bacterial diseases;
 
5) Mites: acariosis, epidemic typhus, rickettsialpox, tularaemia, Saint Louis encephalitis, tick-borne encephalitis (TBE), Crimean-Congo haemorrhagic fever, borreliosis;
 
6) Ticks: borellioses such as  Borrelia  duttoni, tick-borne encephalitis, Q fever ( Coxiella burnetii ), babesioses ( Babesia canis canis ).
 
           
         
       
    
     Examples of vectors in the context of the present invention are insects, such as aphids, flies, leafhoppers or  thrips , which can transmit plant viruses to plants. Other vectors capable of transmitting plant viruses are spider mites, lice, beetles and nematodes. 
     Further examples of vectors in the context of the present invention are insects and arachnids such as mosquitoes, especially of the genera  Aedes, Anopheles , for example  A. gambiae, A. arabiensis, A. funestus , A. dims (malaria) and  Culex , lice, fleas, flies, mites and ticks, which can transmit pathogens to animals and/or humans. 
     Vector control is also possible if the compounds of the formula (I) are resistance-breaking. 
     Compounds of the formula (I) are suitable for use in the prevention of diseases and/or pathogens transmitted by vectors. Thus, a further aspect of the present invention is the use of compounds of the formula (I) for vector control, for example in agriculture, in horticulture, in forests, in gardens and in leisure facilities, and also in the protection of materials and stored products. 
     Protection of Industrial Materials 
     The compounds of the formula (I) are suitable for protecting industrial materials against attack or destruction by insects, for example from the orders Coleoptera, Hymenoptera, Isoptera, Lepidoptera, Psocoptera and Zygentoma. 
     Industrial materials in the present context are understood to mean inanimate materials, such as preferably plastics, adhesives, sizes, papers and cards, leather, wood, processed wood products and coating compositions. The use of the invention for protection of wood is particularly preferred. 
     In a further embodiment, the compounds of the formula (I) are used together with at least one further insecticide and/or at least one fungicide. 
     In a further embodiment, the compounds of the formula (I) are present as a ready-to-use pesticide, i.e. it can be applied to the material in question without further modifications. Suitable further insecticides or fungicides are in particular those mentioned above. 
     Surprisingly, it has also been found that the compounds of the formula (I) can be employed for protecting objects which come into contact with saltwater or brackish water, in particular hulls, screens, nets, buildings, moorings and signalling systems, against fouling. It is equally possible to use the compounds of the formula (I), alone or in combinations with other active compounds, as antifouling agents. 
     Control of Animal Pests in the Hygiene Sector 
     The compounds of the formula (I) are suitable for controlling animal pests in the hygiene sector. More particularly, the invention can be used in the domestic protection sector, in the hygiene protection sector and in the protection of stored products, particularly for control of insects, arachnids and mites encountered in enclosed spaces, for example dwellings, factory halls, offices, vehicle cabins. For controlling animal pests, the compounds of the formula (I) are used alone or in combination with other active compounds and/or auxiliaries. They are preferably used in domestic insecticide products. The compounds of the formula (I) are effective against sensitive and resistant species, and against all developmental stages. 
     These pests include, for example, pests from the class Arachnida, from the orders Scorpiones, Araneae and Opiliones, from the classes Chilopoda and Diplopoda, from the class Insecta the order Blattodea, from the orders Coleoptera, Dermaptera, Diptera, Heteroptera, Hymenoptera, Isoptera, Lepidoptera, Phthiraptera, Psocoptera, Saltatoria or Orthoptera, Siphonaptera and Zygentoma and from the class Malacostraca the order Isopoda. 
     Application is carried out, for example, in aerosols, unpressurized spray products, for example pump and atomizer sprays, automatic fogging systems, foggers, foams, gels, evaporator products with evaporator tablets made of cellulose or plastic, liquid evaporators, gel and membrane evaporators, propeller-driven evaporators, energy-free, or passive, evaporation systems, moth papers, moth bags and moth gels, as granules or dusts, in baits for spreading or bait stations. 
     Description of the Processes and Intermediates 
     The preparation and use examples which follow illustrate the invention without limiting it. The products were characterized by  1 H NMR spectroscopy and/or LC-MS (Liquid Chromatography Mass Spectrometry). 
     The log P values were determined in accordance with OECD Guideline 117 (EC Directive 92/69/EEC) by HPLC (high-performance liquid chromatography) using reversed-phase (RP) columns (C18), by the following methods: 
     [a] The LC-MS determination in the acidic range is carried out at pH 2.7 with 0.1% aqueous formic acid and acetonitrile (contains 0.1% formic acid) as eluents; linear gradient from 10% acetonitrile to 95% acetonitrile. 
     [b] LC-MS determination in the neutral range is effected at pH 7.8 with 0.001 molar aqueous ammonium hydrogencarbonate solution and acetonitrile as eluents; linear gradient from 10% acetonitrile to 95% acetonitrile. 
     Calibration is carried out using unbranched alkan-2-ones (having 3 to 16 carbon atoms) with known log P values (log P values determined on the basis of the retention times by linear interpolation between two successive alkanones). 
     The NMR spectra were determined using a Bruker Avance 400 fitted with a flow probe head (60 μl volume). In individual cases, the NMR spectra were measured with a Bruker Avance II 600. 
     General Synthesis of 5-substituted 2-(hetaryl)-2H-pyrazolo[3,4-c]pyridines of the Formula (I) 
     Examples 1 or 38 
                         
Step 1:
 
     Synthesis of Compounds of the Formula (A-3) (R 2 ═CO—OCH 3 ) 
     
       
         
         
             
             
         
       
     
     1 equivalent of a heterocyclic amino compound (A-2), 0.12 equivalent (3.4 mmol) of para-toluenesulfonic acid (PTSA) and 6 g of 4 A molecular sieve were added to a solution of 28.3 ml of 2-substituted 5-nitro-4-pyridinecarboxaldehyde of the formula (A-1) in 200 ml of toluene. The reaction mixture was then stirred at 110° C. for 16 hours. The reaction mixture was filtered and the filtrate gave, after concentration, the crude products (A-3), which were reacted further without further purification. 
     Step 2 
     Synthesis of 5-substituted 2-(hetaryl)-2H-pyrazolo[3,4-c]pyridines of the Formula (I) 
     1 equivalent of the compounds of the formula (A-3) was dissolved in 30 ml of triethyl phosphite, and the reaction mixture was then stirred at 140° C. for about 16 hours. After concentration of the reaction mixture under reduced pressure, the residue that remained was purified by column chromatography. 
     General Synthesis of 5-substituted 2-(hetaryl)-2H-pyrazolo[3,4-c]pyridine-5-carboxylic Acids of the Formula (I, R 2 ═COOH) 
     
       
         
         
             
             
         
       
     
     1 equivalent of a compound of the formula (I; R 2 ═COOCH 3 ) was dissolved in a mixture of 100 ml of water and 100 ml of tetrahydrofuran, and 3 equivalents of lithium hydroxide monohydrate were added. The reaction mixture was then stirred at 25° C. for about 16 hours. Subsequently, the tetrahydrofuran was removed under reduced pressure and the aqueous phase was adjusted to pH=2 with 1M hydrochloric acid. After extraction with 100 ml of ethyl acetate, the organic phase was dried over sodium sulfate, filtered and concentrated under reduced pressure. The crude product that remained was used in the next reaction step without further purification. 
     a) 2-(1H-7-Azabenzotriazol-1-yl)-1,1,3,3-tetramethyluroniummethanaminium hexafluorophosphate (HATU) Coupling Method 
     1.0 equivalent of 5-substituted 2-(hetaryl)-2H-pyrazolo[3,4-c]pyridine-5-carboxylic acid was dissolved in 3 ml of N,N-dimethylformaldehyde, and 2.4 equivalents (1.2 mmol) of HATU and 6.0 equivalents of N,N-diisopropylethylamine were added. The reaction mixture was then stirred at room temperature for 10 minutes, and 1.2 equivalents of the sulfonamide component were then added. After about 16 hours of stirring at room temperature, the reaction mixture was concentrated under reduced pressure and the residue that remained was purified by preparative chromatography (HPLC). 
     b) 2-(1H-7-Azabenzotriazol-1-yl)-1,1,3,3-tetramethyluroniummethanaminium hexafluorophosphate (HATU) Coupling Method 
     1.0 equivalent of 5-substituted 2-(hetaryl)-2H-pyrazolo[3,4-c]pyridine-5-carboxylic acid was dissolved in 3 ml of N,N-dimethylformaldehyde, and 2.4 equivalents (1.2 mmol) of HATU and 2.4 equivalents of N,N-diisopropylethylamine were added. The reaction mixture was then stirred at room temperature for 10 minutes, and 1.2 equivalents of the amine component were then added. After about 16 hours of stirring at room temperature, the reaction mixture was concentrated under reduced pressure and the residue that remained was purified by preparative chromatography (HPLC). 
     Synthesis of Intermediates 
     Methyl 4-[(1E)-2-(dimethylamino)ethenyl]-5-nitro-2-pyridinecarboxylate 
     
       
         
         
             
             
         
       
     
     86.4 g (0.73 mmol) of N,N-dimethylformamide O,O-dimethyl acetal were added to a solution of 65 g (0.33 mol) of methyl 5-methyl-6-nitro-3-pyridinecarboxylate (Y. Morisawa et al.,  J. Med. Chem.  21, 194-199, 1978) in 415 ml of N,N-dimethylformamide. The reaction mixture was then stirred at 90° C. for 6 hours. The solvent was then removed under reduced pressure and the residue that remained was purified by column chromatography. This gave 56 g (yield 66.7% of theory) of methyl 4-[(1E)-2-(dimethylamino)ethenyl]-5-nitro-2-pyridinecarboxylate. 
     Methyl 4-formyl-5-nitro-2-pyridinecarboxylate 
     
       
         
         
             
             
         
       
     
     142 g (41.98 mmol) of sodium periodate were added to a solution of 56 g (0.22 mol) of methyl 4-[(1E)-2-dimethylamino)ethenyl]-5-nitro-2-pyridinecarboxylate in 550 ml of water and 550 ml of tetrahydrofuran. The reaction mixture was then stirred at 25° C. for 16 hours. The reaction mixture was then diluted with 700 ml of ethyl acetate and then washed with saturated aqueous sodium bicarbonate solution and brine. The combined organic phases were dried over sodium sulfate, filtered and concentrated under reduced pressure. The residue that remained was purified by column chromatography. This gave 45 g (yield 97.3% of theory) of methyl 4-formyl-5-nitro-2-pyridinecarboxylate as a brown solid. 
     
       
         
           
               
             
               
                 TABLE 1 
               
             
            
               
                   
               
               
                 Compounds of the formula 
               
               
                 
                   
                     
                     
                         
                         
                     
                   
                 
               
               
                   
               
            
           
           
               
               
               
               
               
            
               
                 Compound  
                   
                   
                 Yield 
                 Purity 
               
               
                 No. 
                 A 
                 R 2   
                 [in mg] 
                 [in %] 
               
               
                   
               
            
           
           
               
               
               
               
               
            
               
                  1 *) 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 9.07 
                 95.1 
               
               
                   
               
               
                  2 *)  
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 5.10 
                 100 
               
               
                   
               
               
                  3 *) 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 8.57 
                 89.0 
               
               
                   
               
               
                  4 *) 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 13.24 
                 99.3 
               
               
                   
               
               
                  5 *) 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 8.79 
                 93.8 
               
               
                   
               
               
                  6 *) 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 12.50 
                 100 
               
               
                   
               
               
                  7 *) 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 17.53 
                 99.5 
               
               
                   
               
               
                  8 *) 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 20.95 
                 96.5 
               
               
                   
               
               
                  9 *) 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 26.45 
                 93.7 
               
               
                   
               
               
                 10 *) 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 24.42 
                 95.4 
               
               
                   
               
               
                 11  
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 42.50 
                 92.2 
               
               
                   
               
               
                 12 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 29.41 
                 99.4 
               
               
                   
               
               
                 13 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 29.98 
                 100 
               
               
                   
               
               
                 14  
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 33.50 
                 94.9 
               
               
                   
               
               
                 15 *) 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 24.77 
                 98.8 
               
               
                   
               
               
                 16 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 24.33 
                 98.1 
               
               
                   
               
               
                 17  
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 31.38 
                 98.7 
               
               
                   
               
               
                 18 *) 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 24.47 
                 87.3 
               
               
                   
               
               
                 19  
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 36.67 
                 100 
               
               
                   
               
               
                 20  
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 37.27 
                 99.5 
               
               
                   
               
               
                 21 *) 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 22.16 
                 98.5 
               
               
                   
               
               
                 22 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 42.52 
                 99.1 
               
               
                   
               
               
                 23 *) 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 85.10 
                 100 
               
               
                   
               
               
                 24 *) 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 72.03 
                 100 
               
               
                   
               
               
                 25 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 93.41 
                 90.8 
               
               
                   
               
               
                 26  
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 39.12 
                 99.1 
               
               
                   
               
               
                 27 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 46.42 
                 97.1 
               
               
                   
               
               
                 28 *) 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 42.0 
                 99.3 
               
               
                   
               
               
                 29 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 53.29 
                 97.7 
               
               
                   
               
               
                 30 *) 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 40.7 
                 99.4 
               
               
                   
               
               
                 31 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 43.30 
                 99.1 
               
               
                   
               
               
                 32 *) 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 107.27 
                 95.0 
               
               
                   
               
               
                 33 *) 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 55.0 
                 95.7 
               
               
                   
               
               
                 34 *) 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 46.38 
                 100 
               
               
                   
               
               
                 35 *) 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 26.48 
                 99.6 
               
               
                   
               
               
                 36 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 33.96 
                 99.2 
               
               
                   
               
               
                 37 *) 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 21.32 
                 98.2 
               
               
                   
               
               
                 38 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 21.1 
                 91.8 
               
               
                   
               
               
                 *) crystallizes with 1 × HCOOH 
               
            
           
         
       
     
     
       
         
           
               
             
               
                 TABLE 2 
               
             
            
               
                   
               
               
                 Analytical data for the compounds 1-38 
               
            
           
           
               
               
               
            
               
                   
                 Reten- 
                   
               
               
                   
                 tion 
                   
               
               
                 Ex. 
                 time 
                   
               
               
                 No. 
                 [min] 
                   1 H NMR [δ (ppm)] or LC-MS [m/z] 
               
               
                   
               
            
           
           
               
               
               
            
               
                 1 
                 2.922 
                   1 H-NMR(400.0 MHz, d 6 -DMSO): δ = 1.65 (t, 3H, CH 3 ); 
               
               
                   
                   
                 3.85 (m, 2H, CH 2 ); 8.57; 8.78; 8.90; 8.96; 9.44; 9.58 
               
               
                   
                   
                 (6H, ═CH, aryl/hetaryl). 
               
               
                   
                   
                 LC-MS = 319.1 (M + 1) [without HCOOH] 
               
               
                 2 
                 2.553 
                   1 H-NMR(400.0 MHz, d 6 -DMSO): δ = 1.24 (d, 6H, 
               
               
                   
                   
                 2 × CH 3 ); 4.17 (m, 1H, CH); 8.43; 8.51; 8.77; 8.88; 9.39; 
               
               
                   
                   
                 9.56 (6H, ═CH, aryl/hetaryl). 
               
               
                   
                   
                 LC-MS = 283.2 (M + 1); [without HCOOH] 
               
               
                 3 
                 2.843 
                   1 H-NMR(400.0 MHz, d 6 -DMSO): δ = 3.78; 6.20 (2m, 
               
               
                   
                   
                 3H, CH 2 CHF 2 ); 8.51; 8.61; 8.80; 9.31; 9.40; 9.57 (6H, 
               
               
                   
                   
                 ═CH, aryl/hetaryl); 9.05 (br., 1H, NH). 
               
               
                   
                   
                 LC-MS = 322.1 (M + 1); [without HCOOH] 
               
               
                 4 
                 2.141 
                   1 H-NMR(400.0 MHz, d 6 -DMSO): δ = 1.15-1.26 (t + m, 
               
               
                   
                   
                 5H, CH 2 CH 3 ); 8.43; 9.37; 9.57; 9.60 (4H, ═CH, 
               
               
                   
                   
                 aryl/hetaryl); 8.80 (br., 1H, NH). 
               
               
                   
                   
                 LC-MS = 269.1 (M + 1) [without HCOOH] 
               
               
                 5 
                 2.474 
                   1 H-NMR(400.0 MHz, d 6 -DMSO): δ = 3.76; 6.20 (2m, 
               
               
                   
                   
                 3H, CH 2 CHF 2 ); 8.48; 8.56; 8.77; 8.89; 9.42; 9.57 (6H, 
               
               
                   
                   
                 ═CH, aryl/hetaryl); 9.05 (br., 1H, NH). 
               
               
                   
                   
                 LC-MS = 305.1 (M + 1) [without HCOOH] 
               
               
                 6 
                 2.339 
                   1 H-NMR(400.0 MHz, CDCl 3 ): δ = 1.66 (t, 3H, CH 3 ); 
               
               
                   
                   
                 3.84 (m, 2H, CH 2 ); 8.55; 9.37; 9.43; 9.60 (4H, ═CH, 
               
               
                   
                   
                 aryl/hetaryl); 8.96 (br., 1H, NH). 
               
               
                   
                   
                 LC-MS = 319.0 (M + 1) [without HCOOH] 
               
               
                 7 
                 1.889 
                   1 H-NMR(400.0 MHz, d 6 -DMSO): δ = 3.01; 3.04 (2s, 
               
               
                   
                   
                 6H, 2 × CH 3 ); 7.72; 8.01; 8.57; 8.75; 9.34; 9.38; 9.41  
               
               
                   
                   
                 (7H, ═CH, aryl/hetaryl). 
               
               
                   
                   
                 LC-MS = 268.0 (M + 1) [without HCOOH] 
               
               
                 8 
                 2.237 
                   1 H-NMR(400.0 MHz, d 6 -DMSO): δ = 3.42 (s, 3H, CH 3 ; 
               
               
                   
                   
                 8.65; 8.82; 9.33; 9.43; 9.64 (5H, ═CH, aryl/hetaryl). 
               
               
                   
                   
                 LC-MS = 335.9 (M + 1) [without HCOOH] 
               
               
                 9 
                 3.125 
                   1 H-NMR(400.0 MHz, d 6 -DMSO): δ = 1.16 (t, 3H, CH 3 ); 
               
               
                   
                   
                 3.37 (m, 2H, CH 2 ); 3.95 (s, 3H, CH 3 ); 3.57 (2s 6H, 
               
               
                   
                   
                 2 × CH 3 ); 8.17; 8.41; 8.54; 9.11; 9.23 (5H, ═CH, aryl/ 
               
               
                   
                   
                 hetaryl). 
               
               
                   
                   
                 LC-MS = 271.1 (M + 1) [without HCOOH] 
               
               
                 10 
                 2.575 
                   1 H-NMR(400.0 MHz, d 6 -DMSO): δ = 2.93 (s, 6H, 
               
               
                   
                   
                 2 × CH 3 ); 8.62; 8.65; 8.82; 9.32; 9.42; 9.64 (6H, ═CH, 
               
               
                   
                   
                 aryl/hetaryl). 
               
               
                   
                   
                 LC-MS = 365.1 (M + 1) [without HCOOH] 
               
               
                 11 
                 2.138 
                   1 H-NMR(400.0 MHz, d 6 -DMSO): δ = 3.32; 3.72 (2s 6H, 
               
               
                   
                   
                 2 × CH 3 ); 7.73; 8.10; 8.57; 9.46 (4H, ═CH, aryl/hetaryl). 
               
               
                   
                   
                 LC-MS = 284.1 (M + 1); 283.28 (calculated) 
               
               
                 12 
                 2.409 
                   1 H-NMR(400.0 MHz, d 6 -DMSO): δ = 1.16 (t 3H, CH 3 ); 
               
               
                   
                   
                 3.37 (m, 2H, CH 2 ); 8.45; 8.61; 8.80; 9.31; 9.36; 9.55 
               
               
                   
                   
                 (6H, ═CH, aryl/hetaryl). 
               
               
                   
                   
                 LC-MS = 286.0 (M + 1) 285.27 (calculated) 
               
               
                 13 
                 2.592 
                   1 H-NMR(400.0 MHz, d 6 -DMSO): δ = 0.71 (m 4H, 
               
               
                   
                   
                 CH 2 CH 2 ); 8.51; 8.77; 8.88; 9.37; 9.55; 9.58 (6H, ═CH, 
               
               
                   
                   
                 aryl/hetaryl). 
               
               
                   
                   
                 LC-MS = 281.0 (M + 1) 280.28 (calculated) 
               
               
                 14 
                 1.963 
                   1 H-NMR(400.0 MHz, d 6 -DMSO): δ = 2.86 (d, 3H, 
               
               
                   
                   
                 CH 3 ); 8.50; 8.77; 8.88; 9.39; 9.56 (5H, ═CH, aryl/ 
               
               
                   
                   
                 hetaryl). 
               
               
                   
                   
                 LC-MS = 255.0 (M + 1) 254.24 (calculated) 
               
               
                 15 
                 2.044 
                   1 H-NMR(400.0 MHz, d 6 -DMSO): δ = 3.03 (d, 6H, 
               
               
                   
                   
                 2 × CH 3 ); 8.02; 8.77; 8.88; 9.37; 9.48; 9.56 (6H, ═CH, 
               
               
                   
                   
                 aryl/hetaryl). 
               
               
                   
                   
                 LC-MS = 269.1 (M + 1) [without HCOOH] 
               
               
                 16 
                 1.960 
                   1 H-NMR(400.0 MHz, d 6 -DMSO): δ = 1.18 (t, 3H, CH 3 ); 
               
               
                   
                   
                 3.37 (m, 2H, CH 2 ); 8.50; 8.77; 8.88; 9.39; 9.56; (5H, 
               
               
                   
                   
                 ═CH, aryl/hetaryl). 
               
               
                   
                   
                 LC-MS = 269.0 (M + 1) 268.27 (calculated) 
               
               
                 17 
                 2.602 
                   1 H-NMR(400.0 MHz, d 6 -DMSO): δ = 1.20 (d, 6H, 
               
               
                   
                   
                 2 × CH 3 ); 4.16 (m, 1H, CH); 8.60; 8.63; 8.80; 9.31;  
               
               
                   
                   
                 9.37; 9.56 (7H, ═CH, aryl/hetaryl). 
               
               
                   
                   
                 LC-MS = 300.0 (M + 1); 299.30 (calculated) 
               
               
                 18 
                 2.567 
                   1 H-NMR(400.0 MHz, d 6 -DMSO): δ = 3.95; 2.92 (2s, 
               
               
                   
                   
                 6H, 2 × CH 3 ); 8.20; 8.55; 8.58; 9.22; 9.28 (5H, ═CH,  
               
               
                   
                   
                 aryl/hetaryl). 
               
               
                   
                   
                 LC-MS = 350.1 (M + 1) [without HCOOH] 
               
               
                 19 
                 2.521 
                   1 H-NMR(400.0 MHz, d 6 -DMSO): δ = 2.87 (d, 3H, 
               
               
                   
                   
                 CH 3 ); 8.45; 8.61; 8.80; 9.31; 9.36; 9.55 (6H, ═CH,  
               
               
                   
                   
                 aryl/hetaryl). 
               
               
                   
                   
                 LC-MS = 271.9 (M + ); 271.24 (calculated) 
               
               
                 20 
                 2.420 
                   1 H-NMR(400.0 MHz, d 6 -DMSO): δ = 2.02 (d, 6H, 
               
               
                   
                   
                 2 × CH 3 ); 8.01; 8.61; 8.79; 9.31; 9.34; 9.48 (6H, ═CH, 
               
               
                   
                   
                 aryl/hetaryl). 
               
               
                   
                   
                 LC-MS = 285.9 (M + ); 285.2763 (calculated) 
               
               
                 21 
                 2.099 
                   1 H-NMR(400.0 MHz, d 6 -DMSO): δ = 3.32; 3.72 (2s, 
               
               
                   
                   
                 6H, 2 × CH 3 ); 8.10; 8.77; 8.88; 9.39; 9.50, 9.56 (6H, 
               
               
                   
                   
                 ═CH, aryl/hetaryl). 
               
               
                   
                   
                 LC-MS = 285.1 (M + 1) [without HCOOH] 
               
               
                 22 
                 1.834 
                   1 H-NMR(400.0 MHz, d 6 -DMSO): δ = 3.31; 3.71 (2s, 
               
               
                   
                   
                 6H, 2 × CH 3 ); 8.11; 9.36; 9.51; 9.60 (4H, ═CH, aryl/ 
               
               
                   
                   
                 hetaryl). 
               
               
                   
                   
                 LC-MS = 285.1 (M + 1); 284.27 (calculated) 
               
               
                 23 
                 2.104 
                   1 H-NMR(400.0 MHz, d 6 -DMSO): δ = 2.99; 3.02 (2s, 
               
               
                   
                   
                 6H, 2 × CH 3 ); 7.94; 8.16; 8.54; 9.02; 9.29 (5H, ═CH,  
               
               
                   
                   
                 aryl/hetaryl). 
               
               
                   
                   
                 LC-MS = 285.1 (M + 1) [without HCOOH] 
               
               
                 24 
                 2.251 
                   1 H-NMR(400.0 MHz, d 6 -DMSO): δ = 3.40; 3.95 (2s, 
               
               
                   
                   
                 6H, 2 × CH 3 ); 8.20; 8.59; 9.22; 9.29 (4H, ═CH, aryl/ 
               
               
                   
                   
                 hetaryl). 
               
               
                   
                   
                 LC-MS = 321.1 (M + 1) [without HCOOH] 
               
               
                 25 
                 2.376 
                   1 H-NMR(400.0 MHz, d 6 -DMSO): δ = 1.64 (t, 3H, CH 3 ); 
               
               
                   
                   
                 3.81 (m, 2H, CH2); 3.94 (s, 3H, CH3); 8.18; 8.46; 8.56; 
               
               
                   
                   
                 9.14; 9.26 (5H, ═CH, aryl/hetaryl); 8.92 (br., 1H, NH). 
               
               
                   
                   
                 LC-MS = 321.0 (M + 1); 320.29 (calculated) 
               
               
                 26 
                 2.112 
                   1 H-NMR(400.0 MHz, d 6 -DMSO): δ = 3.71; (s, 3H, 
               
               
                   
                   
                 CH 3 ); 8.08; 8.61; 8.79; 9.31; 9.35; 9.49 (6H, ═CH,  
               
               
                   
                   
                 aryl/hetaryl). 
               
               
                   
                   
                 LC-MS = 302.0 (M + 1); 301.27 (calculated) 
               
               
                 27 
                 2.647 
                   1 H-NMR(400.0 MHz, d 6 -DMSO): δ = 1.65 (t, 3H, CH 3 ); 
               
               
                   
                   
                 3.83 (m, 2H, CH 2 ); 8.51; 8.60; 8.80; 9.31; 9.40; 9.58 
               
               
                   
                   
                 (6H, ═CH, aryl/hetaryl); 8.96 (br, 1H, NH). 
               
               
                   
                   
                 LC-MS = 336.0 (M + 1); 335.28 (calculated) 
               
               
                 28 
                 2.485 
                   1 H-NMR(400.0 MHz, d 6 -DMSO): δ = 1.64 (s, 3H, CH 3 ); 
               
               
                   
                   
                 3.83 (m, 2H, CH 2 ); 7.71; 8.51; 8.56; 8.74; 9.38; 9.53 
               
               
                   
                   
                 (6H, ═CH, aryl/hetaryl); 8.95 (br., 1H, NH). 
               
               
                   
                   
                 LC-MS = 318.1 (M + 1) [without HCOOH] 
               
               
                 29 
                 1.888 
                   1 H-NMR(400.0 MHz, d 6 -DMSO): δ = 0.71 (m, 4H, 
               
               
                   
                   
                 CH 2 CH 2 ); 2.94 (m, 1H, CH); 7.71; 8.44; 8.55; 8.68; 
               
               
                   
                   
                 8.74; 9.32; 9.37; 9.50 (7H, ═CH, aryl/hetaryl + NH). 
               
               
                   
                   
                 LC-MS = 280.0 (M + 1); 279.29 (calculated) 
               
               
                 30 
                 2.040 
                   1 H-NMR(400.0 MHz, d 6 -DMSO): δ = 2.86 (d, 3H, 
               
               
                   
                   
                 CH 3 ); 7.71; 8.44; 8.54; 8.75; 9.35; 9.37; 9.50 (7H, 
               
               
                   
                   
                 ═CH, aryl/hetaryl). 
               
               
                   
                   
                 LC-MS = 254.0 (M + 1) [without HCOOH] 
               
               
                 31 
                 2.629 
                   1 H-NMR(400.0 MHz, d 6 -DMSO): δ = 1.15 (t, 3H, CH 3 ); 
               
               
                   
                   
                 3.36 (m, 2H, CH2); 7.71; 8.45; 8.56; 8.76; 8.80; 9.37; 
               
               
                   
                   
                 9.51 (7H, ═CH, aryl/hetaryl). 
               
               
                   
                   
                 LC-MS = 268.0 (M + 1); 267.28 (calculated) 
               
               
                 32 
                 2.133 
                   1 H-NMR(400.0 MHz, d 6 -DMSO): δ = 3.30; 3.71; 3.94 
               
               
                   
                   
                 (3s, 9H, 3 × CH3); 8.03; 8.17; 8.55; 9.06; 9.22 (5H,  
               
               
                   
                   
                 ═CH, aryl/hetaryl). 
               
               
                   
                   
                 LC-MS = 287.1 (M + 1) [without HCOOH] 
               
               
                 33 
                 2.182 
                   1 H-NMR(400.0 MHz, d 6 -DMSO): δ = 1.24 (d, 6H, 
               
               
                   
                   
                 2 × CH 3 ); 4.16 (m, 1H, CH); 8.17; 8.40; 8.54; 9.12; 9.22 
               
               
                   
                   
                 (5H, ═CH, aryl/hetaryl). 
               
               
                 34 
                 2.167 
                   1 H-NMR(400.0 MHz, d 6 -DMSO): δ = 3.75 (br, 2H, 
               
               
                   
                   
                 CH 2 ); 6.17 (dt, 1H, CH); 8.17; 8.45; 8.55; 9.14; 9.25 
               
               
                   
                   
                 (5H, ═CH, aryl/hetaryl); 9.02 (br., 1H, NH). 
               
               
                   
                   
                 LC-MS = 307.1 (M + 1) [without HCOOH] 
               
               
                 35 
                 1.840 
                   1 H-NMR(400.0 MHz, d 6 -DMSO): δ = 2.84 (d, 3H, 
               
               
                   
                   
                 CH 3 ); 3.94 (s, 3H, CH 3 ); 8.16; 8.40; 8.54; 9.11; 9.22 
               
               
                   
                   
                 (5H, ═CH, aryl/hetaryl), 8.72 (1H, NH). 
               
               
                   
                   
                 LC-MS = 257.0 (M + 1) [without HCOOH] 
               
               
                 36 
                 3.085 
                   1 H-NMR(400.0 MHz, d 6 -DMSO): δ = 3.76 (m, 2H, 
               
               
                   
                   
                 CH 2 ); 6.18 (dt, 1H, CH); 7.71; 8.50; 8.56; 8.75; 9.05; 
               
               
                   
                   
                 9.38; 9.53 (7H, ═CH, aryl/hetaryl). 
               
               
                   
                   
                 LC-MS = 304.1 (M + 1); 303.26 (calculated) 
               
               
                 37 
                 2.469 
                   1 H-NMR(400.0 MHz, d 6 -DMSO): δ = 0.70 (m, 4H, 
               
               
                   
                   
                 CH 2 CH 3 ); 2.92 (m, 1H, CH); 8.16; 8.40; 8.54; 9.11;  
               
               
                   
                   
                 9.19 (5H, ═CH, aryl/hetaryl), 8.63 (1H, NH). 
               
               
                   
                   
                 LC-MS = 283.1 (M + 1) [without HCOOH] 
               
               
                 38 
                 2.792 
                   1 H-NMR(400.0 MHz, d 6 -DMSO): δ = 1.21; 1.23 (2s, 
               
               
                   
                   
                 6H, 2 × CH 3 ); 4.15 (m, 1H, CH); 7.71; 8.44; 8.55; 8.74; 
               
               
                   
                   
                 9.36; 9.38; 9.51 (7H, ═CH, aryl/hetaryl). 
               
               
                   
                   
                 LC-MS = 282.1 (M + 1); 281.31 (calculated) 
               
               
                   
               
            
           
         
       
     
     Biological Examples 
       Myzus persicae —Spray Test 
     
         
         Solvent: 78 parts by weight of acetone
       1.5 parts by weight of dimethylformamide   
     
         Emulsifier: alkylaryl polyglycol ether 
       
    
     To produce a suitable preparation of active compound, 1 part by weight of active compound is dissolved using the specified parts by weight of solvent and made up with water containing an emulsifier concentration of 1000 ppm until the desired concentration is attained. To produce further test concentrations, the formulation is diluted with emulsifier-containing water. 
     Discs of Chinese cabbage leaves ( Brassica pekinensis ) infested by all stages of the green peach aphid ( Myzus persicae ) are sprayed with an active compound formulation of the desired concentration. 
     After 6 days, the efficacy in % is determined. 100% means that all the aphids have been killed; 0% means that no aphids have been killed. 
     In this test, for example, the following compounds from the preparation examples showed an efficacy of 100% at an application rate of 500 g/ha: 1, 4, 6, 7, 8, 10. 
     In this test, for example, the following compounds from the preparation examples showed an efficacy of 90% at an application rate of 500 g/ha: 3, 5, 11, 14, 15, 19, 20, 26, 28, 29, 30, 31, 36. 
       Tetranychus urticae —Spray Test, OP-Resistant 
     
         
         Solvent: 78.0 parts by weight of acetone
       1.5 parts by weight of dimethylformamide   
     
         Emulsifier: alkylaryl polyglycol ether 
       
    
     To produce a suitable preparation of active compound, 1 part by weight of active compound is dissolved using the specified parts by weight of solvent and made up with water containing an emulsifier concentration of 1000 ppm until the desired concentration is attained. To produce further test concentrations, the formulation is diluted with emulsifier-containing water. 
     Discs of bean leaves ( Phaseolus vulgaris ) infested with all stages of the greenhouse red spider mite ( Tetranychus urticae ) are sprayed with an active compound formulation of the desired concentration. 
     After 6 days, the efficacy in % is determined. 100% means that all the spider mites have been killed; 0% means that no spider mites have been killed. 
     In this test, for example, the following compounds from the preparation examples showed an efficacy of 90% at an application rate of 500 g/ha: 3. 
       Musca domestica  Test 
     
         
         Solvent: dimethyl sulfoxide 
       
    
     To produce a suitable preparation of active compound, 10 mg of active compound are mixed with 0.5 ml of dimethyl sulfoxide, and the concentrate is diluted with water to the desired concentration. 
     Vessels containing a sponge treated with sugar solution and the active compound formulation of the desired concentration are populated with 10 adult houseflies ( Musca domestica ). 
     After 2 days, the kill in % is determined. 100% means that all of the flies have been killed; 0% means that none of the flies have been killed. 
     In this test, for example, the following compounds of the preparation examples showed an efficacy of 80% at an application rate of 100 ppm: 14, 15.